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Preface 
 
The paradigm of mycobacteria infection is the fact that, in most cases, the host response 
is capable of controlling infection effectively: only a minority of infected individuals 
develops the active disease. Nevertheless tuberculosis remains one of the major 
infectious disease killers in the world. 
Since the seminal studies of Armstrong and Hart, more than 30 years ago, is accepted in 
the field that pathogenic mycobacteria block phagosome maturation persisting in an 
immature phagosome.  Although is not yet clear how this inhibition is achieved there is 
growing evidence that lipids and proteins secreted by the pathogens into the 
phagosomal membrane play a role. Phagosomes are complex organelles capable of a 
range of intricate functions after isolation even when they enclose an inert particle as a 
latex bead. Among its functions we can point acidification, nucleation of actin, binding 
to F-actin, binding and bi-directional motility along microtubules and fusion with early 
and late endosomes. 
Taking advantage of the previous work done by Griffiths’ group on latex bead 
phagosomes with the proposal of the actin track model for actin assembly and the 
knowledge of Anes group in the mycobacteria field a profitable collaboration started in 
the beginning of the present century. In the early years was possible to establish a 
relation between mycobacteria killing, phagosome maturation and actin assembly by the 
phagosome membrane. It was also shown that lipids are important modulators of the 
system. The present work is a follow up of these interesting results in which we try to 
contribute to the elucidation of the molecular mechanisms involved in mycobacteria 
killing and /or survival. 
 
In the Introduction a general overview of the key aspects of mycobacteria/ macrophage 
interaction is given to the reader. The main goals of the work are also presented. 
The second chapter presents a systematic study of J774 macrophages interaction with 
the non-pathogenic mycobacteria: M. smegmatis. This is an interesting model to identify 
the macrophage killer factors since M. smegmatis is cleared intracellularly within 48 h.
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The third chapter is a follow up of the studies started with M. smegmatis now using 
different host macrophages and slow growing mycobacteria with different virulence 
profiles. The avirulent M. bovis BCG and the virulent M. bovis were used. 
After the identification of some of the mechanisms involved in mycobacteria killing we 
modulate the system using lipids with different inflammatory properties. Since MAP 
kinase p38 plays an important role in pro-inflammatory response to bacterial infection 
its modulation by lipids was followed up in detail. A preliminary study of a lipid diet in 
animal models of intracellular pathogens infection was also conducted. All the results 
are presented in chapter 4. 
In the final chapter the main conclusions are presented. 
 
Part of the results obtained so far was presented in scientific meetings, published or 
submitted to publication. 
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Resumo 
 
A infecção pelo Mycobacterium tuberculosis e por outra micobactérias pertencentes ao 
complexo Mycobacterium tuberculosis (MTC) é eficazmente controlada pelo sistema 
imunitário do hospedeiro em 90% dos casos. Contudo, embora os mediadores do 
sistema imunitário envolvidos neste processo estejam devidamente identificados e se 
saiba que o γ-IFN desempenha um papel central é dificíl prever o desfecho de uma 
infecção por micobactérias. Por esta razão é premente estudar a interacção 
micobactéria-hospedeiro ao nível molecular de forma a identificar potenciais alvos 
terapêuticos para o controlo da tuberculose. 
As micobactérias são microrganismos intracelulares facultativos que sobrevivem nos 
macrófagos alveolares ao nível dos fagossomas. Os macrófagos são células fagocíticas 
profissionais com capacidade para eliminar invasores através da resposta imune inata. 
Esta inclui mecanismos como a produção de espécies radicalares de oxigénio e azoto, a 
maturação do fagossoma em fagolisossoma, produção de quimiocinas e a apresentação 
de antigénios micobacterianos ao sistema imunitário que resulta no desenvolvimento de 
uma imunidade adaptativa. As micobactérias patogénicas não só forçam a sua entrada 
nos macrófagos como são capazes de persistir intracelularmente resistindo aos vários 
mecanismos bactericidas dos macrófagos. A inibição da maturação do fagossoma em 
fagolisossoma pelas micobactérias patogénicas é apontada, à mais de três décadas, 
como a principal razão para o sucesso destes patogenes. 
Uma vez que a capacidade de subverter os mecanismos bactericidas dos macrófagos é 
característica das micobactérias patogénicas iniciamos este estudo com um parente 
distante do M. tuberculosis, o M. smegmatis. Nesta parte do trabalho pretendemos 
identificar os mecanismos bactericidas do macrófago activados por uma micobactéria 
não patogénica no decorrer da infecção que resultam na eliminação da mesma. 
Utilizando macrófagos de ratinho (J774 e BMM) verificamos que o M. smegmatis 
apresenta um perfil de sobrevivência intermédio entre o de uma micobactérias de 
crescimento lento como o M. tuberculosis e o apresentado por bactérias de crescimento 
rápido como a E. coli ou o Streptococcus. Estas últimas são eliminadas pelos 
macrófagos em 4 h, enquanto que o M. smegmatis sobrevive intracelularmente até 48 h 
apresentando mesmo ciclos de multiplicação intracelular. 
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Para verificar se este perfil de sobrevivência se deve apenas à micobactéria ou se o 
hospedeiro também desempenha um papel importante no desfecho da infecção usámos 
macrófagos de vários hospedeiros . Em macrófagos de ratinho Raw e em macrófagos 
isolados do sangue periférico de voluntários saudáveis (HMDM) verificamos que o M. 
smegmatis era eliminado de uma forma contínua ao longo de 48 h. 
Assim, tomando partido da capacidade de replicação de M. smegmatis em J774 e das 
vantagens técnicas proporcionadas por uma linha celular de rato iniciámos uma 
abordagem sitemática dos mecanismos envolvidos na eliminação desta micobactéria 
não patogénica de crescimento rápido pelos macrófagos ao longo de 24 h.  
O sistema estudado revelou-se extremamente dinâmico envolvendo um período inicial 
de morte (1-4 h), seguido de um período de replicação (4-8 h) e dois períodos de morte 
(8-12 h e 12-24 h). A síntese de óxido nítrico (NO) constitui o primeiro mecanismo de 
defesa dos macrófagos mas a sua acção está circunscrita à primeira fase de morte. A 
organização de uma rede de actina e a fusão com organelos endocíticos tardios 
coincidem com a primeira e última fase de morte. A reciclagem de marcadores de fase 
fluida e membranar do fagossoma coincidem com a fase de replicação micobacteriana 
(4-8 h). A acidificação e a aquisição de sub-unidades da bomba protónica (V-ATPase) 
pelo fagossoma apresentam um perfil diferente e coincidente com as fases tardias de 
morte. Além do mais, a colocalização da V-ATPase não é coincidente com a dos 
marcadores característicos de endossomas tardios e lisosomas. A MAP cinase p38 é 
crucial para a regulação de todos os processos investigados, excepto a produção de NO, 
funcionando alternadamente a favor do hospedeiro ou do patogene. Um modelo 
matemático suporta a hipótese de que períodos alternados de actividade bactericida da 
célula são mais eficazes para a elimição total de parasitas intracelulares do que uma 
actividade contínua. 
 
Umas vez definidos os perfis de sobrevivência/ morte intracelular de uma micobactéria 
não patogénica de crescimento rápido resolvemos estender a mesma abordagem a 
micobactérias de crescimento lento avirulentas (Mycobacterium bovis BCG) ou 
virulentas (M. bovis). Neste estudo foram utilizados macrófagos de ratinho (J774, Raw e 
BMM) e de dois hospedeiros naturais de M. bovis. Os macrófagos humanos utilizados 
foram isolados a partir do sangue periférico ou da linha celular THP-1. Os macrófagos 
de bovino foram isolados a partir do sangue periférico de animais saudáveis (BMDM). 
O estudo dos perfis de sobrevivência demonstrou que o BCG é eliminado de uma forma 
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contínua em todos os macrófagos excepto nos HMDM onde após um ciclo de replicação 
atinge um estádio estacionário ao fim de 3 dias de infecção. Os perfis de sobrevivência 
observados para o M. bovis são distintos dos do BCG. A micobactéria virulenta 
permanece num estado de latência ou consegue replicar-se activamente em todos os 
macrófagos estudados. Em nenhum dos casos se observou a eliminação desta 
micobactéria pelos macrófagos. 
Os macrófagos de ratinho J774 e os HMDM foram escolhidos para a realização de 
estudos mais detalhados. A nossa escolha recaiu nestas células porque apresentam  
perfis de sobrevivência distintos para as duas micobactérias utilizadas. O facto de serem 
de hospedeiros distintos (rato e Homem) permitiu avaliar a importância do hospedeiro 
no desfecho da infecção.  
A produção de NO pelos macrófagos de ratinho desempenha um papel importante no 
controlo das infecções por estas micobactérias. À semelhança do anteriormente 
observado com M. smegmatis, a acção do NO e dos radicais reactivos de azoto (RNI) 
está limitada aos estádios precoces da infecção (3h-3dias) embora seja possível detectar 
a produção de NO até ao sétimo dia de infecção. Em nenhum momento da infecção foi 
possível detectar uma associação entre a membrana do fagossoma micobacteriano e a 
sintetase inductível do óxido nítrico (iNOS). 
Nas células humanas não foi possível detectar a produção de NO ao longo da infecção o 
que pode, pelo menos parcialmente, explicar a diferença observada nos perfis de 
sobrevivência. 
As micobactérias patogénicas são conhecidas por bloquearem a fusão do fagossoma 
com o lisossoma evitando desta forma a exposição a alguns dos agentes bactericidas 
mais potentes do macrófago. Por esta razão, a acidificação do fagossoma contendo 
M.bovis spp e a sua fusão com vesículas endocíticas tardias e/ou lisossomas foi seguida 
ao longo de 7 dias. Os resultados obtidos demonstram que as duas micobactérias são 
capazes de interferir com a maturação do fagossoma. O fagossoma micobacteriano não 
adquire marcadores de maturação de fase tardia como a V-ATPase ou o ácido liso-bis-
fosfatídico (LBPA), não acidifica o suficiente para acumular o corante acidotrópico 
lysotracker ou fundir com endossomas tardios e/ou lisossomas. Contudo, o mais 
surpreendente nestes resultados é o facto de duas micobactérias com perfis de 
sobrevivência distintos apresentarem perfis de aquisição de marcadores de maturação 
semelhantes. Embora, não nos seja possível apresentar evidências experimentais 
directas uma diferente sensibilidade das duas estirpes de micobactérias à acção de 
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efectores como os RNI e o hidrogenião podem explicar estes resultados. In vitro a 
estirpe virulenta de M. bovis revelou ser mais resistente à acção do pH ácido e do NO do 
que o BCG. A realização de estudos em culturas de macrófagos com inibidores da 
bomba protónica e da  iNOS confirmaram os resultados obtidos in vitro. 
 
A última parte do trabalho consistiu na modulação da resposta inflamatória dos 
macrófagos e no estudo do seu impacto nas infeções por micobactérias. A modulação do 
sistema foi efectuada através da adição de lípidos. A nossa escolha recaiu sobre estas 
substâncias porque (i) existem estudos epidemiológicos que suportam a associação entre 
uma dieta rica em lípidos omega-3 e uma elevada incidência de tuberculose, (ii) estudos 
anteriores em culturas celulares infectadas com o bacilo da tuberculose demonstraram 
que o tratamento com estes lípidos provocam efeitos semelhantes, (iii) os lípidos são 
importantes para a regulação da nucleação da actina e consequentemente para a 
maturação do fagossoma em fagolisossoma. 
O tratamento das culturas de macrófagos com ácido eicosopentaenoico (EPA), ácido 
araquidónico (AA) e ceramida (Cer) produziram efeitos distintos. O lípido omega-3 
(EPA) estimula a sobrevivência do bacilo da tuberculose enquanto que o omega-6 (AA) 
e a ceramida exercem o efeito contrário. A ceramida foi incluída neste estudo por estar 
intimamente ligada com as vias biosintéticas do AA. 
A MAP cinase p38 é importante na sinalização pró-inflamatária durante as infecções 
bacterianas. Neste contexto resolvemos estudar o efeito dos diferentes lípidos na 
actividade desta cinase. Uma vez mais o EPA apresentou efeitos distintos do AA e da 
ceramida. O primeiro lípido não estimula a activação da p38 ao contrário do AA e da 
ceramida. A infecção das culturas de macrófagos com o bacilo da tuberculose altera 
radicalmente a sinalização para a p38. O bacilo é capaz de bloquear a activação desta 
cinase nos estádios precoces da infecção. A sinalização para a p38 é modificada pelo 
tratamento com os lípidos e condiciona a sobrevivência do M.smegmatis nesta linha 
celular. 
 
O conjunto dos nossos resultados demonstra que no decorrer das infecções por 
micobactéria  o hospedeiro utiliza de uma forma faseada os vários mecanismos de 
defesa de que dispõe. Numa fase inicial a produção de NO e de RNIs desempenha um 
papel primordial. A fusão do fagosoma micobacteriano com o fagolisossoma constitui 
um importante mecanismo de defesa do hospedeiro, contudo a eliminação da 
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micobactéria pode ocorrer num fagosoma imaturo. A eliminação das micobactérias no 
compartimento precoce é mais lenta. Finalmente, a modulação do sistema com lípidos 
afecta dramaticamente o desfecho da infecção, contudo, devido à complexidade dos 
mecanismos activados é difícil extrapolar os resultados obtidos em linhas celulares para 
animais de experiência e para o Homem.  
 
Palavras chave: Mycobacterium spp, macrófago, interacção patogéne-hospedeiro, 
lípidos, mecanismos bactericidas 
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Abstract 
 
Non pathogenic mycobacteria are cleared from macrophages within 24 - 48 h while 
pathogenic mycobacteria can persist in the same cells for long periods of time. Using 
the non-pathogenic fast growing Mycobacterium smegmatis and two slow growing 
mycobacteria with distinct virulence (M. bovis BCG Pasteur and M. bovis) we start a 
systematic study to elucidate the role of different killing mechanisms during 
mycobacteria infection. Although all mycobacteria reside in phagosomes the acquisition 
of maturation markers were distinct for M. smegmatis and M. bovis spp. Thus different 
mycobacteria live and are killed in distinct compartments. Nevertheless, macrophage 
control of mycobacteria infections seems to follow a well established program where 
different killing mechanisms play a role at different times of infection.  NO production 
is the first killing mechanism involved then phagossome maturation resulting in 
acidification of phagosome content and acquisition of lysosomal enzymes are also 
involved. Since inhibition of phagosome maturation plays a central role in mycobacteria 
pathogenesis we try to identify key regulators of this process. Previous studies shown 
that actin nucleation plays an important role in this process. In the present study we 
provide evidence that MAP kinase p38, a central player in the pro-inflamatory response 
to bacteria infection, regulates actin assembly by non-pathogenic mycobacteria 
containing phagosomes at early stages of infection. This kinase is a key regulator of all 
killing mechanisms except NO production. 
In the last part of the work we studied the modulation of the host defense mechanism by 
lipid treatment. This approach is supported by (i) the well established link between 
particular diets and tuberculosis incidence and (ii) recent results by Anes group showing 
that omega-3 and omega-6 lipids had opposite effects in M. tuberculosis survival in 
macrophages mediated probably by their ability to regulate actin nucleation and 
phagosome maturation. At the macrophage level, in general, the effects of Cer and/or 
AA were opposite to those of EPA, but in many infection stages these pro- and anti-
inflammatory lipids were capable of reversing the signalling states between killing and 
survival. The effects of Cer and EPA were in part regulated by p38 MAP Kinase. These 
results argue against the idea of considering a simple recommended lipid-based diet 
against mycobacteria. 
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Introduction 
 
 1 
TUBERCULOSIS: THE NEW OLD DISEASE 
 
Tuberculosis (TB) is one of the oldest infectious diseases affecting the human kind. 
Bone TB was identified in skeletons, from Europe and Middle East, as the cause of 
death showing that 4000 years ago this disease was a widespread health problem. In 
recorded history, Hippocrates writes of patients with consumption (the old definition of 
TB), i e, wasting away associated with chest pain and coughing, frequently with blood 
in sputum. The frequency of descriptions of patients with these symptoms indicated that 
the disease was already well entrenched.  
The explosion of European population and the growth of large urban centres made this 
continent the epicentre of many TB epidemics during the 16th and 17th centuries. 
Although, during the first half of the 19th century the incidence of TB peaked causing 
death to approximately one quarter of European population, in the second half of this 
century TB mortality decreased due to improving sanitation and housing. The 20th 
century brought a steadily drop of morbidity and mortality due to TB, in developed 
world, due to better public health practices, massive vaccination with Calmette-Guérin 
bacillus (BCG) vaccine and the advent of antibiotics. This downward trend ended in the 
mid-1980s triggered by emergence of acquired immunodeficiency syndrome (AIDS) 
and an increase in homeless and poverty in the developed word. This fact pointed the 
important role played by the immune system in this disease and also the importance of 
socio-economical factors. More recently the identification of multi-drug resistant 
(MDR) and extensively drug resistant (XDR) strains of mycobacteria turned this disease 
even more frightening 1,2.  
 
Actually more than one-third of the world’s population is infected with Mycobacterium 
tuberculosis (M. tuberculosis). One in every ten of these individuals will develop TB at 
some point in their lifetime and around 2 million people die of this disease every year 3.  
New drugs, better vaccines and new diagnostic methods are desperately needed to 
change and revert this situation. Despite the big effort made in order to develop new 
tools to fight this plague the successful candidate has not been found. In the present 
work we favour the hypothesis of boosting the host natural defence mechanisms to 
contribute to solve the problem. The first step towards this goal will be a better 
understanding of the host-pathogen relationship. 
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THE CAUSAL AGENT 
 
The Mycobacterium tuberculosis complex includes strains from five species- M. 
tuberculosis, M. canettii, M. africanum, M. microti and M. bovis and two subspecies – 
M. caprae and M. pinnipedii 4. These mycobacteria are characterized by 99,9% 
similarity at nucleotide level and virtually identical 16S rRNA sequences 5-8  but differ 
widely in terms of host tropisms, phenotypes and pathogenicity 4,9,10.  
The most notable member of the complex is Mycobacterium tuberculosis the causative 
agent of human tuberculosis which has an exclusive tropism for this host. In contrast, 
M. bovis, the etiologic agent of bovine tuberculosis, cause only 5 -10% of human 
tuberculosis cases and has a wide host spectrum. The impact of M. bovis in human 
health declined sharply after the advent of pasteurization but there are records of new 
cases among immunocompromised individuals and re-activation in elderly individuals. 
Although in some countries eradication of bovine tuberculosis was possible due to 
programs based on a test and slaughter strategy it still constitutes an economic burden in 
developed countries as New Zealand and England 11,12. The persistence of M. bovis 
among wildlife that can serve as a reservoir for domestic animals is the aim of the 
problem. The disease in wild and domestic animals presents a wide spectrum of 
manifestations that mimic the progression of tuberculosis in humans. These animals 
when experimentally infected can serve as useful models of human disease since they 
are outbred, natural host of disease, allow experimental challenge in vaccine trials and is 
possible to monitor the immune response through the progression of the disease13,14. 
The major limitation of the model is the use of M. bovis instead of M. tuberculosis and 
the relative high cost. 
 
 
THE PATHOGENESIS OF TUBERCULOSIS 
 
The infectious bacilli are inhaled as droplets from the atmosphere. In the lung, the 
bacteria are phagocytosed by the alveolar macrophages. The interaction of mycobacteria 
components with macrophage receptors as the Toll-like receptors (TLR) results in 
chemokines and cytokines production 15 that serve as signals of infection. The bacteria 
enter the parenchyma and replicate within the alveolar or lung resident macrophages. 
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The signals induced results in migration of monocyte derived macrophages and 
dendritic cells from the blood stream to the site of infection in the lung. The dendritic 
cells that engulf bacteria mature and migrate to the lymph nodes 16-18. Once there, CD4 
and CD8 T cells are primed against mycobacterial antigens. Primed T cells expand and 
migrate back to the focus of infection in the lungs, probably in response to mediators 
produced by infected cells. This phenomenon of cell migration towards the infection 
focus culminates in formation of a granuloma the wall mark of tuberculosis. The 
granuloma is formed by T cells, macrophages, B cells, dendritic cells, endothelial and 
epithelial cells among others in a proportion that varies with the age of the structure. 
The granuloma walls the bacilli resident within macrophages preventing spreading and 
generating an immune microenvironment which facilitates the interaction between 
cytokines secreted by macrophages and T cells. However, the granuloma also provides 
housing for M. tuberculosis during a long period of time. The latent bacilli could be 
released if the cytokine balance is broken and originate a reactivation of the disease. 
 
 
ENTRY OF MYCOBACTERIA   INTO HOST CELLS 
 
M. tuberculosis entry into macrophages is mediated by receptor binding and 
phagocytosis. Although the majority of studies indicate that the bacilli favour 
interaction with complement and mannose receptors, which are benign because they 
trigger minimal superoxide production, experimental data suggest that the receptor type 
has little impact on the intracellular survival of the bacteria 19,20. Selective receptor 
blockade during phagocytosis does not alter the survival and growth in human 
macrophages 20 although differential use of receptors may affect the invasion of 
different phagocytes populations.  
For instance the macrophage mannose receptors are expressed on mature macrophages 
and allow uptake of virulent M. tuberculosis H37Rv but not the avirulent H37Ra. The 
interaction between the receptor and the mycobacteria is mediated at least by terminal 
residues present in mycobacteria lipoarabinomannam (LAM) 21,22 that are also involved 
in CD14 interaction. Since the expression of these receptors is downregulated by γ-IFN 
their role in mycobacteria ingestion is circumvented to early stages in infection and in 
individuals with compromised cellular immunity 23. In addition to mannose and 
complement receptor other receptors  such as surfactant protein A receptors 24 and class 
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A scanveger receptors 20 are involved in mycobacteria uptake associated with a low pro-
inflammatory response. 
Another group of receptors, the pattern recognition receptors (PPR), are likely to be 
responsible for the immune recognition of pathogens and thus for the pro-inflammatory 
cell signalling rather than bacterial uptake. This group includes Fc receptors and Toll 
like receptors (TLR). Pathogenic mycobacteria avoid binding to this family of receptors 
being preferentially uptake by mannose receptors preventing a strong pro-inflammatory 
response at early stages of infection. If the host immune system secretes high levels of 
γ-IFN at this stage the mannose receptors are downregulated as stated before forcing M. 
tuberculis uptake mediated by PRRs and TLR.  
Mamalian TLR proteins derive their name from the Drosophila Toll protein, to which 
they have sequence similarity. TLRs were first identifies in Drosophila, where they are 
important for resistance to microbial antigens. Subsequently a large number of TLRs 
were identified in mammals and two of them, TLR2 and TLR4, have been implicated in 
the activation macrophages by mycobacteria involving MAP kinases (ERK 1 /2, p38 
and JNK), Janus kinase/ signal transducer and activator of transcription (JAK/STAT) 
and NF-κB pathways.  
The activation of host-cell signalling cascades, such as MAP kinases or JAK/STAT 
pathways results in the production of pro-inflammatory cytokines (such as IL-1, TNF-α 
and interferons) and chemokines. Pathogenic but not non-pathogenic mycobacteria have 
evolved mechanisms to suppress these signal transduction cascades and thereby 
attenuate the cytokine-induced immune response. 
Extracellular signal-regulated kinases (ERK 1 /2) and p38 are members of MAP kinase 
family that became activated through the phosphorylation of tyrosine and threonine 
residues. Pathogenic mycobacteria such as M. avium and M. tuberculosis modulate 
MAP kinase activity. This leads to a decrease in pro-inflammatory response exemplified 
by a decrease in cytokine secretion such as TNF-α and their downstream effector nitric 
oxide (NO).  Since TNF-α receptors are true death receptors the decrease production of 
this cytokine induced by blockade of NF-κB and MAP kinase activation results in 
apoptosis inhibition. The classical programmed cell death pathway is believed to 
constitute a effective mechanism of intracellular mycobacteria killing 25. However, 
many bacterial pathogens alter host apoptotic pathways 26. For example, infection of 
macrophages with virulent strains of M. tuberculosis induces much lower levels of 
apoptosis than does infection with attenuated strains 27. 
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MYCOBACTERIA PERSISTENCE AND HOST DEFENCE MECHANISMS 
 
Macrophages play a unique role in host response to mycobacteria infections. These cells 
represent both the primary effector cell for killing the pathogen and the habitat in whish 
mycobacteria reside. In order to survive pathogenic mycobacteria developed strategies 
to avoid important anti-mycobacteria mechanisms such as NO production and 
phagosome lysosome fusion.  
 
NO and reactive nitrogen radicals (RNI) synthesis 
The tolerance of mycobacteria in vitro to RNI is strain-, dose- and time-dependent, with 
pathogens being inherently more resistant than non-pathogens 28-31. This suggests that 
pathogenic mycobacteria express genes that counteract the bactericidal or bacteriostatic 
effects of RNI. Different experimental approaches lead to the identification of noxR1 
and noxR3 which are able to confer RNI, and also reactive oxygen intermediates (ROI), 
resistance by a still unknown mechanism 32,33. Another gene involved in protection from 
oxidative stress is ahpC 34. The product of ahpC, the alkyl hydroperoxide reductase 
subunit C (AhpC), can metabolise peroxynitrite anion into nitrite, thereby contributing 
to detoxifying this highly reactive species 35. Peroxynitrite is a powerful oxidant 
produced by activated macrophages that can exert its toxic effects through protein 
modification 36. In vitro studies have shown that M. tuberculosis is resistant to this 
oxidant specie but M. smegmatis and BCG are susceptible 37. 
NO produced by the inducible nitric oxide synthase (iNOS) and its derivatives are 
produced by macrophages in response to mycobacteria infection. Pro-inflammatory 
cytokines (e.g. γ-IFN and TNF-α) and bacterial lipopolisaccharides (LPS) enhance NO 
synthesis 38-40. The anti-mycobacterial effects of these intermediates were shown 
experimentally in macrophage cultures infected with Mycobacterium 41,42. Other studies 
in the murine model of infection involving iNOS inhibitors or mice with disruption in 
nos2 gene highlighted the crucial role played by RNI in host defence against 
Mycobacterium infection 43-46. In contrast the importance of NO and RNI in human 
defence against M. tuberculosis is a matter of controversy 47,48.   
Although there is experimental evidence that NO made by iNOS or NOS2 (in humans) 
is required for mycobacteria killing it is unlikely that an effective killing would be 
achieved without delivery of bacteria to acidic compartments (late endosome / 
lysosomes) 45,49. Recent analysis of γ-IFN activated macrophages provided evidence 
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that NO and RNI derived from NOS2 mediated killing is insufficient to clear 
mycobacteria in the absence of a GTPase: LRG47. Experiments with infected 
macrophages have shown that LGR47 favour maturation of M. tuberculosis containing 
phagosomes through acquisition of vacuolar ATPase (V-ATPase) and ultimately 
enhance NO killing effects 49. More recently it was shown that LRG47 mediated 
lysosomal fusion is involved in autophagy rather than in phagosome maturation 50.  
 
 
Phagolysosome biogenesis 
Phagocytosis of pathogenic microorganisms by macrophages is the first step towards 
their eventual degradation. The phagosome eventually matures into a phagolysosome an 
organelle with acid pH, high content of hydrolases, defensins and the ability to generate 
toxic oxidative compounds, responsible for routine elimination of microorganisms 51,52. 
In order to avoid their degradation intracellular pathogens developed several strategies 
including escaping from the maturing phagosome to the cytoplasm (e.g. Listeria, 
Shigella, Ricketsia and Trypanossoma cruzi)53,54, escaping from the endosomal pathway 
to a endoplasmic reticulum derived vacuole (e.g. Chlamydia, Legionella, Brucella)55-58, 
modification of the phagosome or adaptation to the environment of the phagolysosome 
(e.g. Coxiella, Leishmania)59,60 and arrest phagosome maturation at late phase (e.g. 
Salmonella, Histoplasma) 61,62 or at an early phage (e.g. Mycobacterium, Nocardia, 
Rhodococcus) 63-65. The notorious success of M. tuberculosis, a facultative intracellular 
pathogen, rests upon the ability to arrest the biogenesis of the phagolysome. The ability 
of this pathogen to enter host macrophages and persist in friendly phagosomes, which 
do not mature into phagolysosomes 63,66-70, is crucial to tuberculosis infection, latency, 
disease activation, spread and suppression of immunological detection by the host 52,71-
73
. The maturation of a phagosome is a complex and ordered process involving 
interaction of the nascent phagosome with vesicles from the endocytic pathway (Figure 
1). 
When an inert particle as a latex bead (LB) is uptaked by macrophages the formed 
phagosome triggers a sequential series of fission and fusion events described by the kiss 
and run model of phagosome maturation 74. Shortly after their formation phagosomes 
bind to microtubules and start to fuse with early endosomes in a rab 5 dependent 
fashion. The early endosome is characterized by the presence of rab 5, transferin 
receptor (TfRs) or early endosome antigen 1 (EEA1), a relatively poor content of 
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proteases and a mildly acid pH around 6. As a consequence early endosomes contain, 
not only components characteristic of the plasma membrane but also of the early 
endosome. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Phagolysosome biogenesis 
Diagram showing the parallels between endosome progression to lysosome and maturation of a 
latex bead containing phagosome. The fusion of phagosomes with compartments of the 
endosomal pathway follows the kiss and run model proposed by M. Desjardins75. After 
internalization, the phagosome shows transient access to the rapid recycling pathway illustrated 
by the presence of transferin (Tf) its classical marker. During this early stage the phagosome has 
many of the markers found on early endosomes, such as EEA1 and rab5. However phagosomes 
rapidly acquire proteins associated with late endosomes, such as LAMP 1, rab7 and V-ATPase. 
Proforms of lysosomal hydrolases such as procathepsin D also appears in early phagosomes. 
Nevertheless, the processing of cathepsin D to its mature form seems to coincide with V-
ATPase acquisition and pH drop.   Figure from 76 
 
These early markers are then recycled from the phagosomal membrane as maturation 
proceeds 77,78. Through fission and fusion events (kiss and run) phagosomes acquire 
new molecules and recycle others. Therefore the acquisition of rab 7 and the lost of rab 
5 enable subsequent fusion of the phagossome with older organelles as late endosomes 
and lysosomes 74,75. Although the kinetics of maturation differ greatly depending both 
on the particle phagocytised and the cell, phagosomes begin to fuse with late endosomes 
and becoming refractory to early endosomes about 15-30 minutes after formation 78-80. 
As a consequence of phagosome aging they become enriched in late endosome 
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molecules best exemplified by rab 7, lysobisphosphatidic acid (LBPA) and the 
mannose-6-phosphate receptor cation independent 79,81. Nevertheless its presence is also 
transitory since the late phagosome evolved to a phagolysosome characterized by the 
presence of mature forms of lysosomal enzymes such as cathepsin D, lysosome 
associated membrane protein 1 (LAMP 1) and a luminal acidic pH 80. 
Following phagocytosis, the bacteria continue to reside within a membrane-bound 
vacuole of host origin. The seminal studies of D’Arcy Hart in the early 1970s described 
how the absence of fusion correlated with viability of the infecting bacteria 66,82,83. The 
capacity of M. tuberculosis to regulate the fusogenicity of their phagosomes is shared 
with other pathogenic mycobacteria such as M. avium and M. bovis. 
In 1986, Frehel and colleagues observed transient delivery of lysosomal tracers to 
phagosomes containing M. avium and suggest that these phagosomes had access to early 
endosomal compartment 84. Then in 1991 Crowle et al. 85 reported that phagosomes 
containing M. avium and M. tuberculosis were less acidic than neighbouring lysosomes. 
Sturgill-Kozycki 86 reported that pH of mycobacteria containing phagosomes is around 
6.2-6.3 and the deficient recruitment of V-ATPases responsible for the acidification of 
phagosomes.  
Later was shown that mycobacteria containing phagosomes are highly dynamic 
compartments. They had a paucity of V-ATPase complexes and a profile of endosomal 
constituents consistent with the arrest of phagosome maturation at a point that retained 
fusion with early endosomes 87. Consequently, markers of the recycling endosomal 
system, namely transferin receptor could be shown to traffic through the mycobacteria 
containing phagosome 87,88. Although certain “lysosomal” markers, such as cathepsin D, 
could be detected in this compartment, careful analysis revealed that it is an immature 
form of the enzyme 87,89. Most researchers in this field now work under the assumption 
that the phagosome containing pathogenic Mycobacterium spp are blocked at an early 
stage of their maturation process 52,70,76,90-92.  
The exact point where mycobacteria stop the phagosome maturation process is not yet 
identified. Nevertheless the retention of rab5 in mycobacteria containing phagosomes 
indicates that the process is arrested at an early phase between the steps controlled by 
rab5 and rab7 (Figure 1) 81,93.  
The regulation of membrane fusion in endosome biogenesis at this stage of the 
differentiation process is still debated although the major players have been identified 
94,95
. In essence, rab5 binds Vps34, a class III phosphatidylinositol 3-kinase that 
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generates phosphatidylinosithol 3-phosphate (PI 3-P) on the cytosolic face of the 
phagosome. PI 3-P acts has an acceptor for the EEA1 which also complexes with rab5. 
EEA1  binds calmodulin in a Ca2+/calmodulin dependent process 96,97. Acquisition and 
accumulation of EEA1 are necessary for accumulation of rab7, the small GTPase that is 
enriched in lysosomes. 
Malik et al. reported that M. tuberculosis blocked the normal calmodulin dependent 
signal transduction observed in maturation of phagosomes containing latex beads (LB) 
or dead bacteria 98,99. These authors also shown that blockage in Ca2+ mediated 
signalling by live bacteria was due to an inhibition in sphingosine kinase activity 100. In 
another study by Anes et al. it was demonstrated that sphingosine 1-phosphate content 
of the phagosome membrane influenced actin polymerization on isolated phagosomes 
and that M. tuberculosis containing phagosomes were deficient in actin nucleation 101. 
Fratti et al. showed that while M. bovis BCG containing phagosomes acquired rab5 and 
accumulated Vps34, they failed to bind the PI 3-P-binding protein EEA1 79. According 
to Vergne et al this would be due to the absence of PIP-3-P on the cytosolic face of the 
bacterium containing phagosome resulting of the interference with the kinase activity of 
Vps34 through a Ca2+/ calmodulin mediated process 102. For Corvera and collegues 
calmodulin did not affect Vps34 kinase activity but instead blocked EEA1 binding to PI 
3-P 96. 
Despite the apparent controversy between the data generated by different groups it is 
clear that the point of arrest in phagosome maturation is the accumulation of EEA1. 
This process is modulated by molecules that affect Ca2+/ calmodulin and class III PI 3-
kinase activity. 
 
 
ROLE OF ACTIN CYTOSKELETON IN HOST-PATHOGEN INTERACTION 
 
The actin cytoskeleton is involved in several stages of host-pathogen interaction. For a 
long time was accepted that actin was involved in the first step of phagocytosis  103,104. 
More recently was suggested that organelle trafficking and spatial distribution was not 
only dependent on microtubules, but also involve actin cytoskeleton 105,106.  
The first step of phagocytosis, the bacterial uptake, is known to be an actin dependent 
process. Pathogens recognition by phagocytic receptors induces a rapid and massive 
actin assembly locally at the plasma membrane. The phagocytic cup is formed allowing 
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phagosome formation but most of F-actin was lost soon after this step.  Many pathogens 
developed mechanisms to subvert the cellular actin cytoskeleton to trigger their 
internalization into normally non phagocytic host cells in order to escape the humoral 
immune defence. The invasive strategies used by pathogens to enter non-phagocytic 
cells are known as induced phagocytosis via the zipper and trigger mechanisms. In both 
cases actin assembly is stimulated by activation of the Rho-family GTPases Rac1 and 
Cdc42, both capable of eliciting Arp2/3 complex activation via proteins of the Wiskott-
Aldrich syndrome protein (WASP) and WASP family verpolin homologus (WAVE) 
proteins families 107. In the trigger mechanism, adopted by Salmonella and Shigella, the 
pathogen delivers to the host cell virulence factors that induce actin polymerization via 
type III secretion systems. The first evidence for a role of actin in intracellular 
trafficking events came from studies on the interaction of Listeria and vaccinia virus 
53,108
. Both pathogens once within the cytosol are able to recruit G-actin and form actin 
tail comets thus providing the driving force within the infected cell and also to spread 
infection to the neighbouring cells. Since vaccinia virus and small endocytic vacuoles 
are similar in size, researchers wonder when formation of actin tail comets would be an 
ordinary event during small vesicles trafficking. 
Pathogens that show actin based motility can be separated into two groups depending on 
whether they mimic a cellular nucleation-promoting factor (NFP) or they require the 
recruitment of a cellular NPF to the bacteria surface to promote Arp 2/3 mediated 
motility.  The members of the Wiskott- Aldrich syndrome protein (WASP) family are 
an example of NFP recruited by pathogens as Shigella. Other pathogens such as Listeria 
and Ricketsia produce proteins that mimic WASP 109,110. Although the mechanism of 
tail formation induced by Mycobacterium marinum is largely unknown probably it is 
NFP (WASP) and actin related proteins complex 2/3 (Arp 2/3) dependent 111,112. 
In recent years Griffiths provide evidence for the involvement of the actin cytoskeleton 
at late phases of phagocytosis/ endocytosis of latex beads by a mechanism independent 
of ARP 2/3 and alternative to actin tail comets113.  In the actin track model the actin 
nucleation machinery is dependent of the ezrin, radixin and moesin (ERM) family of 
proteins and postulates that if a membrane phagosome is able to filament actin this will 
provide tracks for other organelles to bind and move towards the actin nucleation 
source. In the context of phagolysosome biogenesis this will aid phagosome maturation 
increasing the number of fission and fusion events. Moreover the actin cytoskeleton 
must also be involved in phagosome maturation since poisons of actin such as  
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cytochalasin D and latrunculin A can inhibit this process in 50 % 114,115. In addition 
actin was found associated with endosomes and lysosomes 116,117 as well as several actin 
binding proteins as myosins 114 and moesin 118. Indeed in vitro studies showed that actin 
filaments are able to mediate fusion between late but not early endocytic organelles and 
phagosomes 119. In the context of mycobacterial infections the role of the actin 
cytoskeleton was still in the infancy when our group started to work in this field in the 
beginning of the 3rd millennium. By that time Chantal de Chastellier group reported that 
pathogenic mycobacteria were able to disrupt the actin cytoskeleton within infected 
cells 120.  
Using an in vitro assay that monitors membrane-dependent assembly of actin was 
possible to show that this process is regulated by lipids. The effect of different lipids at 
physiologic (1-5 mM: High ATP) and ischaemic (0.2 mM: Low ATP) concentrations of 
ATP are summarized in figure 2. In physiological conditions this class of lipids 
integrates the phagosome membrane in different amounts depending on the degree of 
vesicle maturation. While early phagosomes are enriched in phosphatidylcholine  (a 
negative efector), late phagosomes  are enriched in sphingomyelin the precursor of 
ceramide (both positive efectors). Thus by changing lipid composition we were able to 
switch on or block actin assembly/ fusion ability in vitro. 
 
  
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Effect of lipids in actin nucleation by LBP 
The effects of lipids on LBP actin nucleation at high and low ATP concentrations. Stimulation 
(+), inhibition (-) or no effect (0) relative to the standard conditions at low and high ATP 
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concentrations are indicated. Abbreviations: AA, arachidonic acid; Cer, ceramide; PC, 
phosphatidylcholine; PA, phosphatidate; Sph, sphingosine; S1P, sphingosine-1-phosphate. 
Figure from 101. 
 
When instead of LBPs were used phagosomes enclosing the non pathogenic 
mycobacteria M. smegmatis we observed that these phagosomes were able to nucleate 
actin in vitro similarly to LBPs. However when phagosomes containing pathogenic 
mycobacteria, such as M. avium or M. tuberculosis, were used the actin nucleation was 
effectively blocked. This enable us to established a link between the ability of 
mycobacteria to assemble actin, phagosome maturation and intracellular pathogen 
killing 101. The most striking result arose from the fact that actin assembly by 
mycobacteria containing phagosomes could be controlled using signalling lipids such as 
arachidonic acid (AA), phosphatidylinositol biphosphate (PIP2) and ceramide (Cer).  
These lipids are potent inducers of actin assembly even in M. tuberculosis containing 
phagosomes allowing the overcome of phagosome maturation block and thus inducing 
an increase in mycobacterial killing within macrophages. 
This study highlighted the opposite role played by two classes of dietary lipids in host 
defence to mycobacteria infections. The polyunsaturated fatty acids (PUFA) omega n-3 
inhibited in vitro and in vivo actin nucleation stimulating mycobacteria survival within 
macrophages whereas the omega n-6 (AA) had the opposite effects. The positive effect 
on actin nucleation by phagosomes was observed not only by adding AA but also by 
addition of its metabolites such as prostaglandin F2 (PGF2) (Gordon Shore, University 
Sterling, Scotland, personal communication). The finding that another metabolite of 
AA, PGE2, when added to the system blocked actin assembly make hard to draw 
straigth prediction for the effect of AA in animal models of infection.  
 
 
DIETARY FATTY ACIDS AND IMMUNE RESPONSE 
 
In western diets omega-6-fatty acids (PUFA n-6) account for the majority of PUFA in 
the food supply. When diets are supplemented with omega-3-fatty acids, the latter 
partially replace the omega-6 fatty acid in the membrane of practically all cells 121,122. 
This change has profound effects on both inflammatory and immune response mediated 
by different mechanisms. 
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PUFA n-3 competes with AA as substrates for different enzymes (Fig 3). Competition 
at the level of ciclooxygenase (COX) and 5-lipoxygenase (5-LOX) 123,124  is of 
particular important since they are involved in the synthesis of key inflammatory 
mediators as prostaglandin, leukotriene (LT) and lipoxins. Thus higher levels of  PUFA 
n-3 in cell membranes reduce the production, in the COX mediated pathway, of pro-
inflammatory eicosanoids (PGE2, LTB4) from n-6 PUFA and increase production of 
eicosanoids from n-3 PUFA (PG3, LTB5) which have weaker or opposite activity. 
However, the situation is complicated, because eicosanoids derived from one precursor 
did not share all the effects. While LT4 tends to enhance NKcells activity and Th-1 
cytokine production (IL-1, IL-6, TNF-α, IFN-γ) PGE2 tends to suppress this functions.  
The role played by products of 5-LOX pathway in host resistance to M. tuberculosis is 
less documented. Nevertheless, there is experimental evidence in mice of the 
importance of lipoxin A4 in infection control 125,126. 
 
 
Figure 3: Synthesis of eicosanoids from AA and EPA 
AA and EPA compete for prostaglandin (PG) and leukotriene (LT) synthesis at cyclooxigenase 
(COX) and lipoxygenase (LOX) level. The PG and LT derived from AA have an overall pro-
inflammatory effect while the ones derived from EPA have anti-inflammatory effect or a 
weaker potent pro-inflammatory effect. In this figure TXA2 means Tromboxane A2  
 
Changes in membrane lipid composition can also interfere with signal transduction. The 
most obvious way would be synthesis of different signalling molecules or the same 
signalling molecule with different biological activity due to changes in fatty acid 
composition 127,128.  A reduction in membrane AA decrease ceramide availability and 
AA in cell membrane 
phospholipids
EPA in cell membrane 
phospholipids
Free AA Free EPA
2-SeriePG
TXA2
4-Serie LT
Lipoxin
3-SeriePG
TX
5-Serie LT
Phospholipase A2
COX 5-LOX
Phospholipase A2
COX 5-LOX
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conducts to the synthesis of a less potent DAG 129 leading to a less potent anti-
inflammatory response. Another mechanism that can account for a different 
inflammatory response is difference in binding of this and other molecules, as cytokines 
130,131
, to their receptors in cell membrane. 
Omega-3 fatty acids can also modulate gene expression of important immune genes. 
Among these are cytokines (TNF-α, IL-1β and IL-6) 132-134, i-NOS135 and transcription 
factors as NF-κB 136. Changes in gene expression can result from direct or indirect 
effects of omega-3 fatty acids. The mechanisms are not fully understood may differ 
from cell types to cell type. For cytokine production, bind of EPA to a class of 
transcription factors known as peroxisome proliferator activactor receptor (PPAR) can 
account for inhibition of macrophage activation and production of TNF-α, IL-1β and 
IL-6 128. And at least, for TNF-α, another indirect mechanism mediated by inhibition of 
NF-κB activation can account for inhibition of TNF-α production. Collectively, we can 
conclude that omega-3 fatty acids can affect the balance between Th-1 and Th-2 
cytokines that are of capital importance in mycobacteria infections 137. 
 
 
INTERPLAY BETWEEN NUTRITION AND TUBERCULOSIS 
 
Under or over nutrition and diet related chronic diseases are unbalanced nutrition status 
that constitutes a critical risk factor to infections. As stated before nutrients in the diet 
play a crucial role in maintaining an optimal immune response, such that deficient or 
excessive intakes can have negative consequences on susceptibility to a variety of 
pathogens. Under nutrition states and metabolic diseases as diabetes favour the 
establishment of infectious diseases including malaria, AIDS and TB while over 
nutrition states favours opportunistic and fungal infections 138,139. 
The link between malnutrition and active TB has been recognized for many years. This 
notion is largely based on historical reports of the first and second world wars and also 
on more recent studies in animals 140,141. In fact food intake increases the levels of γ-IFN 
but not IL-4 secretion whereas starvation enhances IL-4 response but not γ-IFN levels. 
The severe malnutrition observed in tuberculosis patients is the major argument for the 
provision of nutritional supplementation of such individuals. 
In the classical era the Greeks designated TB as “phthisis” meaning waste a way and 
later during the 18th and 19th centuries it was called “consumption”. Nowadays this 
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connection gained importance due to several reasons (i) TB is the most frequent and 
serious opportunistic infection in human immunodeficiency virus (HIV) infected 
individuals, (ii) general use of nutritional supplements and (iii) the increase of TB 
incidence among populations with nutritional deficiencies both in undeveloped and 
developed countries.  
A link between a particular diets and higher TB incidence has been established on the 
basis of epidemiologic studies. Populations following a strictly vegetarian diet consume 
minimal amounts of cobalamin (also known as vitamine B12) and register a significant 
higher incidence of TB comparing with omnivores 142. This can be explained by the 
important role played by cobalamin in intracellular pathogens killing 143,144.  
Eskimos and Inuits following a diet rich in oily fish and fish oil, the best characterized 
sources of omega-3 (PUFA n-3), and register an higher incidence of TB and diarrhea 
but a low incidence of  cardiovascular diseases (CDV), chronic inflammatory or 
autoimmune diseases 145-147. In developing countries CDV are an important cause of 
mortality and morbidity. The WHO estimates that in 2010 CDV will be the major cause 
of death in these countries 148. The preventive treatment of these diseases include a diet 
enrich in omega-3 lipid because they reduce serum cholesterol, low density lipoproteins 
(LDL) and triacyglycerol concentrations 149. However in the context of tuberculosis the 
reduction in cholesterol levels can account for an increase in the active disease. Indeed 
cholesterol rich diets were shown to accelerate clearance of bacilli during the treatment 
of tuberculosis 150,151. 
 
 
THESIS GOALS 
 
Environmental and non-intracellular microorganisms such as E. coli are efficiently and 
quickly cleared by macrophages (within 4 h). Nevertheless, Mycobacterium smegmatis 
universally classified as a saprophyte and non-intracellular species possess the ability to 
persist for 48 h within macrophages 101,152. Since macrophages play a major role as 
primary effectors cells for pathogen killing this fact provides evidence that even a 
saprophyte microorganism can behave, at least partially, as a pathogen and thus have 
transiently intracellular survival ability. Taking advantage of this fact we started to 
study the mechanisms involved in mycobacteria clearance by macrophages and how M. 
smegmatis is able to circumvent the bacterial killing factors of the infected macrophage.  
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After following in great detail how macrophages kill the fast growing species M. 
smegmatis we studied how these mechanisms can be modulated or blocked during the 
infection with pathogenic, intracellular species. The mycobacteria used were the vaccine 
strain BCG and a virulent strain of M. bovis. Since there are no extensive studies on the 
host cell type species interaction with mycobacteria we extend our studies from the 
mouse model to natural hosts of the mycobacteria used. In the present study since we 
use different strains of M. bovis we used human and bovine macrophages. Our work 
was important in deciphering new macrophage compartments where bacteria can be 
killed and outlined the real importance of the nitric oxide and the phagosome lysosome 
biogenesis during the course of the mycobacterial infection. 
Finally, previous work from the group showed that the actin cytoskeleton on the 
phagosomal membranes is important to provide tracks to other organelles to move 
towards the actin nucleating source and thus help phagosome maturation and fusion 
with lysosomes 101,119,153. We have also, previously found that this ability can be 
modulated by signalling lipids 101 and, in the context of TB, some lipids such as 
arachidonic acid and ceramide could overcome the actin nucleation blockade by M. 
tuberculosis containing phagosomes, while the omega 3 lipid EPA had the opposite 
effect. In conclusion, lipids can have a pro or anti-inflammatory role mediated by its 
ability to control actin assembly in the membrane of mycobacteria containing 
phagosomes, which ultimately induces more intracellular mycobacteria killing or 
survival. In the present work we proposed to understand how we could use this 
signalling to modulate the intracellular survival of M. tuberculosis, and thus try to find 
potential therapeutic alternatives for TB treatment or prevention. From the literature 
there are a lot of conflicting results on the effects of essential lipids such as AA or EPA 
during the course of mice infection with intracellular pathogens. Here we studied the 
system in depth, using not only simple models (cells in culture) but also complex 
models, namely animal models of infection. 
Since in the present work we defined a kind of biological clock for killing or survival of 
M. smegmatis during the course of the infection we asked how could these lipids  affect 
the signalling states of the macrophage if they were added to the system at different 
metabolic states of the infected macrophage. The same was applied during M. tb 
infection. 
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Our results were surprising since they showed that there is a complexity of signalling 
states during the time course of the infection and that no dietary lipids are recommended 
during mycobacterial infections. 
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ABSTRACT 
 
After internalization into macrophages non-pathogenic mycobacteria are killed within 
phagosomes. Pathogenic mycobacteria can block phagosome maturation and grow 
inside phagosomes but under some conditions can also be killed by macrophages. 
Killing mechanisms are poorly understood, although phago-lysosome fusion and nitric 
oxide production are implicated. We initiated a systematic analysis addressing how 
macrophages kill ‘non-pathogenic’ M. smegmatis. This system was dynamic, involving 
periods of initial killing, then bacterial multiplication, followed by two additional killing 
stages. Nitric oxide synthesis represented the earliest killing factor but its synthesis 
stopped during the first killing period. Phagosome actin assembly and fusion with late 
endocytic organelles coincided with the first and last killing phase, while recycling of 
phagosome content and membrane coincided with bacterial growth. Phagosome 
acidification and acquisition of the vacuolar V-ATPase followed a different pattern 
coincident with later killing phases. Moreover, V-ATPase localized to vesicles distinct 
from classical late endosomes and lysosomes. MAP kinase p38 is a crucial regulator of 
all processes investigated, except nitric oxide synthesis that facilitated the host for some 
functions while being usurped by live bacteria for others. A mathematical model argues 
that periodic high and low cellular killing activity is more effective than is a continuous 
process. 
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INTRODUCTION 
 
The macrophage phago-lysosome (or ‘late’ or ‘mature’ phagosome) is potentially a 
hostile environment for microorganisms taken up by phagocytosis. Pathogenic 
mycobacteria such as Mycobacterium tuberculosis can block the fusion of phagosomes 
with late endosomes and lysosomes 1-3. This inhibition facilitates pathogen growth, but 
when macrophages are ‘activated’ by effectors such as gamma interferon 4-7 or lipids 8 
they can sometimes overcome the block and induce full phagosome maturation, an 
event that coincides with pathogen killing. Fusion with late endosomes and lysosomes, 
usually considered the most acidic compartments in cells 9-11  is thought to deliver both 
lysosomal enzymes and the vacuolar V-ATPase to phagosomes 12-15.  Lysosomal 
enzyme activity at low pH is widely considered to be the main killing mechanism 
against mycobacteria 16-19. However, the production of nitric oxide (NO) by the iNOS 
enzyme provides an additional mechanism contributing to killing of pathogenic 
mycobacteria, in vitro 20, in cultured macrophages, in animals and in humans 21-23. In 
contrast, reactive oxygen intermediates are generally considered far less important for 
mycobacterial killing 24-27. 
The general view in the field is that pathogenic mycobacteria survive and grow in 
macrophages as a direct consequence of blocking phagosome maturation, while if 
maturation proceeds the bacteria are killed 1,28-34. Most of this evidence is correlative: 
dying or dead bacteria are usually seen in lysosomes (pH 4.5-5.0) whereas living ones 
tend to remain in phago-endosomes (pH 6.2) 34. However, pathogenic mycobacteria can 
also survive and, in the case of M. avium even grow in the low pH, hydrolase-rich 
environment of lysosomes under some conditions 35. In most studies it is hard to rule 
out that a factor ‘X’ killed the bacteria, whose death then serves as a ‘signal’ for 
phagosome maturation. The question - how macrophages kill mycobacteria is crucial for 
understanding how 10 percent of humans carrying M. tuberculosis bacteria develop the 
disease whereas about 90 percent of the infected do not develop tuberculosis 36. Perhaps 
we can develop therapies involving boosting the natural killing abilities of 
macrophages.  
Here, we took advantage of the established ability of J774 macrophages to kill M.  
smegmatis within 48 h 8,37-39. Focusing on this system, our goal was to understand the 
basic or innate cellular mechanisms which allow macrophages to kill intra-phagosomal 
mycobacteria in the absence of exogenous effectors. 
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In recent studies using both the model system latex bead phagosomes (LBP) and 
isolated mycobacterial phagosomes, we showed that the de novo 
nucleation/polymerization (‘assembly’) of F-actin by the membrane of phagosomes and 
late (but not early) endocytic organelles facilitates the fusion between them. Our data 
support an ‘actin-track’ model whereby these actin filaments emanating from the 
organelles provide tracks upon which lysosomes can move towards phagosomes to 
facilitate fusion 40,41. A number of (mostly) pro-inflammatory lipids could activate actin 
assembly on both LBP and mycobacterial phagosomes in vitro and in cells. In 
agreement with the actin track model, these lipids stimulated phago-lysosome fusion 
and acidification and enhanced the killing of pathogenic mycobacteria (M. avium and 
M. tuberculosis) which normally survive in macrophages. In contrast, omega-3 
polyunsaturated fatty acids inhibited phagosomal actin polymerization and facilitated 
pathogen growth 8. In the present study we addressed phagosomal actin assembly in the 
context of M. smegmatis phagosome maturation in more detail. 
In a routine screen of inhibitors that affect the LBP actin assembly in vitro, a specific 
inhibitor of the MAP kinase p38 (SB203580), but not of ERK1/2 was found to inhibit 
this process (Kuehnel et al, in preparation). In the present study we follow p38 in more 
detail. 
MAP kinases are central players in cell signaling and much of their activities are 
localized on membranes 42. There are three different classes of these kinases, namely 
ERK, JNK and p38. A number of studies have shown that these kinases are activated 
upon infection with mycobacteria 5. Moreover, p38 and ERK are activated more during 
infection with non-pathogenic compared to pathogenic mycobacteria, implying that the 
pathogens inhibit these kinases 5,43. The kinase p38 has been implicated in early 
endosome fusion; there, it can phosphorylate and activate Rab-GDI thereby locking Rab 
proteins in their inactive GDP-form and preventing fusion 44. Fratti and colleagues45 
associated p38 activation with an inhibition of phagosome maturation in cells infected 
with M. bovis (BCG) 3. 
Although M. smegmatis is widely considered to be a ‘non-pathogenic bacterium’, our 
data reveal it has a limited capacity to behave as a pathogen that actively manipulates 
the system. The initial infection appears to start a maturation ‘clock’, in which (after 2h) 
p38 plays a crucial role, involving cyclical patterns of signals to different functions. 
Surprisingly, both the macrophage and M. smegmatis take advantage of p38 in a 
molecular tug of war that, on this occasion the macrophage eventually wins.  
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RESULTS 
 
Kinetics of survival of M. smegmatis in J774 macrophages 
M. smegmatis infecting J774 cells are killed within 48 h 38,46. Here, we used GFP-
expressing M. smegmatis and followed the colony forming units (CFU) in bacterial 
culture medium over the course of the infection. In parallel, fluorescence microscopy 
was used to monitor the number of internalized bacteria per cell. 
Using low infectivity (< 1 bacterium per cell) infection of almost confluent cells with 
exponentially growing M. smegmatis the bacteria were rapidly and reproducibly 
eliminated by 4 h post-infection (PI) (Fig. 1A.1; killing phase-1). However, at 5-10 or 
more bacteria per cell there was also effective killing of most bacteria within 4 h, 
followed by an unexpected and striking phase of intracellular growth of M. smegmatis. 
This started after 4 h and reached a peak at 9 h post-infection (Fig. 1A1). The rate of 
doubling was as efficient as that observed under optimal in vitro culture conditions (see 
Fig. 1A2). Examples of the intracellular localization of the bacteria at different infection 
times are shown in Supplementary Materials (Fig. S1C). However, between 9 and 12 h 
there was a striking second phase of rapid killing of the bacteria (Fig. 1A1; Killing 
phase-2). This was followed by a third, slower killing phase that lasted until 48 h, when 
essentially all bacteria had been killed (Fig. 1A1; Killing phase-3) 38. The non-GFP 
parental strain of M. smegmatis gave similar results (Results not shown). In mouse bone 
marrow macrophages the dynamics of M. smegmatis-GFP showed a superimposable 
pattern to that seen in J774 cells (not shown; Jordao et al, in preparation). 
Fig. 1A3 shows the fraction of intracellular M. smegmatis that can be stained with 
propidium iodide after isolating bacteria from cells, and are therefore presumably killed. 
As expected, the fraction of killed bacteria increases steadily over 24 h except during 
the period of bacterial growth (4-9 h). The quantitative analysis of extracellular versus 
intracellular bacteria (shown in Fig. S2) shows that after the first few hours the fraction 
of extra-cellular bacteria is negligible, arguing that we were essentially dealing only 
with intracellular bacteria throughout this study. The fact that after the phase of bacterial 
growth the macrophages subsequently recovered robustly, excluded trypan blue at all 
stages and grew normally after the resolution of infection argues against bacterial-
induced necrosis or apoptosis.  
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Figure 1. Intracellular fate of M. smegmatis and phagosome assembly of actin.   
A1. Showing the CFU for M. smegmatis (GFP) in J774 cells over the time of infection. The 
three killing phases are indicated. MOI indicates multiplicity of infection, macrophages: 
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bacteria. A2. Showing in vitro growth of the bacteria in two different media. A3. Showing the 
percentage of dead bacteria inside macrophages over time. B. Quantification of M. smegmatis 
phagosome actin assembly in vitro with and without the p38 inhibitor. C. Western blots of p38 
and phospho-p38 with M. smegmatis phagosomes isolated at 3h or 12 h post-infection with 0.2 
mM ATP and without the co-incubation with 50 µM PIP2. Anti tubulin was used as a loading 
control. D. Quantification of the percentage of phagosomes with associated actin, using 
rhodamine phalloidin, in cells infected with live and killed M. smegmatis, plus and minus the 
p38 inhibitor. E. Showing double label immunofluorescence microscopy of cells infected with 
live M. smegmatis (GFP-green) for 3 h labelled with rhodamine phalloidin (red). Asterisks 
indicate significant differences as determined by the Student’s T test: *P<0.07; ** P<0.001. 
 
 
Figure S1. Co-localization of late endocytic markers in J774 cells 
A. Uninfected J774 cells- left image, double labelled with LYAAT (red) and Hck (green) and 
right image, with CD 63 (green) and LAMP-1 (red). In both combinations there is extensive 
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overlap. B. Showing a triple label experiments with GFP-M. smegmatis infected J774 cells (2h 
infection) labelled with Lysotracker red and LYAAT, in red in the original (left panel) but 
converted to blue, false color in the right panel, which shown three-colors. C. Showing 
intracellular M. smegmatis at the indicated times in J774 cells that were also labelled with 
rhodamine phalloidin. 
 
This unexpected complexity of the interactions between the macrophages and M. 
smegmatis offered a kinetic, clockwise description of the process that provided the 
foundation for all subsequent experiments; in these, infection conditions giving 
approximately 5-10 bacteria per cell were used. 
 
 
Figure S2. Quantitation of extracellular versus intracellular M. smegmatis. 
Macrophages were infected with M. smegmatis and subsequently fixed at the indicated times 
with 2 % paraformaldehyde. Non internalized bacteria were detected using a rat anti M. 
smegmatis serum followed by an anti- rat antibody coupled to Cy3. Results are given as 
percentage of green (intracellular) and red (extracellular) bacteria. 
 
In vitro assembly of actin by M. smegmatis phagosomes 
The kinetics of survival of M. smegmatis in J774 cells resembled patterns of activities 
seen with LBPs. These showed a periodic pattern of activity in assembling actin in vitro 
and in macrophages, being active at 2-4 h and 24 h, but inactive at 12 h (maturation 
times before isolation)47; this also coincided with the LBP PIP2-levels, and kinase-
activities 48,49. We therefore monitored in vitro actin assembly by live M. smegmatis-
containing phagosomes isolated from macrophages at different infection times and 
phagosomes nucleating the polymerization of rhodamine actin were quantified 47. As 
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shown in Fig. 1B, M. smegmatis phagosomes were active for actin assembly at 3 and 24 
h, but not at 12 h, thus resembling the pattern seen with LBP. The periods of high 
activity coincide with the first and third, but not the second phase of M. smegmatis 
killing (Fig. 1A1). 
As shown in Fig. 1B, the inhibitor of p38, SB203580 (which blocks macrophage p38 
activation, see Fig. 2A3 and A4), inhibited the assembly of F-actin by live M. 
smegmatis phagosomes at both the 3 and 24 h ‘active’ stages, but did not influence the 
(already low activity) 8-12 h stages. Incubation of these phagosomes with a lipid 
effector known to activate actin assembly on LBP, phosphatidylinositol-4, 5 bis-
phosphate (PIP2), as well as 0.2mM ATP 8 led to a significant activation of the 
phosphorylated (active) form of p38 with active (3h) phagosomes, but not with inactive 
(12 h) phagosomes. When M. smegmatis (3h) phagosomes or 12 h phagosomes were 
treated with ATP in the absence of PIP2 the level of activated p38 was below the level 
of detection (Fig. 1C). Collectively, these data argue that p38 activation is a positive 
regulator of actin assembly by M. smegmatis phagosomes. 
 
Phagosomal actin in infected macrophages 
We next investigated actin associated with the M. smegmatis phagosomes in J774 
macrophages using rhodamine-phalloidin 8. Labelled actin could be seen around many 
of the phagosomes (Fig.1E). As seen in Fig. 1D, F-actin accumulated around 
phagosomes enclosing live bacteria in a similar cyclical pattern to that seen in vitro, 
being high at 2-4 and 24 h and low at the 8 h time point. The results for phagosomes 
from cells having killed bacteria were very similar (Fig. 1D). A similar phenomenon 
was seen with LBPs in J774 cells 47. 
The p38 inhibitor inhibited actin associated with phagosomes enclosing live bacteria at 
the 4 h and 24 h time points with no effect seen at other stages. In contrast, it had no 
effect on this parameter with the killed bacterial phagosomes (Fig. 1D).  This provided 
the first hint that the presence of the live M. smegmatis could influence the interactions 
between the phagosomes and the macrophages via pathways involving p38. 
 
Macrophage activation of p38 MAP kinase 
Given the observed effects of p38 on actin assembly by M. smegmatis phagosomes we 
next followed the activity of p38 in macrophages over the time of infection. For this, we 
again took advantage of the antibody that specifically recognizes the active, 
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phosphorylated form of p38 as well as an antibody against the total protein. Uninfected 
(and unstimulated) cells showed a constant level of total p38 but no detectable phospho-
p38 (Fig. 2A3 and A4). Following ‘infection’ with killed M. smegmatis, there was a 
significant activation of cellular p38 already after 20 min, with a small signal even after 
5 min (Fig. 2A1). The bulk of an active p38 was then switched off by 1 h; a faint signal 
remained until 8 h. In contrast, infection with live bacteria reproducibly delayed total 
macrophage p38 phosphorylation until 2h (Fig. 2A2). By 4 h, (coincident with the end 
of killing 1), the levels of the active p38 were visibly reduced, but by 8 h (start of killing 
phase 2), there was again a robust re-activation of p38 with no activity detected at 24 h. 
These data argue that the presence of live M. smegmatis delays the ability of the cell to 
activate p38 until 2h, but thereafter a more complex pattern of activation, de-activation, 
re-activation was observed. Fig. 2A3 and A4 shows that the p38 inhibitor completely 
blocked phosphorylation of p38 in active stages of both live and killed M. smegmatis-
infected macrophages. 
 
 
Figure 2. p38 activity in infected cells 
A1 and A2. Western blots for total macrophage p38 and phospho-p38 (pp38) for live and killed 
M. smegmatis- infected cells over the time-course of infection. A3 and A4: The inhibitor 
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SB203580 completely blocks p38 activation in both live (2h) and killed M. smegmatis-infected 
cells (20 min). Control = uninfected J774 cells without treatment. B. Linear scale (left panel) 
and log scale (right panel) show the effects of the p38 inhibitor on M. smegmatis survival in 
J774 cells. The asterisks indicate significant differences as determined by Student’s T-test * P< 
0.001. 
 
Role of p38 in intracellular survival of M. smegmatis 
Because p38 appeared to regulate processes important for phagosome maturation but 
was also somehow subverted by the live M. smegmatis we tested the effects of its 
inhibitor on the survival of the bacteria in macrophages. As seen in Figs. 2B1 (linear 
scale) and B2 (log scale) treatment of infected cells with the p38 inhibitor led to a small 
but significant increase in bacterial numbers in the first and second/third killing phases 
relative to the untreated controls. By this score, p38 is mostly favouring the cell at early 
and late times of infection. However, during the central period this kinase seems to 
favor M. smegmatis growth because, when inhibited it significantly reduced bacterial 
multiplication. This provides evidence that the live bacterium takes advantage of p38 
activity for some ‘survival’ functions.  
 
Use of markers for late endocytic organelles 
The notion that phago-‘lysosome’ fusion is implicated in killing is complicated by the 
fact that the term lysosome here actually refers to a still poorly defined assembly of late 
endocytic organelles. In many cells including J774 these compartments are 
conventionally separated into the more proximal late endosomes and the more distal 
lysosomes that are functionally distinct 50-53. We therefore decided to undertake a 
detailed analysis of the acquisition of different late endocytic markers by live and killed 
M. smegmatis phagosomes, and the role of p38 in these events.  As the phagosome is a 
more discrete structure than endosomes or lysosomes it is useful to identify different 
types of late endosomes by the extent by which they fuse with, and deliver their 
contents into phagosomes. When two membrane or content markers, from endocytic 
compartments are delivered into phagosomes with distinct rates it leads to the 
hypothesis that the compartments are distinct.  
We analyzed up to seven different labels/markers known or expected to be in late 
endocytic organelles to follow their acquisition by GFP-M. smegmatis phagosomes by 
light microscopy. These were (i) Colloidal gold conjugated to rhodamine internalized 
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for 1 h plus 1 h chase 50,54,55; (ii) LAMP-1 labelling, which labels both ‘late endosomes’ 
and ‘lysosomes’ 50; (iii) Lyso-tracker labelling to identify organelles with a pH below 
5.5-6.0; (iv) Immunofluorescence microscopy (IF) labelling for the V-0 subunit of the 
V-ATPase 56; (v) IF for CD63, which, like LAMP is enriched in late endosomes’ and 
‘lysosomes 57,58; (vi) IF for LYAAT, a recently characterized membrane transporter for 
apolar amino acids out of ‘ lysosomes’59,60. This marker was found to significantly co-
localize with Hck in human macrophages 61; and (vii) finally IF for Hck 61. 
 
Table 1. Colocalization of different late endocytic markers by 
immunofluorescence microscopy in uninfected J774 cells 
Marker LAMP-1 VATPase LYAAT CD63 Hck Lyso Gold 
LAMP-1 --- 1.8 3.1 75.2 13.6 39.4 43.3 
VATPase 1.8 --- ND ND ND 67.9 17.2 
LYAAT 3.1 ND --- ND 67.8 39.5 13.2 
CD63 75.2 ND ND --- ND ND ND 
Hck 13.6 ND 67.8 ND --- ND ND 
Lyso 39.4 67.9 39.5 ND ND --- 63.6 
Gold 43.3 17.2 13.2 ND ND 63.6 --- 
ND, not determined 
 
Table 1 shows a summary of an extensive series of double-labelling IF that we carried 
out on uninfected J774 cells. Examples of key experiments are shown in the 
Supplementrary Material (Fig. S3). Many surprises emerged from this analysis, which 
are relevant for the analysis of infected cells. Only 2 % of V-ATPase-positive vesicles 
were also labelled for LAMP-1, perhaps the most extensively used marker for both late 
endosomes and lysosomes. LAMP-1 itself significantly overlapped (though not 
completely) with CD63 (which was not used in subsequent experiments). Nevertheless 
the majority (67 %) of V-ATPase-positive structures were acidic enough to accumulate 
lyso-tracker; this value was actually higher than the fraction of gold-positive or LAMP-
labelled structures that were acidic. The LYAAT labelled structures were also non-
overlapping with LAMP-labelled structures although they strongly co-localised with 
Hck. While this analysis is certainly not definitive, and still restricted to the light 
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microscopy level, the results indicated that we could expect complex patterns when we 
followed the acquisition by phagosomes of five of these markers in detail. 
 
Figure S3. Co-localisation of markers with phagosomes 
A. Showing colocalization of the indicated marker combinations in uninfected J774 cells. B. 
Showing a triple label experiments to show the distributions of live GFP-M. smegmatis relative 
to rhodamine gold (red) and V-ATPase (blue) at 4 h post-infection. 
 
Phagosome-late endocytic organelle fusion 
Content mixing: A new light microscopy-based fluorescence assay using colloidal gold 
conjugated to rhodamine was first applied to cells infected with M. smegmatis (see 
Experimental Procedures). We used conditions known from electron microscopy 
analysis to allow equilibrium filling with gold of (the accessible part of what we defined 
previously as) late endosomes and lysosomes 52,54,55. This marker was preinternalised 
prior to infection with the GFP-M. smegmatis. Fusion is evident as bright fluorescent 
dots or a halo adjacent to the GFP-labelled bacteria (Fig. 3A and inset). Up to 90 % of 
live M. smegmatis phagosomes fused with gold compartments by 3h (Fig. 3B). There 
was a significant drop in the fraction of labelled phagosomes at the 4-12 h period, 
indicating recycling out of phagosomes, a process described by previously 14,62-65. A 
second period in which gold was reaquired by phagosomes was seen between 12 and 24 
h. As for the phagosomal actin assembly activity, the high fusion stages coincided with 
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killing phases 1 and 3, but not 2 (Fig. 1A1). For killed M. smegmatis, the initial rate of 
fusion was similar to that seen with live bacterial phagosomes. However, no detectable 
recycling of content out of these phagosomes was seen (Fig. 3C). Thus, the ability of 
the phagosome to recycle out content depends on the presence of the live bacterium. 
 
 
Figure 3. Phagosome fusion with late endosomes and lysosomes 
A. Showing examples of the rhodamine-gold (7nm) (red) fusion assay with live and killed M. 
smegmatis (green) (3h) infected J774 cells. The inset shows a higher magnification of the 
colocalization of phagosomes having live bacteria with gold. B and C show the kinetic results 
for the acquisition of gold by live and killed M. smegmatis phagosomes, with and without p38 
inhibitor. D-F. Showing the corresponding labelling and quantitation for LAMP-1. 
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Treatment with the p38 inhibitor over the course of the infection had a significant 
inhibitory effect on the fusion of live M. smegmatis phagosomes with gold-filled ‘late 
endosomes’ at all time points between 3 and 24 h, although less inhibition was observed 
at 24 h (Fig. 3B). This result could also be interpreted as an inhibition of p38 at the 3h 
time point with all subsequent processes behaving normally (because a downward shift 
of the curve is seen with the inhibitor). The inhibition at 3h fits well with the general 
macrophage activation of p38 at this time whereas the recycling out of phagosomes at 
4.5h (Fig. 3B) coincides with a lowered amount of macrophage phospho-p38 at 4 h 
(Fig. 2A2).  
The inhibitor had a less dramatic effect on the kinetics of fusion with dead bacterial 
phagosomes: a small but significant inhibition of fusion was seen at early, but not late 
times after phagocytosis (Fig. 3C). This fits with the restricted early activation of total 
p38 in response to dead bacteria (Fig. 2A1). These data argue that p38 activation 
favours the macrophage since its inhibition lowers the rate of acquisition of gold by 
phagosomes, at least at early stages. 
 
LAMP-1: The unexpected recycling of content out of the phagosomes of live, but not 
killed M. smegmatis led us to test whether a membrane marker would behave similarly. 
We labelled live and killed bacteria-infected cells with anti-LAMP-1 (Figs. 3D and Fig. 
S3A). As shown in Fig. 3E and F, LAMP-1 was delivered efficiently to both live and 
killed bacterial phagosomes with kinetics similar to that of the gold content marker (Fig. 
3B). LAMP-1 recycled out of phagosomes having live, but not killed bacteria (Fig. 3E 
and F). Thus, in what can be considered  ‘routine’ or ‘housekeeping ‘ phagocytosis 
LAMP is acquired by the majority of phagosomes by 4 h and remains there until 24 h, 
as it does with LBPs 66. It was stricking that only with the live bacteria was the 
recycling of membrane (LAMP-1) marker and content (gold) seen after the initial fusion 
event. This recycling step was followed by a second wave of acquisition of both 
markers by phagosomes that coincide with killing stage 3. For LAMP-1 our data do not 
formally rule out the initial loss of signal is due to the molecule being locally degraded 
by live bacterial phagosomes followed by a subsequent wave of new synthesis.  
The p38 inhibitor completely blocked the acquisition of LAMP-1 by live bacterial 
phagosomes, but it had no effect on LAMP-1 labelling of the killed bacterial 
phagosomes at early times, while strongly inhibiting its acquisition at late times of 
infection (Fig. 3E and F). These data argue that following ‘housekeeping’ phagocytosis, 
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the late fusion events that transfer LAMP (as for gold) to phagosomes are not dependent 
on p38. However, again, the presence of the live M. smegmatis dramatically alters the 
system such that the LAMP-fusion event is now totally dependent on p38. The different 
patterns of gold and LAMP-1 acquisition provided further evidence that the two 
compartments are not identical, although they significantly overlap (Table 1). 
 
The amino acid transporter LYAAT: We next investigated LYAAT which is the least 
characterized marker of ‘lysosomes’ 59,60. In uninfected cells, an anti-LYAAT antibody 
labelled vesicles that were widely distributed through the cell, but were quite distinct 
from structures enriched in LAMP-1 (Fig. S3A; Table 1). In cells infected with either 
live or killed M. smegmatis labelling for LYAAT could be seen around a fraction of 
phagosomes (Fig. S1). In both cases there was an early peak at 2h. However, no more 
than 40- 50 % of the live M. smegmatis phagosomes were positive for LYAAT at any 
time (Fig. 4A). Also for this marker some recycling out of phagosomes was seen 
between 4 and 10h. In contrast, the bulk (80 %) of the killed bacterial phagosomes 
acquired LYAAT within 1 h and maintained the marker thereafter, without a recycling 
event (Fig. 4A). These data are consistent with a ‘constitutive’ like process of the 
acquistion of LYAAT by the dead bacterial phagosomes with kinetics similar to the 
acquistion of LAMP-1. So, in ‘routine’ phagocytosis these different compartments 
(Table 1) fuse around the same time, and to similar extents with phagosomes. The 
presence of the live bacterium appears to actively modulate the system; unlike LAMP-1 
which showed a dynamic recycling and re-acquisition after the first phase of fusion, the  
acquisition of LYAAT was apparently actively kept low at all infection times. 
The inhibitor of p38 had no effect on LYAAT acquisition by either live or killed 
bacterial phagosomes in the first 4 h, with both showing a slight inhibition at 5h, and a 
continued inhibition was evident at some later times with live bacteria (Fig. 4A). 
Collectively, these data argue that LYAAT is delivered to phagosomes from a 
compartment distinct, and regulated differently, from gold- and LAMP-1-positive 
compartments. Again, these data show that live M. smegmatis actively modulates the 
system. 
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Figure 4. Acquisition of late endocytic markers by M. smegmatis phagosomes 
A-C. Showing the quantification of the acquisition of the different indicated markers by live and 
killed M. smegmatis phagosomes, with and without p38 inhibitor. In B the acidfication profiles 
of latex bead phagosmes (LBP) are additionally shown in green. D. Showing double-labelling 
for V-ATPase (red) with live (green) M. smegmatis at 4 h post-infection. The lower panel shows 
a high magnification image. E. Indictating the effects of bafilomycin-A1 on intracellular 
survival of M. smegmatis.  F. Showing the effect on M. smegmatis CFU of adding a cocktail of 
inhibitors of lysosomal proteases to the medium of cells either 1 h before infection or at the 
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indicated times. The lower curve is a superimposition of the blue, green and purple curves. The 
upper curve shows the two conditions in which the inhibitors were added coincident with the 
first killing period (blue triangles and red curves). 
 
 
Phagosomal pH 
Phagosomal pH is known to be important for optimal activities of most lysosomal 
enzymes and a pH below 5.5 is generally associated with a fully matured phagosome 
that is equipped to kill pathogens. We therefore analyzed the percentage of acidic 
phagosomes (pH < 5.5) in M. smegmatis infected cells for both live and killed bacteria 
using lyso-tracker-red 8. With live bacteria only 20-25 % of the phagosomes 
accumulated lyso-tracker by 1 h PI, a level that rose only slightly over the next 7h (Fig. 
4B). Only between 8 and 24 h did most phagosomes become acidic, coincident with 
killing phases 2 and 3 (Fig. 1A). In contrast, phagosomes containing the killed bacteria 
acidified rapidly, reaching levels above 80 % positive after 1 h and close to 100 % after 
6h (Fig. 4B). This was similar to the kinetics of acidification seen with latex bead 
phagosomes (Fig. 4B). These results indicate that the live M. smegmatis actively delays 
the acidification process. 
The p38 MAP kinase inhibitor had a surprising effect on the rate of acidification in live 
M. smegmatis phagosomes because it increased the fraction of phagosomes that 
acquired a low pH at early times (Fig. 4B). In contrast, it inhibited the acidification of 
dead bacterial phagosomes at 1 h, but not at later stages. This suggests that during 
‘housekeeping’ phagocytosis the phagosomes are all acidified by about 4 h but only the 
early (1 h) stage of acidification is (positively) regulated by p38, a period in which the 
kinase is still active (Fig. 2A). In contrast, in the live M. smegmatis-infected cells p38-
dependent signaling appears to be subverted by the bacteria to delay the full 
acidification of the phagosomes. 
 
Vacuolar ATPase localisation 
To acidify, the phagosomes must acquire the proton or vacuolar (V)-ATPase. We took 
advantage of a specific antibody against the Vo- (16KDa) subunit of the V-ATPase 56 to 
check for its presence on phagosomes. This labelled distinctly a fraction of the M. 
smegmatis phagosomes (Figs. 4D and Fig. S3). The kinetics and magnitude of the 
acquisition of the V-ATPase marker by live M. smegmatis phagosomes were similar to 
the corresponding pattern of acidification seen using lyso-tracker-Red (Fig. 4C; cf Fig. 
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4B). Thus, the ‘housekeeping’ dead bacterial phagosomes became almost all positive 
for V-ATPase by 6-8 h. In contrast, only 20 % of live bacterial phagosomes acquired 
the V-ATPase over the first 8 h, reaching around 50 % by 24 h. Thus the live bacteria 
actively modulate the system by inhibiting the acquisition by phagosomes of the V-
ATPase.  
In contrast to the effects seen with the acquisition of gold, LAMP-1 and LYAAT, there 
was little effect of the p38 inhibitor on the kinetics of acquisition of V-ATPase by either 
live or killed bacterial phagosomes. Here, we faced an apparent discrepancy between 
the lyso-tracker data (increase in acidification with p38 inhibitor) and the V-ATPase 
data (no increase). Possibly, V-ATPase from other compartments contributes to the 
increased acidification seen under some conditions. Related to this is the question of 
sensitivity. Lyso-tracker-positive organelles must, by definition have functional V-
ATPase. However, many of these acidic vesicles do not label with the anti-V-ATPase, 
suggesting that they are below the detection levels for the enzyme by fluorescence 
microscopy. By this reasoning, the vesicles that do label must have relatively high 
concentrations of V-ATPase and are probably storage sites for the proton pump. Such 
an organelle might be analogous to V-ATPase-rich apical vesicles in gastric epithelial 
cells. 
The comparison of the curves from Fig. 4A (LYAAT), Fig. 4B (acidification) and Fig. 
4C (V-ATPase) for the live bacterial phagosomes shows very similar patterns and 
percentages of labelled phagosomes. This could suggest that LYAAT and the V-
ATPase rich compartments are identical. However, whereas 68 % of the V-ATPase 
labelled phagosomes were lyso-tracker-positive only 40 % of the LYAAT-positive 
structures were acidic. Moreover, in parallel studies with M. bovis BCG we have found 
conditions where 80 % of phagosomes label for LYAAT whereas less that 15 % are 
positive for the V-ATPase in the same cells. We therefore feel justified in proposing a 
model whereby both these markers are enriched in functionally distinct compartments 
(Fig. 7B). 
 
Effect of bafilomycin on M. smegmatis survival 
The finding that the live M. smegmatis phagosome is able to delay the acidification of 
phagosomes suggests that a low pH is something the bacterium would prefer to avoid. If 
so, neutralising the pH of the phagosome should lead to an increase in survival. In 
agreement with this hypothesis the addition of bafilomycin A1, a potent inhibitor of the 
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V-ATPase to cells infected with live M. smegmatis prevented killing of the bacteria at 
all time points until 24 h PI (Fig. 4E). This indicates that a low pH is likely to be an 
important contributor to bacterial killing throughout the infection process. It is 
noteworthy that when the proton ATPase was blocked no growth of the bacteria was 
seen (Fig. 4E). Acidification of the phagosome may therefore serve to activate M. 
smegmatis for growth. 
 
Role of lysosomal enzymes in bacterial survival. 
The above data showed that many different late endocytic compartments fused with M. 
smegmatis phagosomes. Based on many studies by others we could expect that these 
fusion events delivered many ‘lysosomal’ hydrolases to the phagosomes 3. We therefore 
asked whether some of these enzymes contributed to the ability of macrophages to kill 
M. smegmatis. Cells were therefore fed with a cocktail of lysosomal protease inhibitors 
(leupeptin, pepstatin, aprotinin) in order to load them by fluid-phase endocytosis into 
late endosomes and lysosomes. These were added either prior to the infection with live 
M. smegmatis or at the indicated times after infection (Fig. 4 F-upper curve). When 
added 1 h before infection and left on the cells until 3h, or added between 1 and  4 h PI, 
this cocktail significantly reduced the rate of the first bacterial killing stage (between 1 
and 4 h), without affecting the subsequent growth of the bacteria until 9 h.  As a 
consequence of the lowered killing when the inhibitors were added early in the infection 
the total growth seen subsequently was significantly higher than the untreated control 
(Fig. 4F). However, irrespective of when it was applied, it had no obvious effect on the 
subsequent stages of killing (Fig.4 F- lower curves). Thus, we conclude that the delivery 
of those lysosomal enzymes (susceptible to the inhibitors we used) into phagosomes 
during early times of fusion indeed contributes to the first-phase killing of the bacteria 
but, by these criteria we could not support the hypothesis that they were important in the 
two later killing phases. 
 
Role of inducible NO-synthase and NO release 
The best-characterised system for killing mycobacteria is that involving activation of  
iNOS to make NO and downstream metabolites that are known to facilitate killing of 
mycobacteria, including M. smegmatis 67,68. We therefore investigated the role of this 
machinery in killing of M. smegmatis. For this, we first monitored NO using the Griess 
reagent. Cells infected with either live or killed bacteria produced detectable NO only at 
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early times (Fig. 5A). A more detailed analysis showed that between 15min and 2h 
similar levels of NO were made in cells infected with live or killed bacteria. The NO 
produced was the result of iNOS activation because a specific inhibitor of this enzyme 
(L-NAME; 500 µM) significantly inhibited NO release (Fig. 5A). Using an anti-iNOS 
antibody 69, by IF we could discern an increase in the level of iNOS expression in the 
cytoplasm after 1 h of infection with live or dead bacteria (Fig. 5G; not shown), in a 
pattern resembling that seen in γ-interferon treated-cells (Fig. S4). In infected cells, 
much of the labelling was detected in the vicinity of phagosomes (Fig. 5H; however, the 
association with phagosomes was difficult to quantify). 
 
Figure 5.  Nitric oxide release by infected J774 cells 
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 A. Showing the synthesis of NO over the time course of M. smegmatis infection, with and 
without the iNOS inhibitor L-NAME; only the 1 h time point shows a significant difference 
between the untreated and the L-NAME treated cells by the Students t-test (P<0.05). B and C. 
Showing NO release from cells infected with live or killed M. smegmatis, with and without the 
p38 inhibitor, in the period when NO was produced. There were no significant differences in 
any of the values. D. Showing the effect of L-NAME on M. smegmatis intracellular survival. E. 
Showing the effect of the NO donor NOC-18 in elevating macrophage NO levels. F. Showing 
the effects of the NO donor NOC-18, added coincident with infection on CFU of M. smegmatis. 
G. Showing immunofluorescence labelling for iNOs in red in cells infected with GFP-M. 
smegmatis. The image in grey is the corresponding phase-contrast images. 
 
 
The p38-inhibitor had no significant effect on the production of NO at any time in cells 
infected with either live or killed bacteria (Fig. 5B and C). The synthesis of NO by 
iNOS in this system is seen as an early, transient response to live or killed bacteria that 
is evidently independent of p38 signaling.  
 
 
Effects of NO on survival of M. smegmatis in macrophages 
The above data suggested that iNOS might contribute to killing M. smegmatis, but if so, 
this should be restricted to the first 2h when NO is detected. In agreement with this 
notion the inhibitor of iNOS (L- NAME) added coincident with infection was able to 
significantly block the first killing phase and thereafter a progressive killing was seen 
until 24 h. (Fig. 5D). As for bafilomycin treatment it was interesting to note that no 
bacterial growth was evident suggesting that RNI, like acidification, might provide 
positive cues for M. smegmatis growth. The addition of an artificial NO donor, NOC-
18, that elevates NO levels in macrophages (Fig. 5E), when added between 4 and 9 h 
induced a dose-dependent inhibition of bacterial growth (Fig. 5F). Thus, even at this 
stage, M. smegmatis was still vulnerable to the effects of NO (or related metabolites). 
These data are consistent with the NO estimates and show that iNOS-dependent NO 
synthesis is an important first line of attack against M. smegmatis. However, under all 
conditions, this early phase was switched off before 4 h, the end of the first bacterial 
growth phase. 
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Mathematical modelling of intracellular bacterial growth 
The cyclical behavior of the killing/growth of M. smegmatis opened up a paradox. At 
the end of 4 h the majority of bacteria are killed and at low multiplicities all of them are 
eliminated, in terms of their ability to grow in optimal media. Coinciding with this 4 h 
period, however is a period of recycling out of the phagosomes of a key membrane 
protein and its luminal contents. Why would the macrophage apparently work against 
its own killing needs, to the evident (transient) advantage of the bacteria? 
We decided to investigate this using a mathematical model in which a defined number 
of live bacteria are added to a defined number of macrophages (Fig. 6A; for more 
details see Experimental Procedure). A doubling time of 3h was taken for M. smegmatis 
growing exponentially (Fig. 1A2). The model assumes that the macrophage has limited 
resources available that it can use in order to maintain an average killing rate k. We 
then assume that the cell can either maintain this killing rate constant or that it can 
modulate it with time. The experimental data (Fig. 1A1) suggest that cellular killing is 
less efficient for high numbers of bacteria per cell relative to low numbers. To satisfy 
this experimental observation we introduce an ‘efficiency factor’ e for the killing rate 
that is maximal (e = 1) for low numbers of bacteria and minimal (e = 0) for high 
numbers. 
If the killing rate k is set constant at k = k0 and if the effective killing rate e x k is lower 
than the bacterial growth rate exponential growth of bacteria is observed (Fig. 6E, high 
infectivity). However, when the killing activity was allowed to oscillate in time such 
that the average activity was still at the level k0, two different scenarios were seen 
depending on the initial infection load. At low numbers (one bacterium per cell) a one-
step killing was seen between 1 and 4 h (Fig. 6G - low infectivity). At high infection 
rates (seven bacteria per cell) cyclic phases of killing interspersed by bacterial growth 
was seen. Remarkably, the kinetics of both high and low number infections were in 
agreement with our experimental data (Fig. 1A1). In addition, the percentage of killed 
bacteria as a function of time (Fig. 6H) is in good agreement with the experimental data 
shown in Fig.1A3. A comparison of the constant versus oscillating killing activity (Fig. 
6E and G; high infectivity) shows that in both cases that the activity was on average 
maintained at the same level (k0), with the bacteria growing exponentially in one case 
(constant k=k0 effective growth rate 0.16 h-1) but were finally killed in the other case 
(oscillating k). These simulations provide a rationale for why the J774 and primary 
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macrophages may have evolved an oscillating type of killing activity toward M. 
smegmatis. 
 
Figure 6. Mathematical modeling of infection  
A. Undisturbed bacterial growth. B. Bacterial killing together with bacterial growth. C. The 
killing efficiency depends on the number of bacteria per cell. D. The killing efficiency is 
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maximal (e = 1) for low numbers of bacteria per cell and minimal (e = 0) for high numbers. E 
and F. Dynamics of live bacteria per cell in the case of a constant cellular killing activity for 
high (E) and low infectivity (F). G. Live bacteria per cell with an oscillating cellular killing 
activity for high and low infectivity. The insets (red curves) show the corresponding dynamics 
of the stable and oscillating conditions. H. Showing agreement between the predicted 
percentage of killed bacteria over time and the corresponding experimental results (cf Fig. 1A-
3).  
 
 
 
 54 
DISCUSSION 
 
Here, we focused on M. smegmatis in J774 cells because we knew from previous work 
that this macrophage cell line invariably kills M. smegmatis within 48 h 8,38. We 
initiated a broad cell biological analysis towards revealing the mechanisms by which 
this macrophage kills a so-called non-pathogenic mycobacterium. A role for NO and 
lysosomal proteases in killing M. smegmatis was identified. We expect that many of 
these mechanisms will also be relevant to understanding how pathogenic mycobacteria, 
the focus of our ongoing studies, are killed by macrophages.  
J774 cells efficiently internalize both live and killed M. smegmatis and, in both cases, 
by 1-2 hr the vast majority of bacteria are in a potentially degradative (late) phagosomal 
compartment. Indeed, at low infection loads all live bacteria can be eliminated by 4 h. 
However, as the macrophage was challenged with increasing numbers of live bacteria a 
surprising complexity is seen in the dynamics of cell-bacterial interactions. This reflects 
the molecular tug of war for survival between the two protagonists. A summary of our 
data is shown in Fig. 7A which emphasizes the three major phases of killing and one of 
bacterial growth. Figure 7B is our working model whereby four different late endocytic 
compartments fuse with phagosomes. 
 
Killing phase 1 
 The first detectable response of the cells is to release NO, starting already after 15 min 
but was over by the end of killing phase 1 (4 h) irrespective of whether the bacteria 
were alive or killed. NO contributed to killing as blocking its synthesis prevented the 
first killing phase (Fig. 5D). The macrophage evidently becomes programmed for 
releasing NO for a rather limited period in response to live or dead M. smegmatis. Live 
bacteria did not, however, become resistant to NO at later stages since an artificial 
increase in NO after 4 h could still efficiently kill them (Fig. 5F). Why the macrophage 
switches off iNOS activity remains an open question. It cannot be to protect the cell 
since J774 macrophages can secrete detectable NO for many days when they are 
infected with M. bovis-BCG (unpublished data). A fact to consider in future studies is if 
NO can directly activate the transcription of a large number of genes in cells infected 
with M. tuberculosis 70. 
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Figure 7. Summary models 
A. Schematic description of the data with respect to the M. smegmatis life cycle. B. A summary 
of the up to four different vesicular compartments that appear to fuse with late stages of M. 
smegmatis phagosomes. The reversible arrow between LE and the lysosome indicates 
interactions seen earlier in J774 cells 52,53. 
 
In the first killing phase (1-4 h) the macrophage evidently ‘attacks’ with its second 
weapon: late endosomes and lysosomes (defined by their accumulation of gold, and 
LAMP-1). These fuse with more than 90 % of phagosomes. As for NO release, the 
kinetics of this early event was similar for both live and killed bacteria. The lysosomal 
enzymes transferred to phagosomes must have contributed to killing because pre-
loading macrophages with a (limited) cocktail of lysosomal enzyme inhibitors 
significantly reduced the early (but not later) killing effects (Fig. 2C). The overall 
pattern of the fusion events between phagosomes and late endosomes and lysosomes 
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coincided with phagosome actin assembly, providing still more evidence for links 
between these processes 8,40,41. 
Although most phagosomes were lysotracker-negative (pH < 5.5-6) during the first 4 h, 
bafilomycin treatment of cells still prevented killing period 1 (Fig. 4C). Possibly this 
treatment neutralizes phagosomes having a pH above 6 but below 7.  Intriguingly, under 
this conditions no bacterial growth was seen suggesting that low pH (like NO) may 
even favour bacterial growth. It should also be noted that bafilomycin treatment is 
known to stimulate some phagosome fusion events and inhibit others (or stimulate 
selective recycling out of phagosomes) 62. Interpretation is also complicated by the 
observation that V-ATPase has recently been directly implicated in the mechanics of 
membrane fusion events 71,72. 
 
Intracellular growth of M. smegmatis 
By 4 h the macrophage could clear a ‘light’ infection with live M. smegmatis, but at 
numbers above about 1-5 per cell, these bacteria multiplied rapidly. Growth of M. 
smegmatis in monocytes was seen by others, but only after 1-4 days infection 37,39. 
Thus, even a non-pathogenic strain of mycobacterium that normally grows in soil can 
express some ‘pathogenic’ characteristics. However, M. smegmatis growth was 
stringently limited (or loss) to the 4-9 h period; in J774 cells and in mouse primary 
macrophages it was followed by an efficient killing phase (which by itself argues 
against the notion that the growth of M. smegmatis at higher infection loads was 
detrimental to the macrophages). This growth-permissive period coincided with a 
striking recycling of a membrane protein, LAMP-1 and gold content marker out of most 
phagosomes with live, but not killed M. smegmatis. Whether this unexpected recycling 
is a response of the host cell ‘sensing’ the live bacteria, and perhaps ‘lowering its 
guard’, perhaps to divert resources for antigen presentation, or whether it is actively 
induced by the live bacteria will require further studies.  
 
Killing phase 2 
There was a striking and reproducible second phase of killing between 9 h and 12 h 
after infection in J774cells. This suggests that fusion between phagosomes and 
additional compartments must be occurring just prior to this period. Clearly, these 
compartments had to be distinct from conventional late endosomes and lysosomes since 
the bulk of both internalized gold content and LAMP-1 had recycled out of the 
 57 
phagosomes during this period; they were re-acquired only after 12 h, coinciding with 
the third killing period.  
In searching for additional compartment(s) that could fuse with phagosomes to facilitate 
the second killing we were faced with surprising complexity. Most unexpected was that 
the bulk of the detectable V-ATPase resides in a compartment that is distinct from the 
late endosomes and lysosomes (see below) that fuses significantly with the phagosomes 
at a relatively late stage, just before and coincident with killing phase 2. The emergence 
of killing phase 2 also coincided with a significant increase in the fraction of acidified 
phagosomes. Live M. smegmatis was able to significantly delay the acquisition of a low 
pH by the majority of phagosomes until 8 h (relative to killed bacteria or latex bead 
phagosomes). This is likely due to the delay in the delivery of the V-ATPase, since the 
kinetics of lysotracker labelling and the acquisition of the V-ATPase were quite similar 
with live bacteria (Fig. 4B and D). The delivery of active V-ATPase and acidification of 
phagosomes are likely to be crucial for this second (and third) killing phase since 
bafilomycin prevented them. 
There were interesting parallels between the delivery to phagosomes of the V-ATPase/ 
acidification, and the acquisition of the membrane transporter LYAAT. This recently 
discovered marker 60 was rapidly acquired by dead bacterial phagosomes but, as for the 
acidification process, the presence of the live M. smegmatis in phagosomes led to a 
delay in LYAAT acquisition. Like the V-ATPase, the LYAAT compartments were 
mostly distinct from those that labelled for gold or LAMP-1 (see below). The tyrosine 
kinase HcK, which co-localizes with LYAAT in human macrophages 61 behaved 
similarly to LYAAT also in our system (Table 1). Overall, our data lead us to conclude 
that the V-ATPase-enriched structures and the LYAAT-labelled ones were distinct from 
each other and from LAMP–labelled vesicles [(which can be sub-divided into two 
compartments73. However, all these compartments can be classified as late endocytic 
organelles since at least a fraction of all of them are accessible to rhodamine gold 
following a chase period (Table 1; Fig. 7B). We conclude that much remains to be done 
in characterizing late endocytic organelles but these different compartments will all 
have to be considered if we are to understand what in the lumen contributes to killing. 
 
Killing phase 3 
Between 12 h and 24 h the macrophages initiated the third killing phase that was able to 
eliminate almost all live M. smegmatis. This coincided with a second cycle of 
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phagosomal actin assembly (seen in vitro and in cells) and of late endosome/lysosome 
fusion, as seen by the further acquisition of LAMP-1 and gold. The feeding of cells with 
the inhibitors of lysosomal enzymes that we used did not affect this killing phase. Either 
proteases are not involved, or the protease and non-protease enzymes that are involved 
were not susceptible to the effectors we used. At this last stage, the vast majority of the 
phagosomes were strongly acidic and bafilomycin treatment also blocked this killing 
stage. We cannot rule out that additional, still to be identified compartments need to 
fuse with the phagosomes to initiate this third, as well as the second killing phases. 
Based on our data we tentatively conclude that four different late endocytic organelles 
need to fuse with the mycobacterial phagosomes for maximum killing activity (Fig. 
7B). 
 
Role of p38 MAP kinase 
The MAP kinase p38 emerged as an important regulator of a number of the processes 
involved in killing M. smegmatis, in agreement with other studies on mycobacteria 
3,5,43,74-76
. Earlier studies linked p38 to endocytic fusion events 44 and to phagosome-
endosome fusion 7 while here we additionally provide evidence for its importance in 
regulating phagosomal actin assembly, a process linked to some membrane fusion 
events 41. Inhibiting this kinase blocked (the active periods of) phagosome actin 
assembly 8 in vitro while the addition of PIP2 to M. smegmatis, that activates phagosome 
actin assembly, stimulated p38 activation (Figs. 1B and C). The inhibitor also blocked 
phagosomal actin in macrophages and, in agreement with our recent studies 8,41 this 
coincided with a corresponding inhibition of the fusion of phagosomes with late 
endosomes/lysosomes, most prominently seen with M. smegmatis. The MAP kinase p38 
also regulates some stages in the delivery of LYAAT, as well as the delivery of the 
functional V-ATPase to acidify the phagosomes. While the complexity of this system 
defies a simple model, it is clear that p38 is a key regulator of both phagosome actin 
assembly and of most of the late fusion events involving phagosomes. 
An unexpected finding was that p38 signaling could favour the macrophage for some 
functions but some cascades regulated by this kinase appear to have been subverted by 
M. smegmatis for its benefit. As evident in Fig. 2A1 and A2 the pattern of activation of 
macrophage p38 by live and killed M. smegmatis was totally different, with the cell 
responding quickly but transiently to the dead bacteria but showing a complex pattern of 
p38 activity with live ones. It is noteworthy that there was high p38 activity during at 
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least two of the killing periods. The macrophage and the live M. smegmatis thus appear 
to be in a ‘tug of war’ situation with respect to p38 signaling. Collectively, our data 
argue that these signaling events are part of the macrophage pro-inflammatory response. 
The activity of this MAP kinase normally facilitates many macrophage processes, but 
the live bacterium seems to have diverted part of its signaling response towards (i) 
delaying initial activation of p38 (Fig. 2A1 and A2); (ii) Delaying the delivery of V-
ATPase and LYAAT to phagosomes (Fig. 4A and D); and (iii) facilitating its own 
growth (Fig. 2B). The p38 signalling system may have evolved as a ‘sensor’ that 
informs the macrophage of the existence of live bacteria. If so, it is a sensor that the 
mycobacteria had learnt to co-opt, and disrupt for its own goal, survival.       
Our mathematical model of the system complemented our data by providing a dynamic 
description of the infection process. Without invoking any mechanisms of killing this 
model is based only on the following experimental facts (i) J774 macrophages have the 
propensity to kill all M. smegmatis; (ii) the cell shows cycles of high and low activity 
with respect to bacterial killing factors; (iii) M. smegmatis divides every 3h (in vitro; 
Fig. 1A2) and (iv) the efficiency of bacterial killing is reduced at high numbers of 
bacteria per cell, above about 5 77. The model revealed that whereas a certain level of 
killing set at a critical value (k0) led to exponential bacterial growth, a time-modulated 
level of killing with an average value at k0 not only prevented growth but led to 
effective killing. The dynamics of the M. smegmatis growth/killing seen experimentally 
in Fig. 1A1 at both low and high bacterial infection levels could be effectively 
simulated by this model (Fig. 6G). In addition, the time course of the percentage of 
killed bacteria was calculated (Fig. 6H) and shown to be in good agreement with the 
experimental data shown in Fig. 1A3. These simulations suggest that the macrophage 
can be more effective against the bacteria when it concentrates its killing activity to 
transient periods than when it ‘spreads it out’ evenly in a continuous manner. Another 
consideration is that the macrophage may be using up limited resources in every ‘attack’ 
that need to be thereafter replenished. 
Evidently, the interactions between a macrophage cell line and a live mycobacterium 
destined for death is far more complex than one might expect. The macrophage does not 
(and to some extent is not allowed to) kill M. smegmatis by firing all its ‘guns’ in one 
‘shot’ but rather the whole process is a dynamic interplay between the normal killing 
processes, that have a finite limit and capacity, and the presence in phagosomes of the 
live bacterium, that is fighting to survive. The activation of iNOS and of the fusion of 
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up to four (perhaps more) different compartments with phagosomes, all of which are 
likely contribute to the killing process, shows striking temporal regulation (Fig. 7A). 
Besides NO and some lysosomal proteases implicated in this study all the other factors 
that presumably operate to kill mycobacteria within the phagosome lumen remain to be 
identified.  
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MATERIALS AND METHODS 
 
Cell Line and Bacterial Culture Conditions: The mouse macrophage cell line 
J774A.1 was cultured as described previously 8. M. smegmatis mc2 155 harbouring a 
p19-(long-lived) EGFP plasmid was grown in medium containing Middlebrook’s 7H9 
broth Medium (Difco), Nutrient broth (Difco) (4.7 g; 5g per liter, respectively), 
supplemented with 0.5 % glucose and 0.05 % Tween 80 at 37°C on a shaker at 220 rpm. 
In order to stabilize GFP expression medium was supplemented with Hygromycin (50 
µg per ml) and bacteria were subcultured every day in fresh medium for 7-10 days 
before use in infection studies. 
 
Macrophage infection: Bacterial cultures in exponential growth phase were pelleted, 
washed twice in PBS pH 7.4 and re-suspended in DMEM medium to a final OD600:0.1. 
Clumps of bacteria were removed by ultrasonic treatment of bacteria suspensions in a 
ultrasonic waterbath for 15 min followed by a low speed centrifugation (120 g) for 2 
min. Single cell suspension was verified by light microscopy.  
J774 cells were seeded onto 24 well tissue culture plates at a density of 0.5x105 cells per 
well and were incubated for two days until 90 % confluency and infected with bacteria 
at different multiplicity of infection (M.O.I). When we infected macrophages that were 
onl yaround 70 % confluent we observed significant macrophage cell death. To achieve 
more than five bacilli per macrophage after 1 h uptake, a M.O.I of 100:1 was used 
(OD600~0.1). In each experiment, after 1 h infection gentamycin (10µgml-1) was added. 
A number of control experiments were made to ensure that this concentration of 
antibiotic killed all extracellular bacteria without affecting the intracellular ones 
(Results not shown). 
 
Treatment with Inhibitors: When required cells were treated with specific inhibitors, 
unless otherwise stated these were added from 0 to 1 h after uptake, and left throughout 
the experiment. The inhibitors were: p38 MAPK inhibitor SB203580 (2 µM) 
(Calbiochem), the V-ATPase inhibitor, bafilomycin A1, 100nM (Sigma), the iNOs 
inhibitor L-NAME [N(G)-nitro-L-arginine methyl ester hydrochloride (Sigma; 500µM)] 
and the NOC-18 (Sigma; 0.1 or 1µg ml-1) For testing the protease inhibitors effect on 
the M. smegmatis survival, a cocktail of 100 µM of Leupeptin, Aprotinin and Pepstatin 
was added to the culture medium for the times shown in Fig. 2C. At the end of the 
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incubations, intracellular bacteria was recovered by lysis of infected macrophages using 
a 1 % Igepal CA-630 (Sigma) solution in water and plated in medium for CFU 
counting. 
 
Epifluorescence and Confocal Fluorescence Microscopy: Macrophages grown on 
glass coverslips were allowed to take up latex beads or bacteria. Cells were fixed with 3 
% paraformaldehyde in PBS at room temperature for 15 min. Cell permeabilization, 
when required, was achieved with 3 min treatment with 1 % Triton X100 in PBS. After 
blocking with 2 % fetal calf serum in 40mM glycine-PBS, cells were incubated for 30 
min with primary antibody, followed for further 30 min by secondary antibody. For 
actin labelling in vivo rhodamine phalloidin was used as described before 8. Lysotracker 
Red DND-99 (Molecular Probes) staining of acidic organelles was carried out by 
adding a 1:20,000 dilution in DMEM that was added for the last 30 min of the 
experiments. For propidium iodide staining infected macrophages were washed with 
PBS and lysed with 1 % Igepal in water. Bacteria were recovered by 10 min 
centrifugation at 10000 rpm in a table-top centrifuge and washed twice in water. 
Subsequently, dead bacteria were stained by 5 µgml-1 propidium iodide.  Confocal 
microscopy images were collected using the Zeiss LSM510 and the percentage of 
colocalisation was calculated using either the Image J software system or manually. 
Fluorescence labelling and viability of mycobacteria was performed as described 8. 
The following antibodies were used for immunofluorescence microscopy: Anti CD63 
and anti Hck were from Santa-Cruz. The rabbit antibody against LYAAT-1 60 was 
kindly provided by Dr B. Giros (Créteil, France). Anti-mouse LAMP-1 was purchased 
from the Iowa Hybridoma bank. The rabbit V-ATPase antibody against the 16 KDa 
subunit was described by Skinner et al 78.The rabbit iNOS antibody was kindly 
provided by Dr Michael Marletta (University of Berkeley) 69. For co-localization 
experiments of LAMP-1 and V-ATPase or LAMP-1 and LYAAT1 the secondary 
antibodies were linked with Cy3 and Alexa 488, respectively. 
 
Fusion assay: Analysis of phagosome lysosome fusion was done using 7 or 15nm gold 
particles prepared according to Slot and Geuze. Gold particles were saturated with 20 % 
of BSA and centrifuged once for 45 min, 10 000g. The pellet was suspended in PBS- 
Rhodamine-NHS (1mg ml-1) and rotated on a wheel for 1 h, washed three times with 
PBS Glycine 50 mM and resuspended in a small volume of PBS - Glycine 50mM - 
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azide 0.02 % (for storage; this was dialyzed away before use). The OD was estimated at 
520 nm and the rhodamine gold particles are used with an OD520 of 1 in culture medium 
in all fusion experiments. Cells were pulsed for 1 h with these gold particles, washed 3 
times with PBS and chased for 1 h or longer in complete culture medium. Infection with 
mycobacteria was then allowed for 1 h (OD600 of 0.1 for mycobacteria) in complete 
medium without antibiotics. Cells were washed extensively with PBS and chased for the 
different, indicated time points of fusion, fixed in PBS-paraformaldehyde (4 %) and 
analyzed by confocal microscopy. 
 
Isolation of phagosomes: Latex bead or mycobacterial containing phagosomes were 
isolated as described before 8. 
 
Actin nucleation: This assay was described in detail by Defacque et al. 48. In all 
experiments described the errors reported are the standard deviations from at least three 
separate experiments.  
 
Nitric oxide: was measured using Griess reagent following the supplier’s (Sigma) 
instructions.  
 
Preparation of whole cell extracts and immunoblot analysis: Cells where washed 
twice with PBS and lysed in IP buffer (50 mM Tris pH 7.5, 150 mM sodium chloride, 1 
mM EDTA, 1 mM EGTA, 1 % NP-40 and protease inhibitors) at 4ºC for 30 minutes. 
The extracts were sonicated in 5 s bursts until complete homogenization and centrifuged 
at 13000g for 10 min to remove cell debris. When SB203508 was used, cells were 
treated for 1 h before infection with 2 µM SB203508. After 1 h uptake the medium was 
removed, cells were washed three times and new drug was added to the medium. Equal 
amounts of protein were loaded on a 12 % SDS-PAGE, transferred to nitrocellulose 
membrane and probed with a rabbit anti-phospho p38 and anti total p38 (Cell Signaling 
Technology). Enhanced chemi-luminescence (Pierce biotechnology) was used to 
visualize antibody binding. 
M. smegmatis (live or heat killed) phagosomes were isolated as previously described 8. 
For the incubations with PIP2 phagosomes were incubated under actin nucleation 
conditions (without actin and thymosin beta 4) with 0.2mM ATP, with or without the 
lipid. For membrane purification prior to running SDS gels phagosomes were 
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centrifuged at 24000g for 30 min. Pellets were treated as described above for 
preparation of whole cell extracts and immunoblot analysis. Anti-tubulin (Sigma) was 
used to assess the amount of total protein in the different membrane isolates. 
 
Mathematical modeling. 
Principle of the simulation: A defined number of intracellular bacteria B were contained 
within a defined number of macrophage cells C. If they were not disturbed by cellular 
defense mechanisms, the intracellular bacteria grew exponentially with a growth rate g 
(see also Fig. 6A) 
 
     dB/dt = g x B    (1)             
⇒ B(t) = B(0) x exp(g x t) 
 
The growth rate g is related to the doubling time t2 by 
 
     g = ln(2) / t2     (2) 
 
The cellular response to invading bacteria was described by a cellular killing rate k (see 
also Fig. 6B) 
 
     dB/dt = -k x B    (3) 
 
⇒ B(t) = B(0) x exp(-kxt)  
 
We assumed that an individual cell has only limited resources available in order to 
maintain a certain average killing rate k0 (Rook, 1981). The rate can either be constant 
over time k = k0 (inset Fig. 6E and F) or it can be a function of time k = k(t) (inset Fig. 
6G) with an average rate k0 (dashed line) determined by the limited resources available. 
 
As the experimental data shows cycles of high and low cellular activity, we assumed a 
sinusoidal modulation of the killing rate as a first approximation (inset Fig. 6G) 
 
k(t) = k0 + k1 x sin(2pi x ν x t)                         (4) 
 65 
 
where k0 is the time-averaged killing rate and k1 the amplitude of the modulation with a 
frequency ν.  
 
The experimental data (Fig. 1A1) suggests that cellular killing is less efficient for high 
numbers of bacteria per cell b = B/C compared to low numbers of b. Therefore we 
introduced a killing efficiency factor e(b) that was multiplied to the killing rate : 
 
dB/dt = - e(b) x k(t) x B   (3’) 
 
The killing efficiency has to be maximal (e = 1) for low numbers of bacteria per cell (b 
→ 0) and minimal (e = 0) for high numbers of b. Such a behavior is described by a 
sigmoidal curve (Fig. 6D) 
 
e(b) = [1 + exp(-b0 x s)] / {1 + exp[(b-b0) x s] }     (5) 
 
At a critical bacterial density  
 
bc = ln[2 + exp(b0 x s)] / s   (6) 
 
the killing efficiency drops to its half value e(bc) = 0.5 The parameter s describes how 
sensitive the efficiency e(b) depends on the bacterial density at b = bc. A high value for 
s (unit cells per bacterium) means that the killing efficiency e(b) depends strongly on 
the bacterial density b, a low value that it depends weakly on b.  
 
In our model, the total number of cells C was assumed to be fixed, therefore the 
efficiency e(b) depends directly on the number of bacteria B and can be written as e(B). 
Taking together the equations (1) and (3’) yields the following differential equation for 
the number of bacteria B 
 
dB/dt = [g - e(B) x k(t)] x B        (7) 
 
This equation was solved in order to derive the graphs shown in Fig. 6 (E - H).   
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Parameters: For the graphs shown in Fig. 6 (D - H), the following parameters were 
chosen: The doubling time t2 = 3 h of M. smegmatis was derived from Fig. 1A2 yielding 
a growth rate of g = 0.23 h-1 according to equation (2).  
 
The killing rates can be estimated from intracellular bacterial survival curves (Fig. 
1A1). For the case of an oscillating killing rate (Fig. 6G and H), the oscillation 
frequency was ν = 2/day to ensure a transition between high and low killing rates every 
6 h as observed experimentally. The average of the killing rate was chosen k0 = 0.6 h-1 
and the amplitude was k1 = 0.6 h-1 ensuring almost complete killing within the first 4 h 
in case of low infectivity (Fig. 6G, low infectivity). In order to compare the case of a 
constant killing rate with the case of an oscillating one, the constant killing rate k = k0 = 
0.6 h-1 was used for Fig. 6E and F. 
 
To model the observed reduced killing efficiency for high numbers of bacteria per cell a 
critical bacterial density of bc = 4.9 bacteria per cell (b0 = 2.8 bacteria per cell) and a 
sensitivity of s = 0.3 cells per bacterium was used for the graphs in Fig. 6.D - H. With 
these parameters, the killing efficiency drops by δe/e = -20 % if the bacterial density is 
increased by δb = +1 bacterium per cell around the critical density bc (Fig. 6D). 
 
The kinetics of live bacteria for high and low infectivity shown in Fig. 6G are in 
agreement with our experimental data (Fig. 1A1). In addition, the percentage of killed 
bacteria (number of killed bacteria divided by total number of bacteria) as a function of 
time was calculated (Fig. 6H) and shown to be in good agreement with the experimental 
data from Fig. 1A3. A comparison of the constant (Fig. 6E) versus the oscillating killing 
activity (Fig. 6G, high infectivity) at high infectivity shows the following: Although the 
killing rate was on average at the same level (k0 = 0.6 h-1), the bacteria grow 
exponentially (with an effective growth rate of 0.16 h-1) in case of a constant rate (Fig. 
6E) but are finally killed in the case of an oscillating rate (Fig. 6G). 
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ABSTRACT 
 
Both pathogenic and non-pathogenic mycobacteria are internalized into macrophage 
phagosomes. Whereas the non-pathogenic types are invariably killed by all 
macrophages, the pathogens generally survive and grow. Here, we addressed the 
survival, production of reactive nitrogen intermediates (RNI) and intracellular 
trafficking of the non-pathogenic M. smegmatis, the pathogen-like, BCG and the 
pathogenic M. bovis in different mouse, human and bovine macrophages. The 
bacteriocidal effects of RNI were restricted for all bacterial species to the early stages of 
infection. EM analysis showed clearly that all the mycobacteria remained within 
phagosomes even at late times of infection. The fraction of BCG and M. bovis found in 
mature phagolysosomes rarely exceeded 10 % of total, irrespective of whether bacteria 
were growing, latent or being killed, with little correlation between the extent of 
phagosome maturation and the degree of killing. Theoretical modelling of our data 
identified two different potential sets of explanations that are consistent with our results. 
The model we favour is one in which a small but significant fraction of BCG is killed in 
an early phagosome, then maturation of a small fraction of phagosomes with both live 
and killed bacteria, followed by extremely rapid killing and digestion of the bacteria in 
phago-lysosomes. 
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INTRODUCTION 
 
Infection with mycobacteria remains a major health problem. Although in the recent 
years infections by M. avium are gaining importance among imuno-suppressed 
individuals tuberculosis is still the major problem. Mycobacteria from Mycobacterium 
tuberculosis complex, Mycobacterium africannum, Mycobacterium bovis and 
Mycobacterium tuberculosis, are the etiological agents of this disease 1,2. In a number of 
countries, M. bovis is responsible for important economic losses due to bovine 
tuberculosis 3,4. This Mycobacterium can also infect humans, causing tuberculosis, with 
a patho-biology indistinguishable from that one caused by M. tuberculosis 2,5. The 
success of these pathogens is to a large part dependent on their ability to inhibit host 
defence mechanisms and persist in a potentially hostile environment, the macrophage 
phagosome, and is also facilitated by the emergence of multi-drug resistant (MDR) 
strains and extensively drug-resistant (XDR) strains 6.  
The crucial difference between non-pathogenic and pathogenic mycobacteria is that the 
latter arrest maturation of phagosomes at an early stage 7-10. Although the mechanism 
responsible for this process is poorly understood the arrested phagosome provides a 
friendly environment for pathogen survival and even growth 11-13. The mycobacterial 
phagosome has particular characteristics such as low content of vacuolar ATPase (V-
ATPase) 14, and thereby incomplete luminal acidification, as well as a low content of 
mature lysosomal enzymes. Collectively these pathogen-altered conditions are assumed 
to facilitate survival of the mycobacteria 9,13. 
The question of how and where mycobacteria are killed by macrophages is still open, 
both for the non-pathogenic and pathogenic forms 15. From the literature two extreme 
models can be envisaged. In the first, the killing only occurs after phagolysosome 
fusion; in this model the macrophage killing potential depends on its abilty to fuse the 
phagosome with late endocytic organelles, here, often simplified as ‘lysosomes’. 
Thereby, it is presumed that the combination of low pH and a battery of lysosomal 
hydrolases induce both killing and digestion/clearance of the bacteria. In agreement 
with this hypothesis are extensive data correlating a high incidence of phagosomal 
fusion with a high rate of killing, and a low extent of this fusion with high survival 
13,15,16
. This model is widely favoured and is also supported by an early study by Cohn 
17
, who first showed that lysosomal extracts are potentially bacteriocidal; that study 
showed that extracts of macrophage or neutrophil lysosomes can induce killing of E. 
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coli within 1 min. In the case of M. smegmatis in J774 cells a rapid 1-4h killing period 
coincides with extensive phago-lysosome fusion and the internalisation of a cocktail of 
lysosomal enzyme inhibitors by endocytosis into infected macrophages strongly 
reduced the potency of this early killing period Anes et al. (2006) 18. 
An alternative hypothesis emerged from the pioneering study by Armstrong and D’Arcy 
Hart (1971) 19. Based on a thorough EM analysis in which endocytosed ferritin was 
used as a lysosomal marker these authors came to the conclusion that the live M. 
tuberculosis actively avoided phagolysosome fusion, a point that is widely appreciated. 
Less appreciated is their conclusion that only after being killed in a non-matured 
phagosome could the phagosome fuse with lysosomes. In contrast, when M. 
tuberculosis opsonised with a specific anti-M. tuberculosis antibody before 
internalisation the majority of the bacterial phagosomes now fused with lysosomes. 
However, M. tuberculosis nevertheless multiplied at the same rate as the non-opsonised 
bacteria, that were predominantly in non-mature phagosomes 11. A similar conclusion 
was made later by Gomes et al. (1999) 20. In these experiments the accumulation of 
pathogenic mycobacteria in a mature phagolysosome (that also contained Coxiella 
burnetii) did not induce killing of M. tuberculosis or M. avium. More recently elegant 
assays were used to select for M. tuberculosis mutants that can survive in mature 
phagosomes 12,21,22. All these observations are clearly at odds with the model in which 
mycobacteria are killed in mature phagosomes. 
NO produced from iNOS is a more well-defined component of host defence against 
intracellular pathogens including M. tuberculosis 23. Phagocytes produce NO and a 
plethora of other potent mycobacteriocidal reactive nitrogen intermediates following 
stimulation with mycobacteria and this process is accentuated by inflammatory 
cytokines like γ-IFN and/ or bacterial lipopolysaccharides (LPS) 23-25. The tolerance of 
mycobacteria in vitro to RNI is strain, dose and time-dependent, with the pathogens 
being inherently more resistant than the non-pathogens 26-29. In our recent study of the 
non-pathogenic M. smegmatis, the macrophage needs at least 4 h, and up to 24-48 h 
after infection to completely kill the bacteria. Nevertheless, the expression of iNOS and 
the production of NO, that facilitated bacterial killing, was restricted to the first 2 hours 
18
. 
Most published studies have compared up to two different cell types and two different 
mycobacteria, often with different virulence, such as Mycobacterium tuberculosis 
H37Ra and Rv. We decided to make a broader analysis of mycobacterial-macrophage 
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interactions. The main goal was to try to find a pattern of killing or survival that could 
be clearly correlated with macrophage killing mechanisms. Towards this goal, after 
preliminary studies with M. smegmatis, we tested different mycobacteria (M. bovis and 
M. bovis BCG) in up to six different cell types: mouse (bone marrow macrophages 
(BMM), J774 and RAW), human (monocyte derived macrophages from human 
peripheral blood (HMDM) and THP-1) and bovine macrophages (monocyte derived 
macrophages from bovine peripheral blood: BMDM). For M. bovis spp we first 
monitored intracellular survival following colony forming units (CFU) and then 
investigated the role of NO. Subsequently, different assays for phago-lysosome fusion 
and acidification were applied.  
Our results suggest that a specific pathogen-induced macrophage ‘program’ is induced 
upon infection that correlates with the bacterial doubling time, in which phases of 
macrophage high killing potential often alternate with phases conducive to bacterial 
growth. RNI and low pH play key roles in killing during the first day(s) of infection of 
pathogenic mycobacteria. Subsequently, RNI and pH-independent mechanisms kill the 
bacteria within phagosomes. Our results, in conjunction with theoretical modelling for 
BCG infection argue that a significant killing of these mycobacteria must occur in non-
matured, early phagosomes, in agreement with Armstrong and D’Arcy Hart (1971) 19. 
However, the majority of BCG is more likely to be killed and digested after phago-
lysosome formation. 
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RESULTS 
 
Kinetics of M. smegmatis survival in different host macrophages 
From previous studies M. smegmatis infecting J774 are killed completely within 48 h 
under all infection conditions 18,30,31. M. smegmatis survival kinetics inside J774 is 
complex and was characterized in detail previously 18. A striking observation was a 
dynamic interplay between bacteria and J774 cells (Fig. 1A). A first phase of killing (4 
h) was followed by growth (4-8/9 h) and subsequent killing phases between 9 and 48 h. 
Here we used GFP-expressing M. smegmatis and followed the CFU in BMM derived 
from C57BL/6 mice and in HMDM. In BMM the dynamics of M. smegmatis showed a 
super-imposable pattern to that seen in J774 macrophages (Figs. 1A and C). In HMDM 
(Fig. 1D) and RAW (Fig. 1B) the initial killing phase was seen but thereafter different 
kinetics were observed, with the remaining M. smegmatis being killed slowly in a 
continuous fashion.  
 
Figure 1. Intracellular fate of M. smegmatis in different macrophages 
CFU estimates for M. smegmatis (GFP) are shown in J774 macrophages (A), RAW 
macrophages (B), BMM (C) and HMDM (E). 
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For HMDM the same pattern of killing by 4 h was also seen at higher levels of infection 
(Results not shown). It is striking, and surely no coincidence that in all four cell types 
the first killing period is found between 1 and 4 h, and, when growth is permitted, it 
peaks in both cells around 8 h. These data suggest that the timing of these cycles is 
likely to be induced by the bacteria- that divide every 3 hours. 
 
Kinetics of M. bovis spp survival in different host macrophages 
The above data suggested that the cycles of killing and growth might be induced by 
factors related to the cell cycle of the pathogen. This idea made it interesting to 
investigate pathogenic mycobacteria, which have a far longer division time (around 24 
h) than M. smegmatis. We therefore tested BCG and M. bovis in six different cell lines: 
J774, BMM, the human monocytic like cell line THP-1, HMDM and BMDM (Figs. 2A 
to F). 
 
Figure 2. Intracellular fate of BCG (GFP) or M. bovis in different host macrophages 
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CFU estimates for BCG (GFP) in J774 macrophages (A), RAW macrophages (B), BMM (C), 
HMDM (D), THP-1 cells (E) and BMDM (F). A comparison between the CFU estimates for 
BCG (GFP) and M. bovis in J774 macrophages (G) and HMDM (H) is also shown. G and G1 
show the same data plotted differently (see y axis). 
 
We first established infection conditions for BCG-GFP in J774. This GFP strain grows 
at identical rates in vitro and in macrophages to the parental non-GFP strain (results not 
shown). Bacteria were added at OD600nm 0.1 for 3 h; this gave on average 2 to 9 bacteria 
per cell. For the other cells the same conditions were used, except for HMDM and 
BMDM, in which case OD600nm 0.1 appeared to be toxic for the cells. We therefore used 
an OD600nm of 0.01 which allowed the cells to survive normally for at least 7 days. In all 
our reported experiments the total number of live macrophages remained almost 
constant over the period of infection, as accessed by cell counts. 
 Using the trypan blue exclusion method less than 1 % macrophage death was detected 
under all conditions. Thus, in this study macrophage cell death could be excluded as 
having any significant role in the killing of mycobacteria. 
As shown in Figs. 2A to F we saw three different patterns of bacterial survival. In 
BMM, THP-1 and J774 an overall pattern of killing was observed over the 7 days 
period. With RAW neither significant growth nor killing was observed. In contrast, in 
HMDM BCG grew up to 3 days, and thereafter neither growth nor killing was seen. We 
initially used time-scales of hours for these experiments but it soon emerged that the 
switches from killing to growth, when they occurred, happened on a much slower time 
scale with the pathogenic mycobacteria, in agreement with the hypothesis that timing of 
the macrophage cycles of killing and growth is related to the bacterial growth/division 
time. 
We next compared BCG with the virulent strain of M. bovis in J774 and HMDM. In 
J774 whereas BCG could be steadily killed over the course of 7 days infection (Fig. 2G) 
M. bovis could be killed only during the first 24h hours, that was following a growth 
phase; this is more easily observed using a linear scale (Fig. 2G1) rather than the semi-
log scale used in Fig. 2G. With HMDM both BCG an M. bovis could steadily grow at a 
level easily seen on a semi log scale (Fig. 2H). Thus, both bacteria behave quite 
differently in the two macrophage cell types and are better adapted to survive and grow 
exponentially in the human primary macrophages. 
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It is difficult to visualize any meaningful trends in these data, although some cells 
(THP1 and BMM) tended towards a similar gradual killing of BCG. There was no 
obvious ranking of macrophage ‘killer cells’ when we compared their abilities to kill M. 
smegmatis, BCG or M. bovis. For example, J774 kills BCG better than RAW, but RAW 
is much more effective that J774 cells in clearing M. smegmatis.  
 
Role of inducible NO synthase and nitric oxide release  
We next related the pattern of intracellular growth/killing to the pattern of macrophage 
activation that is known to contribute to killing of mycobacteria. We first investigated 
NO production using the Griess reagent. In our recent study on M. smegmatis, in J774 
cells we showed that NO is only produced up to 2 h after infection, where it contributed 
to the first killing phase 18. Here we focussed on BCG and M. bovis. 
First we tested the susceptibilities of different mycobacteria to NO in vitro. For these we 
used two NO sources NOC-18 (Figs. 3A and B) and acidic solutions of sodium nitrite 
(not shown). BCG could be killed by 0.1 µM NOC18 after 1 day but after 14 days in 
culture a 100-fold higher concentration of NOC-18 was needed for efficient killing (Fig. 
3A). In contrast M. bovis was highly resistant; after 1 day in culture only partial killing 
was seen with 1 µM NOC-18 (a 10-fold higher concentration than that needed to kill 
BCG) and to achieve complete killing a 1000-fold higher concentration of NOC-18 was 
required (Fig. 3B). 
We next investigated cell production of NO in response to BCG and M. bovis. NO was 
not detected in supernatants of HMDM under any conditions, in agreement with other 
studies on human macrophages 32. γ-IFN is known to induce strong iNOS activity and 
often also an increase in mycobacterial killing 33-36. As seen in Table 1, overnight 
treatment of J774 cells with γ-IFN before infection led to a highly significant increase in 
NO levels after 1 and 2 days infection with BCG or M. bovis.  
We next tested the effects of NO on M. bovis spp survival in J774. For this we either 
increased NO artificially, using NOC-18 or γ-IFN, or decreased NO levels by blocking 
the enzyme (i-NOS) that synthesizes it, with a specific inhibitor: L-NAME. At 1 day 
post-infection 0.1 or 1 µM NOC-18 were able to significantly increase the killing of 
BCG and M. bovis (around 40 % increase in killing), respectively (Fig. 3C and D). The 
extent of killing by NOC-18 and γ-IFN were similar for M. bovis whereas γ-IFN had a 
small but insignificant effect on BCG survival at day 1 (Figs. 3C and D).  
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Figure 3. Role of nitric oxide (NO) in M. bovis spp survival 
In vitro susceptibility of M. bovis BCG (GFP) (A) and M. bovis (B) to different concentrations 
of the NO donor NOC-18. Effect of L-NAME, NOC-18 and γ-IFN on intracellular survival of 
BCG (GFP) (C) or M. bovis (D) evaluated after 1 day infection. E and F show CFU estimates 
after 7 days of M. bovis BCG (GFP) (E) or M. bovis (F) in J774 macrophages treated with or 
without γ-IFN. (*p< 0.05; **p<0.001). 
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With L-NAME a reproducible and significant (30 and 40 %) increase in survival was 
observed after one-day infection of BCG and M. bovis-infected macrophages (Figs. 3C 
and D). After 1 day neither NOC-18 nor L-NAME affected mycobacteria survival 
(results not shown). Taking in account the limit of quantification of NO using the Griess 
method we observed low but detectable  amounts of NO production during the early 
infection periods with both strains (Table 1: 3h and one day post-infection).  
 
Table 1. Nitric oxide release by infected J774 macrophages 
1.A. BCG  1.B. M. bovis 
[NO] µM  [NO] µM 
Control γ-IFN  Control γ-IFN Time 
Average SD Average SD  
Time 
Average SD Average SD 
3h < 1.0 * 0.40 < 1.0 * 0.40  3h < 1.0 * 0.40 < 1.0 * 0.40 
1 day 1.0 0.5 18.7 0.12  1 day 1.0 0.05 25.4 1.23 
2 days 2.8 0.40 20.5 0.09  2 days 1.3 0.08 25.3 0.91 
3 days 3.2 0.20 4.4 0.03  3 days 1.8 0.05 5.6 0.06 
* extrapolated from the reference standard curve 
 
Figures 3E and F show the effects of an extended treatment of infected cells with γ-IFN, 
until 7 days infection. These results show clearly that for BCG γ-IFN-treatment 
modestly but significantly increases bacterial killing until day 3 with little effect 
thereafter (Fig. 3E). With M. bovis (Fig. 3F) the effect of γ-IFN was predominantly seen 
between 3 h and 1 day. It is notable (and will become more evident in Fig. 7) that the 
main effect of γ-IFN in enhancing killing coincides with an innate early phase of 
bacterial killing. In another series of experiments we saw the same pattern with M. 
tuberculosis in response to γ-IFN (Fig. S1, Supplementary information). We presume 
that the main effect of γ-IFN in the killing process operates via the RNI system. 
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Figure S1. Comparison of CFU of M. tuberculosis in J774 macrophages up to 7 days infection 
with and without γ-IFN treatment. 
 
Since the mouse macrophages made NO in response to the mycobacteria we next 
correlated the expression of iNOS the enzyme that makes it after infection of J774 cells 
with BCG and M. bovis. Using immunofluorescence microscopy we could not detect 
any signal for iNOS in uninfected cells (Fig. 4A) whereas a significant increase in 
cytoplasmic labelling for iNOS was already detected after 1h infection with M. bovis 
(Fig. 4C) or BCG (Fig. 4B). No specific association of iNOS with phagosomes of either 
BCG or M. bovis was seen, in agreement with the data of Anes et al. (2006) 18 and 
Miller et al. (2004) 37. After treatment of uninfected (Fig. 4D) or infected macrophages 
(Fig. 4E) with γ-IFN a general increase in iNOS labelling was clearly observed. 
Immunofluorescence microscopy was a more sensitive estimator of iNOS that Western 
blotting. Although by Western blot iNOS could be detected after treatment with γ-IFN 
no band was detectable in untreated infected cells (Fig. 4F). 
Thus, conditions where NO levels are high correlate with an increase in iNOS protein 
levels, as expected. Collectively, these data lead us to conclude that increased iNOs 
activity early, but not late in infection plays a role in killing mycobacteria in mouse 
cells. γ-IFN treatment enhances the early killing phase, predominantly by stimulating 
iNOS activity. However, the fact that human macrophages have a similar capacity to 
kill non-pathogenic and pathogenic mycobacteria but have no iNOS activity shows 
clearly that RNI is neither the only nor the main  killing mechanism in macrophages. 
  86 
 
Figure 4. Localization of inducible NO synthase (iNOS) in J774 macrophages 
Immunofluorescence labelling for iNOS in untreated and uninfected J774 cells (A), in 
macrophages infected with BCG (GFP) (B) or with M. bovis (C) for 3 h. D and E shows the 
effects of γ-IFN treatment on uninfected cells (D) or cells infected with BCG (GFP) (E). In all 
images iNOS was labelled with Cy3 (red channel) and Mycobacterium spp were labelled with 
GFP (BCG) or Oregon green (M. bovis) (green channel). Western blots for iNOS during J774 
macrophages infection with BCG (GFP) during 3h and 1 day. Macrophages treated with γ-IFN 
were used as positive control. Actin was used as loading control (F).  
 
Phagosome-lysosome fusion and pH 
We next addressed the role of phagosome maturation in mycobacteria killing, focusing 
on phagosome-late-endosome/lysosome acidification and fusion. This is often assumed 
to be the major factor in the ability of the bacteria to survive (no fusion) and for the 
macrophage to kill them (fusion). If this is indeed the key factor, we would predict that 
by following phagosome maturation using a range of markers in different cell types 
infected with BCG and M. bovis, we would see significant correlations between the 
extent of fusion and the degree of killing. 
Late endocytic organelles as well as late phagosomes are predominantly acidic and the 
acquisition of a low pH is an accepted marker for mature phagosomes 15,38-42. Using the 
fluorescent dye lysotracker DND99, which accumulates in acidic compartments (pH< 
  87 
6), the acidification of BCG and M. bovis was monitored by confocal microscopy, 
focusing on J774 and HMDM cells 10,18. In J774 cells 3 h after infection only around 10 
% of both types of mycobacterial phagosomes were acidic and this increased to 20 % at 
day 1. However, by day 3 these values decreased again to around 10 % (Fig. 5A). In 
contrast, in HMDM more BCG-containing phagosomes acidified at 3 h but thereafter 
the fraction of acidified phagosomes remained below 10 %. The fraction of acidic M. 
bovis containing phagosomes never exceeded 10 % and, after 3 days only 5 % were 
acidic enough to accumulate lysotracker (Fig. 5B). 
We next followed phago-‘lysosome’ (late endosome and lysosome) fusion using an 
assay we recently introduced, in which nanogold particles labelled with rhodamine are 
internalised by late endocytic organelles (Figs. 5C and D) 18. Under all conditions in 
J774  and HMDM cells less then 10 % of the phagosomes containing BCG or M. bovis 
fused with rhodamine-labeled ‘lysosomes’. In HMDM cells at late time points less than 
3 % M. bovis phagosomes had fused with this marker. 
When J774 were fed with heat killed BCG the fraction of acidified phagosomes 
increased from 25 % at 3 h to around 80 % after 1 day (Fig. 5E). These argue that 
phagosome containing dead bacteria matured efficiently, as expected 7,32,43.  
The fraction of phagosomes that fused with lysosomes also increased between 3 h and 1 
day; however, whereas only 40 % of the heat killed BCG phagosomes had fused with 
lysosomes, the fraction that acidified was 80 %. This difference in the levels of 
acidification and fusion can be rationalised by our recent observation 18 showing that in 
J774 cells the bulk of V-ATPase is delivered to phagosomes from a late endocytic 
vesicle that is distinct from the “classical” late endosomes that label with LAMP-1 
32,44,45
.  
Using a different late endosome marker lysobisphosphatidic acid (LBPA) 46 with live 
BCG-infected J774 and HMDM cells a similar low fraction of phagosomes was found 
to co-localise with this marker (Fig. 5F). These data collectively show that overall, less 
than 10 % of BCG or M. bovis fused with late endosomes and lysosomes, or acidified in 
J774 or HMDM cells.  
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Figure 5. Phagosome acidification and fusion with late endosomes and lysosomes 
Acquisition of lysotracker and rhodamine gold by live BCG or M. bovis phagosomes in J774 (A 
and C) or HMDM (B and D) and heat killed BCG phagosomes in J774 (E). Shown in (F) is the 
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acquisition of LBPA and gold by live BCG phagosomes either in J774 or HMDM. The effects 
of bafilomycin A1 in macrophages infected with BCG are seen in (G) and with M. bovis spp 
(H). 
 
When one compares the overall pattern of phagosome maturation over the infection 
period with the growth of BCG or M. bovis (Figs. 2G and H) it was difficult to observe 
any clear correlations. 
In our earlier study on M. smegmatis in J774 cells we showed that a low pH in the 
phagosome contributes to the killing of these bacteria since the V-ATPase inhibitor 
bafilomycin A1 reduced the extent of killing 18. Given that even the early phagosome 
stage has a pH around 6.2 13,47, that will not be detected by lysotracker we asked 
whether lowering the pH had any effect on the survival of BCG or M. bovis in vitro. An 
early study 48 had shown that M. tuberculosis has an optimal pH for growth in vitro at 
pH 6.2 but there was significant less growth as the pH was reduced. In contrast, M. 
smegmatis is highly robust and can grow well in a wide pH range (from 4.5 to above 8), 
as might be expected for an organism found naturally in soil. As observed in Table 2, 
while M. bovis was not affected in our experiments by pH down to 5.5 BCG was more 
susceptible, with 20 % even being killed at pH 6.5. At pH 4.5 however, 40 % of M. 
bovis and over 80 % of BCG were killed.  
 
Table 2. Effects of pH on BCG and M. bovis in vitro 
 CFU compared to the control (%) 
M. bovis BCG 
pH 
1 day 7 days 1 day 7 days 
6.5 --- --- 20 10 
5.5 --- --- 20 10 
4.5 40 40 84 84 
 
CFU estimate of BCG and M. bovis incubated at different pH values. The data are presented as 
the percentage of bacteria killed relative to comparing the control (bacteria grown in standard 
medium) after 1 and 7 days.  In this table (---) means no difference relative to the control. 
 
If we extrapolate these pH values to those found in the different phagosomes in 
macrophages -early phagosomes around pH 6.2 and late phagosomes down to pH 4.5 47 
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these data predict that in ‘non-matured’ early phagosomes BCG could be exposed to a 
partial bactericidal effect of pH whereas M. bovis would not be affected by the mild 
acidity. In contrast, should either bacteria find themselves in fully matured phagosomes 
(pH 4.5-5) both would be susceptible to low pH killing. In order to test this hypothesis 
we used the V-ATPase inhibitor bafilomycin A1 to neutralize the pH of all endocytic 
compartments.  We showed earlier that this treatment significantly reduced the killing 
of M. smegmatis in J774 cells 18. 
J774 cells infected with BCG or M. bovis were treated with bafilomycin A1 at the 
different time windows indicated in Figs. 5G and H. The treatment with 25 or 50 nM of 
the drug led to a significant increase in growth of BCG between the 3 and 24 h time 
points and at the 1-3 day period but it had no effect at subsequent times up to day 7 
(Fig. 5G). For M. bovis a similar result was seen with bafilomycin (at 50 but not 25 nM) 
between 3 and 24 h whereas no effect was seen at later times (Fig. 5H). These data 
show that (i) a low pH does contribute significantly to killing of both BCG and M. bovis 
but this effect is restricted to the early phases of the infections and (ii) the period (up to 
day 1) in which BCG is resistant to pH is significantly longer (up to 3 days) than for M. 
bovis (up to 1 day). As shown below these periods coincide precisely with initial strong 
bacteriocidal stages in macrophages that are different for the two mycobacteria. 
 
All mycobacteria are exclusively in phagosomes 
Although it is generally accepted that intracellular mycobacteria in macrophages are 
always enclosed by membranes of phagosomes or phago-lysosomes, two earlier EM 
studies suggested that M. tuberculosis could under some conditions escape out of the 
phagosome 49,50. This idea, received with scepticism in the field was recently re-
awakened by a more convincing EM study by Peters and collaborators 51. Using the 
Tokuyasu cryo section EM method following chemical fixation, these authors provided 
a striking scenario in which M. tuberculosis H37Rv-enclosing phagosomes in human 
blood macrophages and dendritic cells fused significantly with lysosomes after 2 days 
infection (as monitored via acquisition of LAMP-1, CD63 and cathepsin D). After this 
period the phagosomes were found to lyse and M. tuberculosis escaped into the 
cytoplasm, where bacterial growth was observed. In contrast BCG remained within 
phagosomes at all times after infection. This result fits well with the behaviour of the 
closely related pathogen M. marinum 52,53, that was even able to move actively through 
the cytoplasm by actin comets, similar to Listeria and other pathogens 54. 
  91 
The possibility that M. bovis in particular could escape into the cytoplasm in our 
experiments offered an attractive alternative hypothesis to explain the lack of obvious 
correlation between its intracellular growth/killing and the fraction of fully matured 
phagosomes. We found no conditions in this study (even after treatment with γ-IFN- 
Results not shown) in which BCG, M. bovis or M. tuberculosis -containing phagosomes 
showed an index of phago-lysosome fusion much above the 10 % value, at least up to 7 
days. Similar conclusions were drawn by Armstrong and Hart (1971) 19 after monitoring 
the infection with M. tuberculosis up to 15 days in primary macrophages. Nevertheless, 
perhaps this abrupt maturation of pathogen-containing phagosomes seen by Van der 
Wel et al. (2007) 51 might have occurred too rapidly in our cell systems. If the bacteria 
were in the cytoplasm they could not be expected to contain any lysosomal marker. 
Clearly, this question could only be addressed using electron microscopy. An obvious 
worry for any EM study using conventional fixation is the question of fixation artefacts, 
a problem that can be particularly difficult in preserving membranes 55. Only by use of 
cryo-immobilization methods such as freeze substitution or cryo electron microscopy of 
vitrified sections (CEMOVIS) 56 can one be sure to avoid all chemically-induced 
artefacts. However, if pathogens are to be investigated by these more modern 
technologies it requires the combination of  a high pressure freezer machine in a bio-
safety level 3 facility,  a combination that we currently do not have. 
There is, however one proviso for using conventional chemical embedding that makes 
this approach suitable for analysing pathogen phagosomes. While there is always the 
possibility that phagosomal membranes can lyse, or even perhaps disappear in response 
to fixation, we consider it highly unlikely that a bacterium free in the cytoplasm can 
acquire a membrane artifactually as a result of this procedure. This discussion is highly 
relevant to interpretation of EM images of chemically fixed specimens, and to the data 
we now present. 
We chemically fixed J774 or HMDM infected with BCG, M. bovis or M. tuberculosis 
with glutaraldehyde, post-fixed in osmium and uranyl acetate and embedded the 
samples in epoxy resin. Alternatively, after only glutaraldehyde fixation the cells were 
infused with sucrose and prepared for cryo-sectioning 57; these were contrasted either 
with uranyl acetate or ammonium molybdate in combination with methyl cellulose 55. 
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Figure 6. Mycobacterium spp reside in a phagosome compartment at all infection times 
A-D. Epoxy resin plastic section of J774 macrophages infected after 3 days infection with M. 
bovis (A, B) or M. tuberculosis H37Rv (C, D). E and F show thawed cryo-sections of HMDM 
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infected for 3 days (E) and 5 days (F) with M. bovis; sections stained with ammonium 
molybdate and methyl cellulose. In all Figs Mycobacteria are marked with an asterisk (*) and 
arrow-heads indicate the membrane of phagosomes that enclose the mycobacteria. Plasma 
membrane (PM), nucleus (Nu) and endoplasmic reticulum (ER) are also indicated.  
 
Using both approaches thin section EM analysis showed unequivocally that all of the 
bacteria we observed within the macrophages were invariably surrounded by a 
phagosome membrane at all times up to 6 days infection. Examples of these images are 
shown in Fig. 6. Thus rules out the possibility that any cytoplasmic mycobacteria exist 
under our conditions and supports the observations of Armstrong and D’Arcy Hart 
(1971) 19 who found M. tuberculosis to be enclosed by a phagosomal membrane at all 
times over two weeks of infection.   
 
Killing of mycobacteria occurs in mature and non-mature phagosomes 
From the above results both BCG and M. bovis reside in macrophages in phagosomes 
that we can operationally separate into ‘early’ or non-matured phagosomes (not fused 
with ‘lysosomes’ and lyso-tracker negative) and ‘late’ or mature phagosomes (fused 
with lysosomes and lysotracker positive). The vast majority (90 %) of both BCG and M. 
bovis phagosomes were in early (non-mature) phagosomes. We wanted to distinguish 
between the two extreme models presented in the Introduction, first, killing occurs only 
after a live bacterium finds itself in a matured phagosome and, second, killing occurs in 
early phagosomes and is perhaps a pre-requisite for some of these phagosomes to 
mature into a hydrolytic compartment that degrades the pathogens.  
To address this issue we set up an experiment in which we could distinguish between 
live and dead bacteria per cell, using an approach similar to that described by Anes et al. 
(2006) 18 and Barker et al. (1997) 58. For this, we infected J774 cells with M. bovis that 
had been surface-stained with Oregon green or with GFP-BCG. Subsequently, the cells 
were lysed and the recovered bacteria were stained with propidium iodide, a red dye 
that is unable to cross intact bacterial membranes but stains nucleic acid in dead 
bacteria. This allowed us to distinguish between dead (red or yellow) and live bacteria 
(green) and by separately counting the number of macrophages we could relate the 
numbers of bacteria to the numbers of cells. Importantly, the viability and the total 
number of macrophages during the time of the experiment remained constant. Less than 
1 % of macrophages could be stained with trypan blue in infected cultures for 7 days. 
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The quantitative analysis of this experiment was quite revealing (Fig. 7A). With both 
BCG and M. bovis the number of green (live) bacteria dropped at a similar initial rate 
giving a total killing of around 40 % during the first day of infection (Table 3). From 
the data in Figs. 3C, 3D and 5G it seems likely that RNI and a low pH are the major 
factors responsible for this early killing of both bacteria. In the case of M. bovis day 1 
was the start of a continuous growth period whereas for BCG killing proceeded until 
day 3 when a static condition was reached. The initial decrease in the number of green 
bacteria, up to day 3, was however, not correlated with an increase in the number of 
red/yellow bacteria, as we expected. Rather, this number was kept at a consistently low 
value of around 0.5- 1 bacteria per cell, for both M. bovis and BCG. Our interpretation 
at this point is that we have dead bacteria in different stages of digestion and only the 
best-preserved ones would be recovered after macrophages lysis and propidium iodide 
staining. Clearly, these killed bacteria must be cleared relatively fast, and at a similar 
rate for both bacteria. Taking this into account we consider that the rate of 
disappearance of the green bacteria provides the best independent estimate of the killing 
rate. This assumption was supported by the excellent correlation between CFU (Fig. 
7B) and the different kinetics of disappearance of BCG and M. bovis green bacteria 
(Fig. 7A).  
During the first 24 hours, the rate of killing for BCG and M. bovis was similar (Table 
3). Thus, both BCG and the pathogenic M. bovis are subjected to a similar macrophage 
killing potential early in infection.  After 1 day M. bovis strikingly switched to a state of 
growth, with the number of green (live) bacteria increasing to give an average of 8 
bacteria per cell after 7 days, as seen by direct microscopy counts and by CFU 
estimations (Figs. 7A and B). So the major difference between BCG and M. bovis is that 
BCG continuously suffers a net loss until a steady state is reached after three days, 
whereas M. bovis is able to switch to a growth phase after 1 day- we presume that this 
involves a signalling switch from a pro-inflammatory signalling state of macrophages to 
an anti-inflammatory one (Jordao et al-submitted). Nevertheless, since a constant 
number of dead bacteria are seen at all times for M. bovis (Figs. 7 A, B) it argues that 
the net growth seen for M. bovis reflects a balance between growth and a constant rate 
of killing; a similar conclusion was made for M. marinum in phagosomes 58. Although 
no net growth is seen for BCG at any time, the constant ratio of live to dead bacteria 
also argues that this bacterium is also at a steady state with continuous growth and 
killing. Since roughly half the BCG population in these late infection period is dead, 
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and only 5-10 % are in phagosomes that have fused with lysosomes we interpreted these 
data to mean that some bacteria must be killed in non-matured phagosome. 
We also analysed the rate of disappearance of heat killed GFP-BCG and M. bovis taken 
up by phagocytosis by J774 cells. The rate of clearance was identical for both bacteria 
(Table 3) with 67 % of these killed bacteria having disappeared from cells between 3 h 
and 1 day. Between 1 and 3 days almost all remaining bacteria were eliminated (n.b. for 
this experiment we used a low number of bacteria for infection in order to more clearly 
visualise the bacteria; see below).  
A comparison of Figs. 7A and B with Figs. 5G and H reveals an interesting correlation. 
For both BCG (with net killing until day 3) and M. bovis (killed until day 1) these 
periods of killing coincided precisely with the times that blocking phagosomal 
acidification prevents killing. This provides more compelling evidence that low pH is 
directly involved in the initial net killing period, but not thereafter. 
Under some conditions particles within phagosomes can exit cells by exocytosis of the 
phagosomes 59. We therefore hypothesized that the potential live (green) bacteria that 
were ‘lost’ from cells might be exocytosed after (or even before) killing. However, 
extensive microscopy and CFU counts of live and killed bacteria on the surface of cells 
or released into medium showed no significant release of bacteria to the extra-cellular 
space (results not shown). This indicates that the digestion and clearance of bacteria 
must occur in the lumen of the early or late phagosomes. 
 
Modeling intracellular transport and killing of BCG 
 We then assessed whether the data in Figs. 7A and B for BCG could be fitted to a 
simple model considering two compartments (early and late) and the rates of bacterial 
growth, killing, disappearance, and transport between compartments (i. e, phagosome 
maturation). We described the system by defining the seven different reactions shown in 
Fig. 7D, each having a rate constant, k1-7. A set of differential equations were 
generated in the COPASI modelling program (see Experimental procedures and Fig. 
7C). This elegant program allows one to change each constant independently and then 
the program is run to see what pattern of curves emerge for the number of bacteria over 
time. COPASI can be instructed to find the set of constants that best reproduce the 
observed values.  For this exercise we used all available experimental evidence we had. 
The data for dead and live bacteria at different times after internalization were taken 
from Fig. 7A (BCG).  The values for the fraction of bacteria in early compartments 
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were taken from Fig. 5C (BCG).  The dynamics of transport to late compartments 
(along with phagosome maturation) and the disappearance from macrophages of dead 
BCG were those shown in Fig. 5E and Table 3.  
 
 
Figure 7. Evaluation of mycobacteria growth/survival by different methods and the 
COPASI models for BCG transport and killing in J774 macrophages. 
Evaluation of live and dead M. bovis spp in J774 macrophages over 7 days by microscopy (A) 
or  by CFU (B). Table 3 shows a numerical summary of parameters calculated from Fig 7A and 
B. Fig 7 C shows the results of two modelling scenarios, A and B. The different reaction 
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constants that were necessary for the curve fitting in A and B are given in Fig D that shows 
schematically the seven reactions modelled for the two models -for more details see 
Supplementary information (COPASI file). In C the open symbols show the experimental data 
from Fig 7A while the filled symbols indicate the values obtained by modeling. The first 
numerical value for each constant (K) gives the average rate (number of bacteria per hour) while 
the number in parentheses give the average time in hours that each reaction takes. In the model 
two phagosomal compartments are considered (early or non-matured, and late or matured).  The 
bacteria can divide, be killed, or transported from early to late compartments.  Kinetics 
constants in C are: k1, rate of transport (by maturation) from early to late compartments for live 
BCG; k2, rate of transport from early to late compartments for killed BCG; k3, rate of killing of 
BCG in early compartments; k4, rate of killing of BCG in late compartments; k5, rate of 
disappearance of BCG from early compartments; k6, rate of disappearance of BCG from late 
compartments; k7, rate of duplication of BCG in early compartments.   
 
The general features for BCG intracellular transport and survival in J774 macrophages 
i.e., most bacteria present in early compartments at all times after infection, a stable 
amount of dead microorganisms, and an exponential decrease of live bacteria could be 
reproduced quite well by two totally different scenarios (Figs. 7C, D).  In the first 
(Model A) the majority of the bacteria is killed in, and disappears from early 
compartments whereas in the second (Model B) the majority of the bacteria is first 
transported to late compartments where they are quickly killed and degraded (Fig. 7D). 
It is interesting to notice that both models require killing in the early compartments -as 
postulated by Armstrong and D´Arcy Hart (1971) 19 in order to fit the experimental 
data. However, whereas this process is the main player in model A it plays a 
quantitatively less important role in model B. The time-limiting step for BCG 
disappearance in the first model is the killing and degradation in the early compartments 
whereas for the second, it is the transport to late compartments.  It is worth mentioning 
that we could not find any other set of parameters that fit the experimental data, 
although calculations were started from 8 different initial conditions.  
At first glance model A was attractive since it seems to be consistent with the low 
fraction of bacteria in phago-lysosomes and the low rate of killed bacteria. If the 
majority of the bacteria are cleared from an early compartment (a phenomenon that has 
never been observed) it might explain why we detected such apparent low values for 
phago-lysosome fusion as well as the relatively low numbers of dead bacteria. 
However, a deeper analysis makes us favour much more the second model B in which 
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an important small fraction of bacteria are killed in early phagosomes. Both live and 
killed bacteria phagosomes have a relatively low chance of undergoing full maturation, 
but when they do they face a compartment where the live bacteria are rapidly killed (30 
min) and both this pool, and the bacteria already killed in early phagosomes, are rapidly 
digested and disappear (60 min). In model B the almost perfect fitting of theoretical 
values to our experimental data is observed with a duplication time for BCG (k7 in Fig. 
7D) of 17 h. This value, which was important for the curve fitting, is within the range 
estimated for the cell division time of 23 h for BCG growing in vitro 60. In contrast, in 
model A the fitting of theory to experimental data necessitated a k7 value of over 500 h, 
a value that is totally unrealistic. 
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DISCUSSION  
 
Here, we addressed those factors that were believed to contribute to killing 
mycobacteria in macrophages and investigated the interactions between three 
mycobacteria, M. smegmatis, BCG and M. bovis in up to six different cell types. We 
started our analysis by further investigating M. smegmatis, that we have recently 
characterized in great detail in J774 cells 18. In these cells M. smegmatis is exposed to a 
first killing phase (1-4 h) a subsequent growth phage (4-8/9 h) and two further killing 
stages with different kinetics (9-24 h). It was striking that the three other cell types we 
tested (RAW, mouse BMM and human HMDM) all showed the same kinetics of 
efficient killing between 1 and 4 h; this argues that the bacteria bind receptors which 
induce the same dynamics of early signalling in all the cells. At subsequent times the 
pattern of M. smegmatis growth in BMM cells was almost identical to J774 cells 
whereas different patterns were seen with RAW and HMDM, although all the cells 
effectively cleared M. smegmatis by 48 h.  
Differences between cells became much more apparent when we compared six different 
macrophage types following infection with M. bovis BCG (GFP). No easily discernable 
pattern emerges from this analysis, arguing that each combination of cell-
mycobacterium tends to behave differently. Further, the ability of a cell type to kill 
BCG or M. bovis could not easily be correlated with their ability to kill M. smegmatis. 
Extensive literature argues that NO produced by iNOs in macrophages is a crucial 
killing factor for mycobacteria in macrophages 26,61-63. Our data lend support to this 
hypothesis and to the notion that the pathogenic M. bovis is more resistant to the killing 
effects of NO in vitro than is BCG. There is also significantly less NO produced from 
M. bovis - relative to BCG-infected mouse macrophages although these levels could be 
increased dramatically in both infections with γ-IFN treatment; this resulted in a slight 
increase in killing of BCG and a significant increase in killing M. bovis after one day, 
but not at later days of infection. Effects of γ-IFN in killing mycobacteria in 
macrophages have been described earlier 10,36,64.  In mouse cells there was a good 
correlation between the levels of NO and the killing of mycobacteria, with both higher 
levels of NO and iNOS-dependent killing being restricted to the first 1-2 days infection. 
A similar pattern was seen earlier with M. smegmatis in J774 cells in which the NO 
production and iNOS-dependent killing was restricted to the first 2 h of infection. That 
RNI is not the only killing mechanism is also seen by the fact that human macrophages 
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are unable to show iNOS activity but are still capable of killing mycobacteria. Here, 
HMDM produced undetectable levels of NO but were nevertheless capable of killing M. 
smegmatis in the first 4 h infection at the same rate as the three types of mouse cells 
(Figs. 1A-D). 
An additional factor that was important for the early killing potential of macrophages 
was a low pH. When BCG or M. bovis-infected J774 macrophages were treated with the 
V- ATPase inhibitor bafilomycin A1 there was a significant increase in bacterial growth 
at the 3-24 h period for M. bovis and between 3-24 h and 1 and 3 days for BCG. 
However, this drug had no effect at later times of infection for either bacteria up to 7 
days (Fig. 5G). The early infection period where a low pH facilitates killing coincides 
with the period of iNOS activity and it is known that a low pH synergizes with the RNI 
system to induce more potent killing activity 29. It is striking that the period where a low 
pH is needed for net killing of both bacteria coincides precisely with the early infection 
period in which the bacterial counts were decreasing strongly (the pro-inflammatory 
phase), as accessed both by direct microscopy estimates and CFU (Figs. 7A and B). We 
propose that the combination of RNI and a lowered compartment pH synergise to 
provide the first killing process. The early mycobacterial phagosomes have a pH of 
around 6.2 while the late ones are at 5 or slightly below 14,32,47. Since NO and its 
relatives are freely diffusible it is conceivable that its combination with a lowered pH in 
early or late endocytic organelles could induce killing in either compartment; our data 
do not allow us to distinguish between these options. The observation that blocking 
phagosome acidification at days 3-7 had no effect on the survival of BCG or M. bovis 
was especially surprising. Since both these bacteria must be continually killed, even 
after the RNI wave it, argues that whatever mechanism that kills them is not dependent 
on a low pH.  
The interpretation of our data was not straightforward, given the many different 
potential reactions that operate in the highly dynamic system- in which a variable 
fraction of the pathogens can divide and a different, variable fraction can be killed at 
any time by the macrophage. We therefore carried out a more detailed analysis of the 
BCG and M. bovis infections by estimating the total numbers of live and killed bacteria 
in the cells at different times of infection. Both bacteria were initially killed rapidly until 
day 1 (M. bovis) or day 3 (BCG). Thereafter M. bovis switched to a robust net growth 
phase while BCG retained a constant low level of live bacteria per cell until day 7. 
Surprisingly, the fraction of bacteria that were rod-shaped but accessible to propidium 
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iodide, and therefore presumed to be dead, remained at a constant value of around one 
dead bacterium per cell at all infection times for both BCG and M. bovis. Clearly the 
killed bacteria must be digested and the number of dead ones identified at any stage 
represents the balance between the rate of killing and the rate of digestion.  
The use of the COPASI program to model our data turned out to be a very powerful 
tool. When one deals with complex multi-step processes such as phagosome maturation, 
pathogen growth and killing processes it is very difficult to make an intuitive 
interpretation of the data. In fact, without such modelling we would have concluded that 
the quantitatively most significant killing of the bacteria occurs in an early 
compartment, in agreement with the classical study by Armstrong and D’Arcy (1971) 
19
. However, the theoretical modelling led to us a different conclusion. In this exercise 
the overall process of infection is separated into seven distinct reactions with their own 
rate or activity constants. The COPASI program then allows on to find estimates for 
these seven parameters that gives the best fit of the dynamics of the bacterial 
growth/killing with the observed experimental data (Figs. 7A and B). We found two 
quite different potential ‘solutions’ that accurately mimicked the experimental data (Fig. 
7D). The main difference between the two models is that in model A, the majority of 
bacteria are killed and cleared from early phagosomes whereas in model B these 
processes predominantly occur in late compartments. As already pointed out, the latter 
model makes more sense, for example because it assumes a reasonable doubling time 
for BCG in the macrophage of 17 h whereas model A predicts a totally unrealistic value 
for this parameter of over 500 h. Moreover, the input value of 17 h in model A was 
essential for the good fit between theory and experiment; with slightly higher or lower 
values there was  poor agreement between theory and experimental data. 
Of course a model that accurately fits the data is far from guaranteeing that its 
assumptions are correct; after all model A, that we believe is unrealistic, also gives an 
excellent concordance between theory and experiment. Nevertheless, a model can lead 
to predictions that can be tested in further experiments. The preferred model B predicts 
that: (1) A small but significant degree of BCG killing (and presumably M. bovis) must 
occur in early phagosomes. (2) A rate-limiting step of maturation of phagosomes 
containing both live and killed bacteria occurs. (3) Once phagosomes have matured the 
live bacteria are killed very rapidly, on average in 30 min. (4) The bacteria that were 
killed in early phagosomes and those that are killed in late phagosomes are rapidly 
digested, and disappear from the system within 1 h. A recent study by Majlessi et al. 
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(2007) 22 provides support for the hypothesis that both the early and late mycobacterial 
phagosome can show hydrolytic activity since the same level of mycobacterial antigen 
presentation was seen irrespective of whether the bacteria resided in early or late 
phagosomes. We are currently setting up experiments to test some of these predictions, 
most notably the idea that the bacteria are killed and removed from the late 
compartments in a relatively short period, using live cell imaging methods. 
Our data collectively argue that for BCG and M. bovis the killing by macrophages 
occurs in two distinct phases, the first, an early low pH- and RNI-dependent process, the 
second independent of both. The hypothesis emerges that multiple bacteriocidal factors 
must be delivered into the pathogenic mycobacterial phagosome. The first, early phase 
may be explained by the combination of a pH below neutrality and RNI. The second, 
later phase that occurs for sure after (and perhaps also before) the RNI wave evidently 
occurs independently of a low pH. We presume that two sets of hydrolytic enzymes or 
factors must contribute to the small degree of killing postulated to occur in early 
phagosomes and to the more extensive killing that likely occurs in late phagosomes. 
Factors such as cathelicidin, that has recently been implicated in killing M. tuberculosis 
65
 can be expected to contribute to the overall killing process. Although hydrolases are 
generally more active at lowered pH the late killing factors that we observed in this 
study were not affected by blocking the proton pump with bafilomycin. However, some 
lysosomal enzymes have an optimal activity at neutral pH 66, and even some enzymes 
with a low pH optimum may still retail significant activity at neutral pH. The 
identification of all the factors within both early and late phagosomes that have the 
potential to kill pathogenic mycobacteria, especially M. tuberculosis is now crucial to 
our understanding of the macrophage killing potential, and to evolve therapies that 
could boost this process. 
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MATERIAL AND METHODS 
 
Bacterial culture conditions: M. tuberculosis H37 Rv, M. bovis BCG Pasteur 
(ATCC35734),  M. bovis BCG harbouring a pMN437 plasmid and a strain of  M. bovis 
genetically characterized isolated from a bovine were grown on Middlebrook’s 7H9 
broth Medium (Difco) supplemented with 10 % OADC (v/v) and 0.05 % Tween 80 
(v/v) until exponential phase at 37ºC / 5 % CO2 . Media were supplemented with 50 
µg/ml hygromycin (Roche) for selection of recombinant mycobacteria.  
 
Cell line culture conditions: The mouse macrophage cell lines J774.A1 and RAW 
264.7 were cultured as described previously. Two days before infection macrophages 
were seeded onto 24 wells culture dishes and left for 2 days in a 5 % CO2 incubator at 
37ºC (105 macrophages/ml). 
THP-1 cells were grown in RPMI 1640 (Gibco) supplemented with 10 % fetal bovine 
serum (FBS: Gibco), 1 % Hepes (Gibco), penicillin and streptomycin (Gibco). The cells 
were seeded onto 24 well cultures dishes at a density of  5 x 105 cells/ml  and treated 
overnight with 5 nM phorbol myristate acetate (PMA: Sigma). Then cells were washed 
three times with PBS and incubated for one more day. 
 
Human monocyte derived macrophages (HMDM) isolation and culture: HMDM 
were prepared from venous blood from healthy volunteers donors using density gradient 
centrifugation as described before 67. Cells were platted at a density of 2 x 106 cells/ml 
and incubated for 3 days with RPMI 1640 supplemented with 30 % FCS and 10 % 
human type AB serum (Sigma). Then cells were washed three times with warm 1 % 
FCS in PBS and cultured for 7 days before infection. 
 
Bovine monocyte derived macrophages (BMDM) isolation and culture: BMDM 
were prepared from venous blood from healthy 8-9 months old male Holstein Friesian 
bovines using density gradient centrifugation. The protocol used was similar to the 
described above for HMDM. The density gradient used was different (NycoPrep 
1.077A from AXIS-SHIELD) and the 10 % of human type AB serum added to RPMI 
medium was replaced by 10 % homologous bovine serum. 
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Bone marrow derived macrophages (BMM) isolation and culture: Experiments 
were performed with 3 weeks old C57BL/6 male mice from Jackson Laboratory. Mice 
were killed by cervical dislocation, and the femur and tibia bones were removed. The 
bones were trimmed at both ends, and the marrow was flushed out with 5 to 10 ml of 
RPMI containing 10 % FCS using a 23 gauge needle. The cell suspension was 
centrifuge for 4 minutes at 900 g and the pellet was gently ressuspended in RPMI 
supplemented with 10 % FCS, 1 % penicillin/streptomycin, 1 % non-essencial amino 
acids (Gibco) and 15 % L929 supernatant and plate into bacterial Petri dishes. After 3 
days monolayers were washed with warm 1 % FCS in PBS and incubated for more 3 
days. At this point more than 95 % of the cells were CD14 (BD Pharmigen) positive by 
flow citometry. Cells were scrapped and platted at a density of 2.5 x 105 cells/ml and 
incubated overnight before infection. 
 
Macrophage infection: Bacterial cultures on exponential grown phase were pellet, 
washed twice in PBS pH 7.4 and resuspended in PBS to a final concentration of 5-10 x 
109 cells/ml. Single cell suspensions were generated by 2 min pulse in a water-bath 
sonicator (room temperature) followed by passage through a 23-gauge needle to disrupt 
remaining bacterial clumps. Before infection, residual bacterial aggregates were 
removed by low speed centrifugation (120 x g) for 2 min. Single cell suspension was 
verified by light microscopy.  
Before infection, non adherent cells were removed by wash with PBS and the medium 
replaced by antibiotic free medium supplemented with 10 % FBS. For achieve 2 to 8 
bacilli per macrophage after 3 h uptake, an OD600nm~0.1 was used for all the 
macrophages used except HMDM. For these macrophages an OD600nm~0.01 was used 
instead. The cells were washed twice with PBS to remove free mycobacteria. At 
infection time (3 h) and after several days (3, 5 and 7 days) infected macrophages were 
washed with PBS and lysed with 1 % Igepal (Sigma) solution in water. Serial dilutions 
of the lysate were prepared in water and platted at Middlebrook 7H10 medium 
supplemented with OADC. After about 3 weeks of incubation at 37ºC colonies were 
counted.  
For M. smegmatis a similar protocol was used with the following differences: (i) an 
OD600nm~0.1 was used for all the macrophages and (ii) cells were allowed to uptake 
bacteria only for 1 h. 
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Treatment with γ-IFN, inhibitors and NOC-18: When required cells were treated 
with murine γ-IFN (50 IU) overnight before infection. γ-IFN was a kind gift from the 
Centralised Facility for AIDS Reagents.  
When treated with iNO inhibitor N-(G)-nitro-L-arginine methyl ester hydrochloride 
(500 µg/ml L-NAME; Sigma) this compounds was added to the medium 1h before 
infection and left until the end of the experience. When treated with NOC-18 (0.1 or 1 
µM; Calbiochem) this compound was added to the medium at time zero and left until 
the end of the experience. Chemicals were renewed during the course of the 
experiments according to their half-lives. 
The V-ATPase inhibitor, bafilomycin A1, 25 nM or 50 nM (Sigma) was added to the 
medium in the following time windows: 3 h-1day, 1-3 days, 3-5days and 5-7days.  
 
Nitric oxide: Culture supernatants were collect at several time points for determination 
of nitrite contents. Nitrite concentration indicating the NO production was performed 
using the standard Griess reaction adapted to microplate. 
M. bovis spp in vitro sensitivity to NO was determined using serial dilutions of an 1000 
µM NOC-18 solution in DMEM supplemented with 10 % FCS. After 1, 7 and 14 days 
serial dilutions of control and samples were platted on 7H10 supplemented with OADC 
supplement. After about 3 weeks of incubation at 37ºC colonies were counted.  
 
Epifluorescence and Confocal Fluorescence Microscopy: Macrophages grown on 
glass coverslips were allowed to uptake M. bovis BCG harbouring a pMN437 plasmid 
(live / heat killed) or M. bovis stained with Oregon green (Molecular Probes). Cells 
were fixed with 3 % paraformaldehyde at room temperature for 15 min.  
Lysotracker Red DND-99 (Molecular Probes) staining of acidic organelles was carried 
out by adding a 1:10.000 dilution in DMEM that was added for the last 30 min of the 
experiments. Cell permeabilization, when required, was achieved with 20 min treatment 
with 0.1 % Triton X100 (Sigma) in PBS. After 30 min blocking with 5 % goat serum 
(Sigma) in 0.1 % BSA/PBS, cells were incubated for 1 h with primary antibody, 
followed for further 30 min by secondary antibody. For LBPA staining and blocking 
were made with 0.1 % BSA/PBS, followed by simultaneous permeabilization 
/incubation with primary antibody diluted in a 0.05 % saponin (Sigma) solution in PBS, 
followed for further 30 min incubation with secondary antibody. 
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Confocal microscopy images were collected using the LSM510 from Zeiss and the 
percentage of co-localisation was calculated using either the Image J software system or 
manually. Fluorescence labelling and viability of mycobacteria was performed as 
described 30. 
The following antibodies were used for immunofluorescence microscopy: The mouse 
iNOS antibody was purchased from BD Pharmigen and the LBPA antibody was a kind 
gift from Jean Gruenberg. The secondary antibodies used were linked to Cy3 
(Molecular Probes). 
 
Fusion assay: Analysis of phagosome lysosome fusion was carried out using 7 nm gold 
particles as describe before 18. Macrophages were pulsed for 1 h with these gold 
particles, washed three times with PBS. Then one of two treatments was done: (a) chase 
for 1 h in complete culture medium, infection with mycobacteria 3 h in complete 
medium without antibiotics or (b) chase for 4 h in medium without antibiotics. The first 
treatment was applied for 3 h time point and the second for all the others. Macrophages 
were fixed with 3 % PFA in PBS and processed for microscopy.  
 
Dead vs live bacteria determination: 3 h, 1, 3, 5 and 7 days post-infection 
macrophages were scrapped, stained with trypan blue (Sigma) and counted in a 
Neubauer chamber. Infected macrophages were then lysed with 1 % Igepal in water. 
Dead mycobacteria were stained with PI as described in Anes et al. (2006) 18. 
Mycobacteria pellets were ressuspended in PBS and dead (red or yellow) and live 
(green) bacteria were counted in a Neubauer chamber by fluorescence microscopy. 
 
Preparation of whole cell extracts and immunoblot analysis: Whole cell extracts 
were prepared as previously described 18. Equal amounts of protein were loaded on a 6 
% SDS-PAGE, transferred to nitrocellulose membrane and probed with a mouse anti-
iNOS (BD Pharmigen) and mouse anti-actin (BD Pharmigen) antibodies. Enhanced 
chemi-luminescence (Pierce biotechnology) was used to visualize antibody binding. 
Actin was used to assess the amount of total protein in the different membrane isolates. 
 
Electron microscopy: Macrophages (J774.A1, HMDM) infected with M. bovis spp as 
described previously in this section were fixed with 1 % glutaraldehyde (EM grade 
Sigma) in cell culture medium without serum during 10 minutes at 37ºC. Cell cultures 
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were washed several times with 200 mM Hepes pH 7.4 and incubated overnight at room 
temperature with 1 % glutaraldehyde in 200 mM Hepes 7.4. Samples were processed 
for cryo-sectioning as described by Tokuyasu (1973) 57. Negative staining using 
ammonium molybdate was done as described before by Griffiths et al (1993) 55. 
After fixation some samples were post-fixed in osmium and uranyl acetate and 
embedded in epoxy resin as described previously 68,68. Thin sections were stained with 
lead citrate and uranyl acetate and analysed by transmission electron microscopy. 
 
Modelling the intracellular transport and killing of M. bovis BCG:  A set of 7 
differential equations were generated in the COPASI 4.0.20 modelling program 
(http://www.copasi.org) 69 describing the duplication, killing in early and late 
compartments, transport of live and dead bacteria from early to late compartments (= 
phagosome maturation) and disappearance (digestion) of bacteria in early and late 
compartments . Simple mass action reactions were used for the kinetics of all steps.  
The same program was used to find a set of parameters that minimize the weighted sum 
of square differences between values predicted for the model and the experimental data. 
The COPASI file is available in the following webpage http:// 
www.ff.ul.pt/paginas/eanes/COPASI.  
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ABSTRACT 
 
Recently we showed that treatment of mycobacteria-infected macrophages with pro-
inflammatory lipids, especially the omega-6 lipid, arachidonic acid (AA) and ceramide 
(Cer) enhanced bacterial killing whereas the anti-inflammatory, omega-3 lipid 
eicosapentanoic acid (EPA) stimulated bacterial growth. The latter result agreed with 
earlier studies with M. tuberculosis and another intracellular pathogen in mouse 
infection models. We therefore tested the effects of diets enriched in omega-3 and 
omega-6 lipids on these pathogens in mice. In contrast to the results with macrophages, 
the omega-6 supplemented diets tended to increase survival of both pathogens, while 
the omega-3-rich diet tended to increase pathogen killing. Given these unpredictable 
results we focused in more detail at the macrophage level. We recently showed that M. 
smegmatis in macrophages is subjected to alternate cycles of pro-inflammatory killing 
and anti-inflammatory survival/growth responses. Here in macrophages infected with 
M. smegmatis and M. tuberculosis H37Rv the three lipids could switch the system 
between pro- and anti-inflammatory signalling states. In general, the effects of Cer 
and/or AA were opposite to those of EPA, but in many infection stages all three lipids 
could be either pro-inflammatory (more killing of bacteria) or anti-inflammatory (more 
growth). These results argue against the idea of considering a simple recommended 
lipid-based diet to treat mycobacteria-infected individuals. 
 116 
INTRODUCTION 
 
An important part of the life cycle of M. tuberculosis and related pathogens in infected 
animals is spent within phagosomes inside macrophages. These cells will take up all 
mycobacteria but a striking difference is seen between the non-pathogenic types, such 
as M. smegmatis, that are killed by macrophages, and the pathogens, such as M. 
tuberculosis that can survive and multiply in macrophages 1-3. After phagocytic uptake 
of M. smegmatis into phagosomes, these organelles undergo a maturation process 
involving multiple fusion events with early endosomes and the late endocytic organelles 
that are generally classified as late endosomes and lysosomes or, often simply 
‘lysosomes’. As a consequence of the late fusion events, the phagosomes acquire 
hydrolytic enzymes and the proton ATPase that acidifies the lumen, the phagosomes 
thereby undergo complete maturation. Collectively, these factors together with free 
radicals, may contribute to killing M. smegmatis, that is cleared by macrophages within 
24-48 h 4-6. In contrast, the pathogenic mycobacteria block late fusion events allowing 
M. tuberculosis and related pathogens to grow and divide within an arrested early 
phagosome 7-11. 
In recent studies, we provided evidence for links between the ability of phagosomes to 
assembly actin filaments de novo on the cytoplasmic surface to the late fusion events 
between phagosomes and late endocytic organelles. Indeed, under an increasing set of 
conditions that stimulate macrophages, the ability of phagosomes to assemble actin 
correlates well with both their increased fusion with later endocytic organelles and their 
acidification as well as with an increased ability of infected macrophages to kill non-
pathogenic and pathogenic mycobacteria. In contrast, conditions that inhibit 
phagosomal actin assembly are correlated with less fusion/acidification but more 
growth of the mycobacteria 4,5,12-14. This leads us to hypothesize that the nucleation of 
actin on membranes is part of the pro-inflammatory response. The MAP Kinase p38 
was found to be a key regulator of many of the processes relevant for the macrophage-
phagosome interactions. Whereas some functions regulated by p38 seemed to favour the 
macrophage infected with M. smegmatis other functions appeared to favour the bacteria, 
at some particular stages of the life cycle 5. 
A striking effect of stimulating phagosomal-actin assembly activity, and consequently 
late fusion and killing of mycobacteria was seen after adding to J774 macrophages 
infected with M. smegmatis and pathogenic strains of M. tuberculosis spp complex a 
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number of pro-inflammatory lipids, especially arachidonic acid (AA) and Cer. In 
contrast, the anti-inflammatory lipid eicosapentanoic acid (EPA) induced an increase in 
mycobacterial growth in macrophages 4. These results were exciting because they fitted 
nicely into a general pattern seen with these classes of lipids in whole organisms. In 
fact, two earlier studies showed that a high omega-3 diet indeed led to significant 
increases in growth of Salmonella in mice 15 and M. tuberculosis in guinea pigs 16,17. 
An omega-3 enriched diet was correlated over 30 years ago with a higher incidence of 
tuberculosis in Eskimos and Inuits, whose diet is rich in fish oil, the best-characterized 
source of omega-3 lipids 18,19. Parallel studies by Bang and Dyerberg 20,21 showed the 
importance of the dietary intake of both omega-3 and omega-6 fatty acids -that are now 
accepted as being essential constituents of a healthy diet. The modern Western diet 
tends to be deficient in omega-3 fatty acids and a large number of case studies argue for 
the beneficial effects of omega-3 supplements, or eating fatty fish 22-25. 
Collectively, the above data suggested that a high omega-6 diet might be beneficial 
against mycobacteria, while a high omega-3 diet might be detrimental. Given the 
increasing tendency of omega-3 dietary supplements, that are generally beneficial to 
uninfected people, to be recommended and used 18,21,26-30  it follows that for patients 
suffering from tuberculosis and other diseases it is important to know whether these 
lipids influence the course of infection, one way or the other. 
However, when one looks at the literature on the effects of omega-3 and -6 lipids on a 
variety of different pathogens, especially at the level of animal models, the conclusion is 
more sobering. While these lipids have tremendous effects on many processes related to 
infections, the results are highly contradictory. In a critical evaluation of all the 
experiments done to test the effects of omega-3 lipids in the context of infections 
diseases Anderson and Fritsch 31 concluded that, of the 30 papers they examined there 
were “an equal number of papers published that report an adverse effect of (n-3) 
polyunsaturated fatty acids (PUFA) on host infectious disease resistance as those that do 
not show an effect or show a beneficial effect”. Later in the same article they wrote “It 
is unclear why so much inconsistency exists”. 
Given this situation, we decided to test omega-3 and omega-6 rich diets in mouse 
models of Salmonella typhimurium 15,32,33 and M. tuberculosis H37 Rv 17. The results 
we obtained and described here were disappointing, in that the opposite effects were 
seen in the animal to what had been seen in macrophages – but they agreed fully with 
the assessment of  Anderson and Fritsche 31. 
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We therefore decided to step back in complexity and make a more comprehensive 
analysis at the macrophage level of two pro-inflammatory lipids, AA and Cer, and the 
anti-inflammatory lipid EPA. After initial studies in M. tuberculosis-infected 
macrophages, we focussed in more detail on M. smegmatis in J774 cells, a system we 
have recently characterized in great detail 5. In J774 cells, and in mouse primary bone 
marrow macrophages (Jordao unpublished results) this bacterium follows a complex 
dynamics in which periods of killing are interspersed with a transient stage of bacterial 
growth. Three distinct killing stages were seen between 1and 4 h, 8-12 h and between 
12 and 24 h after infection; the second and third killing phases could be separated by the 
fact that the 8-12 h one was independent of phagosome actin assembly and lysosome 
fusion whereas both 1-4 h and the 12-24 h correlated with these processes. In between 
killing phase 1 and 2, the 8-12 h phase is a period conducive for M. smegmatis growth 
34
. An identical pattern was seen in M. smegmatis infection in mouse bone marrow 
macrophages. However, with monocyte derived macrophages from human blood and 
RAW macrophages, while the 1-4 h killing was identical, thereafter a period of stasis 
was seen (Jordao unpublished results). 
These data suggest that the macrophage can alternate between cytoplasmic states that 
are beneficial to the host and to the bacteria. That different macrophage states exist was 
also shown by analysis of latex bead phagosomes; whereas 2-4 h LBP are active in actin 
assembly, high in phosphatidylinositol biphosphate (PIP2), and in total kinase activity 
the 8-12 h stages are low in these parameters. Strikingly, at 24 h the phagosomes are 
again active 35-37. The cyclical pattern of actin assembly was also seen with isolated M. 
smegmatis phagosomes 5. 
We therefore took advantage of these different macrophage cytoplasmic states and 
tested the addition of AA, Cer and EPA, that were added at restricted times of infection, 
on M. smegmatis survival in J774 cells. Strikingly, all the lipids can stimulate either 
bacteria killing or survival depending on when they are added during the time course of 
infection. Cer has been shown to stimulate p38 in many studies 38-40. We provide more 
evidence for links between Cer and p38 in the context of M. smegmatis and M. 
tuberculosis infection of macrophages. 
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RESULTS 
 
Effects of omega-3 and omega-6 enriched diets on the infection of mice with 
Salmonella and M. tuberculosis. 
We first tested the effect of  Omega-3 and Omega-6 enriched diets on the survival of  
S.typhimurum in order to extend the earlier studies of Chang et al 15. For this, we 
investigated the ability of Salmonella to colonize and persist in vivo in mice receiving 
one of three different diets:  control (soy), omega-3 rich (menhaden oil) or omega-6 rich 
(Safflower oil). Balb/C mice were fed with these diets one week before and during 
infection. The animals were infected by the oral route with the virulent strain ATCC 
14028. The number of bacteria recovered from Peyer's patches, mesenteric lymph-
nodes, spleen and liver were determined at different time intervals. On day 3 post-
infection, similar numbers of bacteria were recovered in Peyer’s patches and mesenteric 
lymph nodes from mice under all treatment conditions (Fig.1A). This argued that the 
bacterial capacity to infect, invade and survive within the host was not affected by any 
of the lipid diets. However, when liver and spleen were considered, bacterial loads 
seemed to be higher in animals receiving the omega-6 enriched diet. This pattern was 
even more striking on day 7 post infection (Fig.1A), since in all tested organs the 
number of bacteria per gram of tissue was significantly higher (P<0.05) than in the 
groups receiving the standard (soy) and omega-3-enriched  (i.e., menhaden) diets.  
 
 
Figure 1A. Persistence of S. enterica serovar Typhimurium in organs from mice receiving 
diets enriched in specific fatty acids 
After 5 weeks on the diets enriched in specific fatty acids, mice were challenged with 5x106 
cells of the virulent S. enterica strain ATCC 14028 by oral route. On day 3 and 7 post infection, 
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mice  were sacrificed (n=3) and the number of viable bacteria present in Peyer’s patches (PP), 
mesenteric lymph nodes (MLN), spleen and liver was determined by plating serial dilutions. 
Results are expressed as colony forming units (CFU) per gram of tissue. The standard error of 
the mean is indicated by vertical lines. The differences between experimental groups were 
statistically significant at P < 0.05 (*) or 0.01 (**). 
 
These results suggest that in animals receiving the omega-6 enriched diet, the non 
specific clearance mechanisms were less efficient in controlling bacterial spread and 
dissemination. However, despite the fact that the omega-3 diet conferred a better edge 
to control infection, in the long term none of the diets was able to confer full-protection 
against a lethal challenge. Although mice receiving soy and menhaden enriched diets 
survived longer than those on the omega-6 diet (9 versus 11 days), the differences were 
not statistically significant (P>0.05).  
We next carried out a similar strategy to test the effects of the lipids on M. tuberculosis 
infection (done in a separate laborarory). Balb/C mice were fed with a basal low fat diet 
supplemented or not with 10% safflower oil (rich in omega-6) or 10% Ropufa fish oil 
(rich in omega-3), and were infected intra-nasally with 103 M. tuberculosis H37Rv 
colony forming units (CFUs). Diets were given two weeks prior to infection, and were 
continued during the infection. One, 21 and 56 days after inoculation, lungs and spleens 
were recovered, homogenized and plated onto agar medium for CFU scoring (Fig. 1B).  
 
 
 
Figure 1B. Persistence of M. tuberculosis in organs from mice receiving diets enriched in 
specific fatty acids 
Mice where divided in two groups, one receiving a normal lipid containing diet and the other 
receiving a low fat regimen. Both groups were then submitted to diets enriched in specific fatty 
acids. After 2 weeks on these regimens, mice were challenged with 103 cells of the virulent M. 
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tuberculosis H37Rv by intranasal route. On day 1 and 21 and 56 post infection, mice were 
sacrificed (n=3) and the number of viable bacteria present in the lung and spleen was 
determined by plating serial dilutions. Results are expressed as colony forming units (CFU) per 
gram of tissue. The standard error of the mean is indicated by vertical lines. The differences 
between experimental groups were statistically significant at P < 0.05 (*) or 0.01 (**). 
 
 
While the omega-6 regimen had only a weak and statistically non-significant effect on 
progression of the infection in the lungs and the spleen of the animals, omega-3 
treatment led to a slight, but statistically significant reduction in mycobacterial loads in 
the lungs and spleen both after 21 and 56 days after inoculation (Fig. 1B- Low fat 
regimen). This result suggest that, if anything, the omega-3 had an antimycobacterial 
effect in vivo rather than being conducive to pathogen survival, as we had predicted. 
 
Effect of EPA, Ceramide and AA on M. tuberculosis growth in J774 macrophages 
Given the fact that the effects of the pro and anti-inflammatory lipids were the opposite 
at the animal level to what we observed at the in vitro macrophage level we decided to 
go back to the macrophage level for further analysis. We started to investigate the effect 
of pre or co-infection treatment with pro-inflammatory (AA) or the anti-inflammatory 
(EPA) lipid on the survival of M. tuberculosis H37Rv (Fig. 2). 
 
 
Figure 2. Effects of EPA or AA during the course of M. tuberculosis H37Rv 
infection in J774 macrophages (A)  
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Cultures of J774 macrophages were pre-treated from 3 days before infection with EPA or AA. 
After uptake DMEM medium was replaced without adding more lipids (B) Infected cultures 
were put in contact with EPA or AA after 3 h of bacteria uptake. Bacteria were recovered for 
CFU counting during the course of the infection. P<0.05 (*) 
 
In accordance with our previous data 4 M. tuberculosis survival in J774 macrophages 
was enhanced by EPA and decreased by AA addition. These general effects could be 
observed for both kinds of lipid treatments, as seen in Fig. 2A (pre-treatment) and Fig. 
2B (Co-treatment) although some differences could be observed. The magnitude of the 
observed effects was higher after co-treatment with both lipids (Fig. 2B) than with pre-
treatment (Fig. 2A). 
We next tested another lipid, Cer that we had also found to be effective in killing M. 
tuberculosis in J774 macrophages. This lipid is generated from sphingomyelin by the 
action of sphingomyelinase, whose activity is stimulated by AA 41,42. Thus, Cer may be 
a downstream effector of AA. Many of the effects of Cer can be considered pro-
inflammatory 43. When added after infection (3h) to J774 cells Cer significantly 
enhanced M. tuberculosis killing, with the effects increasing from day 3 to day 7 when 
80 % of bacterial killing was achieved (Fig. 3).   
 
Figure 3. Effects of ceramide during the course of M. tuberculosis H37Rv infection in J774 
macrophages  
Cultures of J774 macrophages were pre-treated from 3 days before infection with Cer and after 
uptake DMEM medium was replaced without adding more lipids (Pre-Cer). Infected cultures 
were put in contact with ceramide after 3 h of bacteria uptake (Post-Cer). Bacteria were 
recovered for CFU counting during the course of the infection. P<0.05 (*), P<0.01 (**). 
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When cells were pre-treated with Cer for 3 days before infection and the lipid were left 
on the culture there was also a tendency for increasing killing at days 3 and 5. However, 
at day 7 a significant increase in growth was seen (Fig. 3). So at this particular time, the 
pre-treatment with Cer seems to switch the system from a pro-inflammatory to an anti-
inflammatory state.  
 
Pro- and anti-inflammatory lipids regulate TNF-α secretion 
In macrophages infected with pathogenic mycobacteria TNF-α is known to be an 
important cytokine whose extra-cellular levels correlate strongly with the ability of 
macrophages to kill mycobacteria both in vitro studies and in animal models 44-47. In 
response to the non-pathogenic, M. smegmatis macrophages secrete high amounts of 
TNF-α whereas M. tuberculosis-infected cells secrete much less 48. In in vitro 
macrophage infection the secreted TNF-α has the potential to activate the TNF-α 
receptor to induce an autocrine signalling cascade. In the case of non-pathogenic 
mycobacteria these cascades somehow induce more killing of the bacteria, whereas the 
pathogens have the ability to block these signalling events 49. Here, we asked whether 
EPA, Cer or AA could modulate the levels of TNF-α secretion. We therefore asked 
whether any of the three lipids had any effect on the secretion of TNF- α in J774 cells 
infected with M. tuberculosis H37Rv. 
 
 
Figure 4. Effects of lipids on TNF-α pro inflammatory response in J774 cell cultures 
infected with M. tuberculosis H37Rv  
The supernatants of the infected cultures either treated before infection with EPA, AA or 
Ceramide mix (CM) (preT) or treated post-tinfection with  these lipids (postT) was assessed for 
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TNF alpha production. There’s no effect of lipids observed in non-infected cells (cells) P<0.05 
(*). 
 
In uninfected cells, a basal secretion level of TNF-α was detected (200 pmol/ml) and 
lipid treatment did not affect this level (Fig. 4 shown: Lipids control:cells). M. 
tuberculosis infection of macrophages treated with lipids induced secretion under 
specific conditions. Co-treatment with Cer, increased secretion of this pro-inflammatory 
cytokine while pre-treatment of macrophages prior infection with Cer had no effect. A 
similar increase in TNF-α was observed using AA. In contrast macrophages treatment 
with EPA prior to infection with M. tuberculosis had reduced TNF-α secretion (Fig. 4). 
In general these results support the notion that the pro-inflammatory lipids tend to 
increase TNF- α levels in the medium whereas the anti-inflammatory lipid EPA had the 
opposite effect. Moreover kinetics of TNF-α release was in good agreement with the 
killing pattern induced by these lipids in J774 infected macrophages (Figs. 2 and 3). 
 
 
The links between lipids (ceramide and EPA) and p38 MAP kinase activity during 
M. tuberculosis infection. 
Pro-inflammatory TNF-α downstream signalling events could lead to MAP Kinase 
activation.  We and others had previously showed that p38 MAP Kinase is a crucial 
player in mycobacterial infections 4,50,51. For this reason we decided to investigate a 
possible connection between M. tuberculosis survival profiles modulated by Cer, AA or 
EPA with p38 activation. When phosphorylated on serine residues this kinase becomes 
activated, a process that can be evaluated by immunoblotting against an antibody that 
recognises the phospho-p38.  In uninfected cells, without lipid treatment or treated with 
EPA p38 activation was not detected during 5 days but both AA and Cer were able to 
activate this kinase. As early as 3h after addition of AA a strong activation of p38 in 
uninfected cells was detected. This signal persisted until 5days. The activation of p38 
induced by Cer was slower, than with AA, showed a peak of activity after 3 days and a 
significant reduction after 5 days (Fig. 5A).  
Interestingly, when J774 cells were infected with M. tuberculosis H37Rv and treated 
with these lipids coincidental with infection, there was no activation of p38 by AA or 
EPA. In contrast, Cer induced a significant activation of p38 after 3h, but by 3 days no 
activity could be detected. These data argue that the presence of M. tuberculosis in these 
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macrophages strongly inhibited the ability of AA and (after 3h) also Cer to activate p38 
MAP Kinase (Fig. 5B). Collectively these data argue that the ability of Cer and AA to 
induce killing of M. tuberculosis 4 is independent of its ability to activate p38. Looked 
at from the perspective of the pathogen, although it completely blocks p38 under all 
conditions, it is still susceptible to killing by Cer and AA. 
 
 
 
Figure 5. Lipid-induced phosphorylation of p38 in J774 macrophages during M. 
tuberculosis infection 
(A) Western-blot for phospho-p38 and total p38 for uninfected macrophage not treated with 
lipids during 5 days (B) Western-blot for phospho-p38 and total p38 for macrophage infected 
with M. tuberculosis not treated with lipids up to 5 days 
 
 
Effect of EPA, ceramide and AA on M. smegmatis growth in J774 macrophages 
Given the complex effects of the three lipids on the infection with M. tuberculosis we 
decided to focus in more detail on the M. smegmatis model, in which the pro- and anti-
inflammatory phases have been described in more detail 5. 
Since our previous study with J774 cells and M. smegmatis had revealed the alternate 
phases of killing (1-4 h), growth (4-8 h) and then two distinct consecutive stages of 
killing (8-12 h; 12-24 h), we decided to test the effects of the pro-inflammatory lipids 
AA and Cer and the anti-inflammatory lipid EPA by adding them at those specific 
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stages of the infection. The rationale here being that a pro-inflammatory lipid might 
accentuate the effects of a pro-inflammatory phase (increasing killing) while it might 
reduce the rate of growth seen in the anti-inflammatory phases (and vice-versa for an 
anti-inflammatory lipid). In addition, a pro-inflammatory lipid might reverse a ‘natural’ 
anti-inflammatory phase while an anti-inflammatory one might dampen the pro-
inflammatory phase killing. 
We first added these lipids, at concentration optimised previously 4, at different time 
windows starting 1 h before infection, with the last period being from 16-24 h, a time in 
which the vast majority of bacteria are normally killed 5. We then estimated CFU of 
bacteria after isolating them from cells after 24 h in all experiments. A highly 
heterogeneous response was seen for all lipids, with the same overall tendency seen 
earlier: EPA tended to stimulate growth and AA and Cer tended to induce killing of the 
bacteria (Fig. 6A). 
 
 
Figures 6 A. Persistence of M. smegmatis in J774 macrophages in culture supplemented 
whit specific fatty acids during distinct phases of intracellular killing cycles Effects of 
Arachidonic Acid (AA: 125 µM), Eicosapentaenoic Acid (EPA 15µM), or ceramide from a mix 
of brain ceramides (5 µg/ml) on killing of intracellular Mycobacterium. (A)  
 
When the lipids were added 1 h before infection and left on the cultures until 4 h, EPA 
gave a 3.5 fold increase in CFU (after 24 h). When added only in a restricted time 
window corresponding to two killing phases, 4-8 h and 16-24 h, the addition of EPA 
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also increased bacterial growth, therefore suggesting that this lipid can reverse these 
pro-inflammatory stages into a bacterial growth stage. However, the addition of EPA at 
1-4 h, 8-12 h and 12-16 h had no effect on the growth of bacteria by 24 h (Fig. 6A).  
The striking effect seen in Fig. 6.A is the enormous increase in growth after 24 h when 
EPA is present only from -1 to 4 h. Since the 1-4 h addition had no effect, we conclude 
that one hour “priming” of the macrophages prior to infection has a strong anti-
inflammatory effect on the cell. AA showed an effect only when added at time windows 
coincident with the second and third killing phases (8-12 h, 12-16 h and 16-24 h). This 
lipid significantly induced bacterial killing at this stages (Fig. 6A). In contrast the 
addition of Cer significantly increased killing at all stages except the 8-12 h stage. 
Notable was the inability of Cer to affect killing during 8-12 h, whereas AA was also 
effective during this period. 
The same set of experiments was repeated by estimating CFU at the end of the period of 
adding the lipids; for example, if AA was added between 4 and 8 h, the bacterial growth 
in vitro was estimated after 8 h. With this experimental approach we tried to relate the 
changes in signalling due to the lipids with M. smegmatis survival in a time window of 
approximately one division time.  
When EPA was tested in this way we saw a significant increase in bacterial growth at -1 
to 4 h, a slight increase between 1- 4 h and between 16- 24 h but a significant increase 
in killing was seen between 12 and 16 h (Fig. 6B). This result provides evidence that in 
the 12-16 h period the cells are in a different signalling state to the 16-24 h period. 
When AA was tested a surprising result was that this lipid could significantly increase 
bacterial growth between -1 and 4 h and even more dramatically between 8 and 12 h 
(Fig. 6C). This latter result was highly paradoxical: AA added between 8 and 12 h 
significantly decreased total CFU estimated after 24 h (Fig. 6A) but, within this time 
window it stimulated the rate of bacterial growth five-fold (Fig. 6B).  
The treatment of infected cells at the different times with Cer led to less dramatic effect 
in this assay (Fig. 6D). However, also here an unexpected result was seen. Whereas the 
treatment with Cer between 4-8 h led to a significant increase in killing after 24 h (Fig. 
6A), it had no killing effect within this time-frame (Fig. 6D). These results 
unexpectedly argued that the tested lipids can all induce pro- or anti-inflammatory 
effects - depending on the cellular state of the macrophages during the infection cycle. 
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Figures 6 B-D. Persistence of M. smegmatis in J774 macrophages in culture supplemented 
whit specific fatty acids during distinct phases of intracellular killing cycles  
(B) EPA, (C) AA, or (D) Cer were added in specific time windows to macrophages and bacteria 
were recovered for CFU plating at the end of lipid treatment, namely 4 h, 8 h, 12 h, 16 h and 24 
h post-infection. 
 
Pre-treatment of cells with EPA 
Given that pre-treatment with EPA of cells for 1 h strongly facilitates M. smegmatis 
growth between 1-4 h and up to 24 h we asked what would happen if we pre-treated the 
 129 
macrophages with EPA for 3 days before infection, as we had done for M. tuberculosis. 
We first followed bacterial survival during 24 h following the 3 days pre-treatment with 
EPA. As shown in Fig. 7A this treatment strengthened the first killing phase (1-4 h) but 
completely abolished the second (8-12 h) and third killing phases (16-24 h). 
 
  
Figure 7A. Effects of EPA pre-treated macrophages prior to infection on the intracellular 
survival of M. smegmatis  
Cultures of J774 macrophages were pre-treated from 3 days before infection with EPA. (A)  
 
Since cells pre-treated with EPA for 1 h or 3 days behaved quite differently to untreated 
cells we next repeated the experiment in which Cer and EPA were also added at 
different time windows during bacteria infection after the 3 day pre-treatment with 
EPA. In the first experiments the CFU was estimated only after 24 h (Fig. 7B). Under 
this condition the addition of EPA between -1 and 4 h and 4-8 h significantly increased 
growth by 24 h, whereas the other time points showed no significant differences 
compared to the control (macrophages infected with M. smegmatis treated with EPA 
during 3 days before infection). For Cer an unexpected result was the finding that its 
addition in the 8-12 h period, that was refractory to Cer in cells not pre-treated with 
EPA (Fig. 6A), was now able to induce a significant killing of M. smegmatis  (Fig. 7B). 
In contrast, at the 16-24 h stage, when Cer normally induces killing in the pre-EPA 
treated cells this stage was now refractory to killing by this lipid. 
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Figures 7 B and C. Effects of EPA pre-treated macrophages prior to infection on the 
intracellular survival of M. smegmatis  
After infection DMEM medium was replaced without any supplement of lipids. Bacteria were 
recovered from infected macrophages for CFU counting following the time post-infection. (B) 
After infection DMEM medium was replaced supplemented either with more EPA or with 
ceramide. Bacteria were recovered for CFU counting 24 h post infection. (C) Effects of 
ceramide added at specific time windows to macrophages. Bacteria were recovered for CFU 
plating at the end of lipid treatment namely 4 h, 8 h, 12 h, 16 h and 24 h post-infection. 
 
Another set of experiments was conducted as before, with the CFU estimated at the end 
of the period of lipid addition (Fig. 7C). Thus, after pre-treatment with EPA, Cer would 
be added for example between 1 and 4 h and the CFU estimated after 4 h. A striking 
result that emerged was that Cer treatment significantly increased the effectiveness of 
the 8-12 h (second) killing period whereas it had no effect when added without the EPA 
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pre-treatment (Fig. 7C and Fig. 6D). Conversely, whereas Cer induced killing between 
16 and 24 h in the absence of pre-EPA treatment (Fig. 6D) the pre-treatment with EPA 
prevents Cer from having an effect during this period (Fig. 7C). Pre-treatment of cells 
for three days with EPA therefore completely re-programs the macrophage response to 
Cer in the context of M. smegmatis infection. 
These experiments make it clear that the different time windows we analysed must 
represent functionally distinct macrophage signalling states, each with its own specific 
response to each lipid. Pre-treatment with EPA seems to set a different ‘clock’ in the 
macrophage. 
 
The links between lipids (ceramide and EPA) and p38 Map kinase activity during 
M. smegmatis infection. 
Since Cer mediated p38 activation could be linked to M. tuberculosis killing we decided 
to investigate this MAP kinase in the context of M. smegmatis infection. The above 
results show that Cer induced killing of M. smegmatis could be modulated by pre-
treatment of the infected macrophages with EPA. In earlier published data we compared 
the kinetics of activation of p38 in cells infected with live or heat-killed M. smegmatis 
52
. An intriguing difference was seen in that the killed bacteria induced a rapid 
activation of p38 that was essentially turned off by 1 h. In contrast, with the live 
bacteria the first activation was not seen until 2h. At 4 h, a period in which the system 
switches from a killing phase to a bacterial growth phase the p38 activity was repressed. 
However, a strong re-activation was seen at 8 h, followed by a low signal at the 24 h 
time point Fig. 8A 5. 
 
 
Figure 8. Ceramide-induced phosphorilation of p38 in J774 macrophages  
(A) Western-blot for phospho-p38 for macrophage infected with M. smegmatis over the time 
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course. (B) After treatment with ceramide of non-infected cells (C: ceramide) or infected cells 
(I: infected) total proteins were probed anti phospho p38 and, after stripped reprobed with anti-
tubulin antibody. Note the blocking on p38 phosphorilation at 8 h post infection in cells treated 
with ceramide. Every group of C I corresponds to ceramide treated cells vs ceramide treated 
cells and infected. The results shown are from three independent experiments. 
 
Here, we first compared the kinetics of activation of p38 in response to Cer in 
uninfected cells and in cells infected with live M. smegmatis (Fig. 8B). In uninfected 
cells the addition of Cer induced a remarkable oscillatory pattern of p38 activation and 
de-activation. There was no activity until 2h, when the p38 activity peaked, followed by 
lower activity of the kinase at 4 h. A strong activation followed at 8 h, as well as at the 
24 h time point, with a weak signal also at 48 h. A similar pattern was seen when Cer 
was added to M. smegmatis-infected cells with one notable exception: the p38-active 8 
h time point seen in uninfected cells treated with Cer, as well as in untreated cells 
infected with M. smegmatis, was completely switched off when Cer was added to 
infected macrophages. The latter result suggested that one of the switches in the system, 
between the generally bacterial friendly 4-8 h phase and the bacteriocidal 8-12 h are 
controlled by p38, in such a way that it can be regulated by Cer. In agreement with this 
hypothesis was the observation that an inhibitor of p38 strongly inhibited the killing 
period 2 (8-12 h) 5. 
 
 
 
Figure 9. Differential lipid induced phosphorylation of p38 in J774 macrophages during 
M. smegmatis infection 
Western-blot for phospho-p38 and total p38 of macrophages infected with M. smegmatis after 8 
h and 24 h is shown. These macrophages did not receive lipid treatment (control) or received 
co-treatment with Cer in different conditions. Ceramide was either added to untreated 
macrophages (+Cer T0) or macrophages treated during 3 days with EPA (Pre/EPA+Cer T0). 
Western-blot for uninfected cells treated with ceramide after 8 and 24 h for phosphorylated and 
total forms of p38 is also shown. 
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In both uninfected and infected cells p38 phosphorylation was not induced by EPA 
addition (Results not shown). We next investigated Cer induced p38 activation in cells 
pre-treated for 3 days with EPA. In uninfected cells, EPA-pre-treatment allowed Cer to 
activate p38 at 8 h as well as at the 24 h time point. In contrast, in infected cells the 
ability of Cer to activate p38 was blocked after 8 h, and completely inhibited after 24 h 
(Fig. 9). This result argues that the anti-inflammatory effect of pre-treatment with EPA 
is in part due to its ability to antagonise the effect of Cer on p38 MAP Kinase 
activation. 
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DISCUSSION 
 
In an earlier study 4 we found a striking effect whereby adding AA or Cer to cells 
infected with non-pathogenic and pathogenic mycobacteria significantly enhanced 
bacterial killing. Conversely, the fish oil lipids (especially EPA) significantly enhanced 
the intracellular growth of virulent strains of M. tuberculosis. The latter experiment 
leads to the interesting conclusion that even in (not classically activated) macrophages 
(in the absence of EPA), although the pathogen multiplies, its ability to do so is still 
repressed to some extent by the innate pro-inflammatory mechanisms of the 
macrophage. The overall anti-inflammatory properties of EPA tend to suppress these 
mechanisms, leading to more growth of the pathogen. The availability of human and 
animal data showing the same effect with Salmonella and M. tuberculosis (see 
Introduction) made it an attractive hypothesis that EPA, increasingly used as a human 
nutritional supplement, should be something avoided in humans infected with 
tuberculosis and other diseases. Dietary lipids are absorbed directly into the body 
(unlike proteins, polysaccharides and nucleic acids). This also made the alternative 
hypothesis, that pro-inflammatory lipids might have therapeutic effects against 
tuberculosis and related diseases, a more interesting hypothesis from a therapeutic 
perspective. 
Our data with both Salmonella and M. tuberculosis in infected mice provided no 
support whatsoever for these hypotheses, with a trend seen towards the opposite results 
to what was predicted. These mice experiments are obviously open to many criticisms, 
including the debate as to whether mouse is, or is not a good model to study 
tuberculosis 53,54 and the fact that we used crude, rather than pure lipids. Due to the 
time-consuming aspect, and expense of these experiments, our data can only be 
considered as preliminary, in that only a limited set of conditions were tested. 
Nevertheless, our data fit nicely into a general pattern of unpredictable results with 
omega-3 lipids in animal models, as comprehensibly discussed by Anderson and Fritche 
31
. 
Our macrophage level experiments provide a strong rationale for expecting the 
unpredictability of EPA, as well as for the pro-inflammatory AA and Cer. While the 
overall trend of the effects of these lipids were similar to our earlier study 4  by adding 
the lipids for more restricted periods all these lipids could induce a pro- or anti-
inflammatory effect, depending on how and when they were added. 
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A recent, detailed analysis of the infection cycle of M. smegmatis in J774 cells gave us 
the first indication that, even with a mycobacterium that can eventually be briefly killed 
by macrophages the interaction between the live bacteria and its host induced a dynamic 
cycle of killing (pro-inflammatory) and growth (anti-inflammatory) phases. Theoretical 
modelling of the infection provided a plausible explanation why cyclical on/off killing 
phases can be more effective for killing than a one-shot program 5. Having defined the 
periodicity of these phases in this system, our goal here was to ask how the pro-
inflammatory AA and Cer, and the anti-inflammatory EPA could influence the system 
when added only at the pro- or the anti-inflammatory phases seen earlier 5, namely 1-4 h 
(pro) 4-8 h (anti), 8-12 h (pro) 12-24 h (pro). Our data here are fully consistent with the 
notion that these phases represent different signalling states of the macrophages. They 
also reveal that the 12-16 and 16-24 h periods are functionally distinct from each other, 
and in general pro-inflammatory (e.g. see Figs. 6A-D and 7B-C). 
By adding the lipids only for a window of time corresponding to the above periods we 
found a striking effect on total killing/survival after 24 h. This first experiment (Fig. 
6A) revealed that EPA only significantly increases M. smegmatis growth when added at 
4-8 h. However, when EPA was added 1 h before infection, until 4 h, it induced a 
massive growth of the bacteria by 24 h. A comparison of Fig. 6A, with Fig. 6B, in 
which the lipids were added as for Fig. 6A but CFU were estimated directly at the end 
of the period of interest,  revealed that the only time in which EPA could significantly 
induce growth was during the 1-4 h period (that was strictly dependent on the 1 h pre-
addition of EPA). So, the 1-4 h period that normally represents a strong killing phase is 
switched to a strongly anti-inflammatory state by a 1 h pre-treatment with EPA. A 
longer pre-treatment with EPA was also able to stimulate growth at 4-8 h (Fig. 7A). 
AA showed a pattern of effects that were quite different to EPA. When added only at 
the different stages and CFU collected after 24 h, it had potent killing-inducing 
properties at all times. However, if added from 1-4 h it did not induce killing, and 
showed a tendency to increase growth (Fig. 6A). This latter effect was more evident 
when the CFU were estimated at the end of the time period when AA was added (Fig. 
6C). This experiment revealed two surprising findings. First, AA could not induce more 
killing during the first 1-4 h killing period (in contrast to Cer). More strikingly, the 
addition of AA during the second killing period (8-12 h) induced a striking increase in 
bacterial growth in this period (Fig. 6C). Thus, although AA addition at 8-12 h led to an 
overall increase in killing at 24 h it induced a 5-fold increase in growth between 8-12 h 
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relative to the un-treated control.  This figure shows clearly that the killing effects of 
AA are restricted to 4-8 h, 12-16 h and 16-24 h. 
The effects of the second pro-inflammatory lipid Cer were quite different to what was 
seen with AA. In Fig. 6A Cer induced a significant increase in killing after 24 h when it 
was added at any of the time periods tested, with one notable exception. When added 
during the 8-12 h period it had no effect on overall growth over 24 h. However, when 
the CFU were estimated at the end of the period of Cer addition, (Fig. 6D), there was a 
striking difference to what was observed with AA (Fig. 6C). Only when added 1-4 h or 
16-24 h could it induce significantly more killing with a trend to reverse the killing 
between 4 and 8 h. 
Given the striking effect of pre-treatment of cells with EPA it was interesting to ask 
how this treatment affected the response to Cer (Fig. 7B). Under this condition, the 
addition of Cer between 8-12 h, that had no effect without EPA pre-treatment (Fig. 6A) 
was able to induce a strong killing effect during this period, in effect enhancing the 
innate killing ability of the macrophage during this period. So the pre-treatment with 
EPA that strongly favours bacterial growth between 8 and 12 h (as well as between 12-
16 and 16-24 h) induces Cer to become more pro-inflammatory. This experiment is one 
of many that we would cite in support of the utter unpredictability of the effects of these 
lipids, which are even more striking when used in combination. 
The cyclical phase of killing/growth seen with M. smegmatis can also be seen during 
infection with M. tuberculosis and M. bovis (Jordao unpublished results). Here the 
length of the phases is longer than with M. smegmatis, observable over days, rather than 
hours, and presumably related to the longer doubling time of these bacteria (24 h) 
relative to M. smegmatis (3h). For these bacteria we carried out a more limited set of 
experiments to see how the addition of lipids during these different phases affected the 
pattern of growth or killing of M. tuberculosis. We first compared the effect of pre-
treatment of cells with EPA, AA (Fig. 2A) or Cer (Fig. 3). Pre-treatment with EPA led 
to increased growth of M. tuberculosis up to 9 days infection whereas pre-treatment 
with AA had a striking effect in increasing killing. In contrast, pre-treatment with Cer 
showed no effects until after 3 days, with continued increase in killing until day 5. 
However, by day 7 a paradoxical increase in growth, relative to the untreated control 
was seen, again a striking example of unpredictability of the effects and the ability of 
lipid treatment to switch the inflammatory state of the macrophage. 
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When the lipids were added at the end of the 3 h infection period and left on the 
cultures, the pattern of effects was completely different to the pre-treatment. EPA 
showed a tendency to increase killing of M. tuberculosis after day 1 but it led to a five-
fold increase in bacteria by day 3, with little effect thereafter (Fig. 2B). When AA was 
added post-infection it had a striking killing effect at all times (Fig. 2B). In this 
experiment Cer behaved similarly to AA, with a tendency for killing at all times. 
Our data revealed that one of the key regulators of a number of the switches between the 
pro- and anti-inflammatory response that were influenced by EPA and Cer was p38 
MAP Kinase. We had earlier described activity of these enzyme cycles in relation to M. 
smegmatis infection phases 48 and, using a p38 inhibitor, we provided evidence that the 
activity of p38 could facilitate either macrophage killing capacity, or the growth of M. 
smegmatis (8-12 h), depending on when the inhibitor was added. Our data here show 
that Cer inhibited the normal 8 h activation of p38 by M. smegmatis-infected cells. They 
also show that the pre-treatment of cells by EPA allows some activation of p38 by Cer, 
relative to cells only treated with Cer. More strikingly, the pre-EPA treatment blocks the 
ability of Cer to activate the system over 24 h (Fig. 1C). AA was also a potent 
stimulator of p38 in uninfected macrophages at periods from 3h to 5 days (Fig. 4). 
The ability of pathogenic mycobacteria to block MAP Kinase, including p38 activity 
has been well documented 55-58 for M. tuberculosis and M.avium. We could confirm this 
result for M. tuberculosis at 24 h (Fig. 4). This inhibition could not be overcome by AA 
treatment at the start of infection nor, after 3 days infection when Cer was added; Cer 
could, however, transiently overcome the block transient between the 3h and 1day 
period. Since both AA and Cer are potent inducers of M. tuberculosis (and M.avium) 
killing over a 7-14 day period 4, when p38 is switched off, this argues clearly that p38 
activation is not essential for these killing events. Thus, while p38 plays a crucial role in 
the killing and growth phases of M.smegmatis (up to 48 h) in macrophages, it deos not 
regulate the longer-term killing growth phases in the M. tuberculosis-infected 
macrophages. 
We could, however, make a more positive molecular connection between the effects of 
EPA, AA and Cer to the pro-and anti-inflammatory responses in M. tuberculosis-
infected macrophages when we investigated TNF-α release. As mentioned, the synthesis 
and release of this cytokine tends to correlate with pathogenicity, with non-pathogens 
inducing higher release than the pathogens. High TNF-α secretion leads to the activation 
of signalling by its receptor that somehow facilitates killing. We found that after pre-
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treatment with EPA, there was less TNF-α released whereas pre-treatment with AA, but 
not Cer, induced more secretion of TNF-α after day 3. Post-infection treatment with 
EPA had no effect while post-treatment with both AA and Cer significantly increased 
TNF-α level at day 1. These data argue that synthesis or secretion of TNF-α is one 
mechanism that is targeted by EPA, AA and Cer. The mechanism by which TNF-α 
facilitates mycobacterial killing is still to be defined. 
An interesting picture emerges from this work. The infection of macrophages with live 
non-pathogenic (or pathogenic) mycobacteria induces a dynamical system that switches, 
clock-like from pro-to-anti-to-pro-inflammatory signalling states, including two 
consecutive, but differently regulated killing phases (12-16 h and 16-24 h). Overall, the 
pro-state facilitates host killing while the anti-state facilitates pathogen survival and 
growth. Specific and reproducible albeit unpredictable and often counter-intuitive 
effects of EPA, Cer and AA could be observed in switching one state into the other. We 
will need to understand the networking properties of the signalling networks in order to 
interpret these switches, which is currently beyond our means. Given the complexity of 
the responses at the macrophage level, it seems difficult to imagine a clear rationale for 
suggesting a lipid-diet that could lead to a potential therapy against M. tuberculosis, or 
for making any conclusions as to whether the omega-3 lipids should be avoided in the 
diet. 
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MATERIALS AND METHODS 
 
Bacterial strain and growth conditions: The virulent Salmonella enterica serovar 
Typhimurium strain ATCC 14028 was routinely grown at 37°C in brain heart infusion 
(BHI) broth or agar (Difco). For challenge studies, bacteria were grown in 250 ml 
Erlenmeyer flasks at 37°C with gentle shaking (50 rpm) until they reach an OD600 of 
approximately 0.8 (middle exponential growth phase). Then, they were harvested by 
centrifugation (3,000 x g) and resuspended in 5% bicarbonate buffer. The number of 
viable bacteria was evaluated by plating serially diluted samples on BHI agar plates.  
M. smegmatis mc2155 was grown in medium containing Middlebrook’s 7H9 broth 
Medium (Difco), Nutrient broth (Difco) (4.7 g and 5 g per litre, respectively), 
supplemented with 0.5% glucose and 0.05% Tween 80 at 37°C on a shaker at 220 r.p.m. 
Bacteria were subcultured every day in fresh medium for 7–10 days before use in 
infection studies. M. tuberculosis H37Rv was grown in Middlebrock 7H9 medium 
(Difco) and was maintained as described before 4. For CFU experiments bacteria was 
platted on Middlebrook’s 7H10.  All M. tuberculosis culture conditions where 
supplemented with 10% OADC (Difco).  
 
Animals and diets: All investigations involving animals were conducted in conformity 
with Public Health Service Policy on Human Care and Use of Laboratory Animals, 
incorporated in the Institute for Laboratory Animal Research Guide for Care and Use of 
Laboratory Animals. All investigations were approved by appropriate National 
Institutional Committees. 
For Salmonella infection, female BALB/c (H-2d) mice (10 weeks old) were purchased 
from Harlan-Winkelmann GmbH (Borchen, Germany) and treated according to local 
and European Community guidelines. Animals received a fat-free diet for one week, 
then, they were divided into three groups, which received the following diets: (i) 3.5 % 
of soy oil (normal fat content), (ii) 10 % of sunflower oil (i.e., omega 6), and (iii) 10 % 
of menhaden oil (i.e., omega 3). Food lots were fractioned and conserved at 4°C, and 
the food pellets were changed daily to preserve lipid content and properties. 
For M. tuberculosis infection, 6-8 week old female BALB/c mice were fed with low fat 
diet supplemented or not with 10 % safflower oil (i.e., omega 6), or 10 % Ropufa (i.e., 
omega 3). Special diets started 2 weeks before infection and were maintained during the 
course of infection. 
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Challenge experiments: After five weeks on the fat-specific diets, mice were gently 
feed with a suspension of the S. enterica serovar Typhimurium strain ATCC 14028 in 
bicarbonate buffer (20 µl containing 5x106 bacteria/mouse; lethal dose 50 (LD50) by oral 
route 4.2x105). To evaluate bacterial invasion, survival and in vivo dissemination, three 
mice from each group were sacrificed by CO2 inhalation on days 3 and 7. Spleen, liver, 
Peyer’s Patches and mesenteric lymph nodes were aseptically removed, weighed and 
homogenized in sterile PBS. The number of viable bacteria present in the organs was 
determined by plating appropriate dilutions on BHI agar plates. The results were 
expressed as number of CFU/g of tissue. 
For M. tuberculosis H37Rv experiments, after two weeks receiving fat specific diets, 
mice were infected intranasally with 103 CFU of bacilli. Five mice were used per time-
point. One, 21, and 63 days after infection, mice were sacrificed and lungs and spleen 
were collected, homogenized and serial dilutions of homogenates were plated onto 
7H11 agar medium. Plates were incubated for at 37°C for 3 weeks and CFU were 
scored. 
 
For M. tuberculosis H37Rv experiments, after two weeks receiving fat specific diets, 
mice were infected intranasally with 103 CFUs of bacilli. Five mice were used per time-
point. One, 21, and 63 days after infection, mice were sacrificed and lungs and spleen 
were collected, homogeneized and serial dilutions of homogeneates were plated onto 
7H11 agar medium. Plates were incubated for at 37°C for 3 weeks and CFUs were 
scored. 
 
Cell line, macrophage infection and survival experiments: The mouse macrophage 
cell line J774A.1 was cultured as described previously 4. Bacterial cultures in 
exponential growth phase were pelleted, washed twice in PBS pH 7.4 and re-suspended 
in DMEM medium. Clumps of bacteria were removed by ultrasonic treatment of 
bacteria suspensions in a ultrasonic water bath for 15 min followed by a low speed 
centrifugation (120 g) for 2 min. Single cell suspension was verified by light 
microscopy. 
J774 cells were seeded onto 24 well tissue culture plates at a density of 0.5x105 cells per 
well and were incubated for 2 days until 90% confluency and infected with bacteria. To 
achieve more than five bacilli per macrophage after 1 h uptake, a multiplicity of 
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infection of 100:1 was used (OD600 ∼0.1). In each experiment using M. smegmatis, 
after 1 h infection gentamicin (10 µg ml−1) was added in order to prevent extracellular 
multiplication of the remaining non-uptaked bacteria (Anes et al., 2006). Intracellular 
viable bacteria were recovered from infected macrophages as described in Anes et al., 
2006 5. A similar procedure was used for M. tuberculosis but instead of 1 h uptake we 
used 3h uptake.In all experiments described the errors reported are the standard 
deviations from at least three separate experiments. For all lipid treatments the stock 
lipids were dissolved in ethanol (1mg/ml). In all experiments the lipid at the following 
empirically determined optimal final concentrations: 125µM AA, 15µM EPA, 5µM Cer 
(mixture of bovine brain ceramides; all from Sigma) Solvent without lipids was 
routinely tested. TNF-α was assessed in culture supernatants following the mouse 
Quantitine TNF-α kit instructions from R&D. 
 
Preparation of whole cell extracts and immunoblot analysis: When needed lipid 
treatment was performed as described under Cell line, macrophage infection and 
survival experiments. Cells where washed twice with PBS and lysed in IP buffer (50 
mM Tris pH 7.5, 150 mM sodium chloride, 1 mM EDTA, 1 mM EGTA, 1% NP-40 and 
protease inhibitors) at 4°C for 30 min. The extracts were sonicated in 5 s bursts until 
complete homogenization and centrifuged at 13000 g for 10 min to remove cell debris. 
Equal amounts of protein were loaded on a 12% SDS-PAGE, transferred to 
nitrocellulose membrane and probed with a rabbit antiphospho p38 and anti total p38 
(Cell Signaling Technology). Enhanced chemi-luminescence (Pierce biotechnology) 
was used to visualize antibody binding. Total p38 was used to assess the amount of total 
protein in the different membrane isolates. 
 
Statistical analysis: The statistical significance of the differences observed in bacterial 
loads was analyzed by the Student’s t-test, whereas those from the mice survival studies 
were analyzed using the logrank test. Differences were considered significant at P<0.05. 
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A better understanding of mycobacteria interaction with the host cell could provide 
valorous tools for TB treatment. Although mycobacteria interference with host defence 
is well documented the molecular mechanisms underlying it are poorly elucidated. Our 
knowledge of the exact position occupied by mycobacteria phagosome in the endosomal 
continuum as well as its luminal and membrane composition is also scarce.  
While it is consensual that mycobacteria uptake triggers several defence mechanisms 
the relevance of each one in infection resolution is not. For example, phagosome 
maturation into phagolysosome is pointed as a key mechanism in pathogen clearance so 
the ability of pathogenic mycobacteria to avoid it is seen as crucial for their success. 
Nevertheless, other mechanisms such as RNI and ROI production are regarded as minor 
players in mycobacterial infection clearance.  
All together our data show that mycobacteria uptake triggers a complex macrophage 
defence program in which different bactericidal mechanisms are sequentially activated. 
The mechanisms and the order in which they are activated are independent of the 
mycobacteria uptaken. In the early stage of infection NO plays a crucial role in mice 
macrophages but it is absent both in human and bovine macrophages. Although 
mycobacteria killing can occur in immature phagosomes it is more efficient in acidified 
compartments probably due to synergistic effects with proteases and RNI.  Since all 
mycobacteria are exposed to the same defence program and have different fates their 
pathogenicity play an important role. Pathogenic mycobacteria are more resistant to 
effectors molecules as NO and protons. 
When macrophages were fed with heat killed mycobacteria we faced a completely 
different scenario. Although these bacteria are more efficiently uptaken they trigger a 
weaker production of NO and RNI, produce a different pattern of p38 MAP kinase and 
lack the ability to avoid phagosome maturation into phagolysosome. These results 
suggest that further studies to elucidate the differential mechanisms of live/dead 
mycobacteria uptake are needed. The analysis of both host and mycobacteria up and 
down regulated in both conditions can also provide clues for further elucidation of this 
enigma.  
In the present study we clearly show that intracellular mycobacteria live in membrane 
surrounded compartments at all stages of infection. This observation is valid for all host 
macrophage and mycobacteria strains used regardless of host and mycobacteria 
virulence. Nevertheless, mycobacteria phagosome is a complex and dynamic structure 
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that acquires and recycles a vast number of phagosome maturation markers during its 
lifetime. The acquisition of most of these markers is regulated by the p38 MAP kinase. 
This kinase plays an important role in the regulation of actin assembly by phagosome 
membrane which is important for phagosome maturation and mycobacteria killing. It 
was also shown that the activity of this kinase could be modulated by dietary lipids.  
All the lipids that enhance p38 activation increase mycobacteria killing and lipids that 
block this kinase activity enhance mycobacteria survival at the macrophage level. 
Nevertheless, when we step-forward in complexity moving from a cellular model to an 
animal (model) we could not confirm our prediction. Several factors such as the use of 
lipid sources instead of raw lipids, amount of lipid effectively delivered to the target 
organ and/or cell, genetic background of the animal model, conditions of mycobacteria 
infection and others contribute for this disappointing result.  Nevertheless it also clearly 
showed us the need to establish a model of intermediate complexicity for example 
comprising different cells known to play an important role in tuberculosis. The most 
obvious system would be formed by macrophages and dendritic cells the most 
important effector and presenting cell in tuberculosis pathogenesis. Another alternative 
would be a more efficient delivery of lipids to target organs and cells modifying their 
distribution in the animal model. This goal could be accomplished by using liposome or 
nanosome formulations of lipids that present as a plus the possibility of enhancing lipid 
stability by including anti-oxidants. 
 
 
 
 
 
 
 
